>

Microba Research Discovery Report

Analysis: Aim 2 Longitudinal Fibre Intake Effect

Functional profiles: MetaCyc Pathway

Quantitative visualisation of the top most abundant microbial functions identified in the analysed samples.

Scaled heatmap of most abundant features ordered by study group

Features were filtered by mean abundance. Samples were first ordered by study group and then clustered within each study group. Abundances were scaled to a max value of 1. Color scale shows not-detected (white), and abundance ranging from low (blue) to high (yellow).

Click here to open full-sized image in new window.

Heatmap of most abundant features ordered by study group

Features were filtered by mean abundance. Samples were first ordered by study group and then clustered within each study group. Color scale shows not-detected (white), and abundance ranging from low (blue) to high (yellow).

Click here to open full-sized image in new window.

Scaled heatmap of all features

Profiles were clustered by hierarchical clustering. Abundances were scaled to a max value of 1. Color scale shows not-detected (white), and abundance ranging from low (blue) to high (yellow).

Click here to open full-sized image in new window.

Heatmap of all features

Profiles were clustered by hierarchical clustering. Color scale shows not-detected (white), and abundance ranging from low (blue) to high (yellow).

Click here to open full-sized image in new window.

Scaled heatmap of top most abundant features filtered by mean abundance

Profiles were clustered by hierarchical clustering. Abundances were scaled to a max value of 1. Color scale shows not-detected (white), and abundance ranging from low (blue) to high (yellow).

Click here to open full-sized image in new window.

Heatmap of top most abundant features filtered by mean abundance

Profiles were clustered by hierarchical clustering. Color scale shows not-detected (white), and abundance ranging from low (blue) to high (yellow).

Click here to open full-sized image in new window.

Scaled heatmap of top most abundant features filtered by max abundance

Profiles were clustered by hierarchical clustering. Abundances were scaled to a max value of 1. Color scale shows not-detected (white), and abundance ranging from low (blue) to high (yellow).

Click here to open full-sized image in new window.

Heatmap of top most abundant features filtered by max abundance

Profiles were clustered by hierarchical clustering. Color scale shows not-detected (white), and abundance ranging from low (blue) to high (yellow).

Click here to open full-sized image in new window.

Scaled heatmap of top most variable features

Profiles were clustered by hierarchical clustering. Abundances were scaled to a max value of 1. Color scale shows not-detected (white), and abundance ranging from low (blue) to high (yellow).

Click here to open full-sized image in new window.

MetaCyc Pathway

Functional Alpha Diversity

This page provides an overview of the functional alpha diversity of the analysed sample. Alpha diversity was measured using the Shannon index and functional richnes. Richness measures the total number of gene functions present in each sample. Shannon index combines richness and evenness.

Methods:

Shannon diversity was compared using linear mixed effect regression, including Participant as a random effect (intercept), and Fibre_Intake, Treatment, and Fibre_Intake vs Treatment as fixed effects. Effect tested: Fibre_Intake vs Treatment. Richness was compared using linear mixed effect regression, including Participant as a random effect (intercept), and Fibre_Intake, Treatment, and Fibre_Intake vs Treatment as fixed effects. Effect tested: Fibre_Intake vs Treatment. Data was rarefied to 16649 reads.

Index: Richness

Index: Shannon index

Summary Table

Index rarefiedTo P lmer treatment effect (interaction) Mean Pos Mean Abundance Median Abundance Mean Fibre_Intakelow:Treatmentpre_treatment Median Fibre_Intakelow:Treatmentpre_treatment SD Fibre_Intakelow:Treatmentpre_treatment Mean Fibre_Intakelow:Treatmentpost_treatment Median Fibre_Intakelow:Treatmentpost_treatment SD Fibre_Intakelow:Treatmentpost_treatment Fold Change Log2(Fibre_Intakelow:Treatmentpost_treatment/Fibre_Intakelow:Treatmentpre_treatment) Positive samples Positive Fibre_Intakelow:Treatmentpre_treatment Positive Fibre_Intakelow:Treatmentpost_treatment Positive_Fibre_Intakelow:Treatmentpre_treatment_percent Positive_Fibre_Intakelow:Treatmentpost_treatment_percent Mean Fibre_Intakehigh:Treatmentpre_treatment Median Fibre_Intakehigh:Treatmentpre_treatment SD Fibre_Intakehigh:Treatmentpre_treatment Mean Fibre_Intakehigh:Treatmentpost_treatment Median Fibre_Intakehigh:Treatmentpost_treatment SD Fibre_Intakehigh:Treatmentpost_treatment Fold Change Log2(Fibre_Intakehigh:Treatmentpost_treatment/Fibre_Intakehigh:Treatmentpre_treatment) Positive Fibre_Intakehigh:Treatmentpre_treatment Positive Fibre_Intakehigh:Treatmentpost_treatment Positive_Fibre_Intakehigh:Treatmentpre_treatment_percent Positive_Fibre_Intakehigh:Treatmentpost_treatment_percent
Shannon 16649 0.12 5.3 5.3 5.3 5.4 5.3 0.18 5.3 5.3 0.19 -0.027 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 5.3 5.3 0.1 5.3 5.3 0.13 0 11 / 11 (100%) 11 / 11 (100%) 1 1
Richness 16649 0.38 400 400 390 430 390 80 410 370 90 -0.069 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 390 390 33 390 390 39 0 11 / 11 (100%) 11 / 11 (100%) 1 1
Download diversity values in csv format . On some platforms (including Windows) you may need to change the suffix from .txt or .html to .csv before opening the file in a spreadsheet program, like Excel.

Functional clustering and ordination

Microbial functions were analyzed using supervised and unsupervised multivariate techniques. Functional profiles were ordinated using the unsupervised methods Principal Coordinates Analysis (PCoA), Non-Metric Multidimensional Scaling (NMDS) and Principal Component Analysis (PCA). The supervised methods Adonis and Redundancy analysis (RDA) were used to assess if variance in the functional profiles was significantly associated with the study condition. A guide explaining these methods can be found here. Sparse Partial Least Square Discriminant Analysis (sPLS-DA) from the MixMc package was additionaly used to extract features associated with the condition of interest.

Unsupervised ordination




Interactive PCA (clr transformed)

Please click here to view an interactive 3D PCA.

MetaCyc Pathway

Univariate analysis of microbial functions

Differentially abundant microbial functions were identified using the univariate methods ANOVA or LMER (linear mixed effect regression) on clr transformed relative abundance data, Fisher's exact test, and Aldex2 (ANOVA-like Differential Expression). Aldex2 was run on read count data. Fisher's exact test was used to test for diffrerences in the presence and absence (detection rate) of microbial functions across study groups.

LMER is used for repeated measures data, using random effects to control for correlation between samples from the same subject. Fixed effects are included for treatment groups, time, and treatment over time, where appropriate. The LMER P values correspond to a nested model test of the significance of including the corresponding fixed effect.

ALDEx2 uses subsampling (Bayesian sampling) to estimate the underlying technical variation. For each subsample instance, center log-ratio transformed data is statistically compared across study groups and computed P values are corrected for multiple testing using the Benjamini–Hochberg procedure. The expected P value (mean P value) is reported, which are those that would likely have been observed if the same samples had been run multiple times. The expected values are reported for both the distribution of P values and for the distribution of Benjamini–Hochberg corrected values.

Function P lmer study group effect (sqrt) FDR lmer study group effect (sqrt) Pbonf lmer study group effect (sqrt) P lmer time effect (sqrt) FDR lmer time effect (sqrt) Pbonf lmer time effect (sqrt) P lmer treatment effect (interaction) (sqrt) FDR lmer treatment effect (interaction) (sqrt) Pbonf lmer treatment effect (interaction) (sqrt) P lmer study group effect (clr) FDR lmer study group effect (clr) Pbonf lmer study group effect (clr) P lmer time effect (clr) FDR lmer time effect (clr) Pbonf lmer time effect (clr) P lmer treatment effect (interaction) (clr) FDR lmer treatment effect (interaction) (clr) Pbonf lmer treatment effect (interaction) (clr) Mean Pos Mean Abundance Median Abundance Mean Fibre_Intakelow:Treatmentpre_treatment Median Fibre_Intakelow:Treatmentpre_treatment SD Fibre_Intakelow:Treatmentpre_treatment Mean Fibre_Intakelow:Treatmentpost_treatment Median Fibre_Intakelow:Treatmentpost_treatment SD Fibre_Intakelow:Treatmentpost_treatment Fold Change Log2(Fibre_Intakelow:Treatmentpost_treatment/Fibre_Intakelow:Treatmentpre_treatment) Positive samples Positive Fibre_Intakelow:Treatmentpre_treatment Positive Fibre_Intakelow:Treatmentpost_treatment Positive_Fibre_Intakelow:Treatmentpre_treatment_percent Positive_Fibre_Intakelow:Treatmentpost_treatment_percent Mean Fibre_Intakehigh:Treatmentpre_treatment Median Fibre_Intakehigh:Treatmentpre_treatment SD Fibre_Intakehigh:Treatmentpre_treatment Mean Fibre_Intakehigh:Treatmentpost_treatment Median Fibre_Intakehigh:Treatmentpost_treatment SD Fibre_Intakehigh:Treatmentpost_treatment Fold Change Log2(Fibre_Intakehigh:Treatmentpost_treatment/Fibre_Intakehigh:Treatmentpre_treatment) Positive Fibre_Intakehigh:Treatmentpre_treatment Positive Fibre_Intakehigh:Treatmentpost_treatment Positive_Fibre_Intakehigh:Treatmentpre_treatment_percent Positive_Fibre_Intakehigh:Treatmentpost_treatment_percent
PWY-5481~pyruvate fermentation to (S)-lactate 0.045 0.8 1 0.4 1 1 0.11 0.88 1 0.074 0.68 1 0.18 0.85 1 0.063 0.8 1 0.013 0.013 0.014 0.011 0.0093 0.0034 0.012 0.013 0.0046 0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.015 0.014 0.0057 0.013 0.014 0.0029 -0.21 11 / 11 (100%) 11 / 11 (100%) 1 1
P108-PWY~pyruvate fermentation to propanoate I 0.055 0.8 1 0.036 1 1 0.013 0.64 1 0.0045 0.53 1 0.018 0.82 1 0.017 0.68 1 0.002 0.00079 0 0.0011 0.00055 0.001 0.00038 0 0.00066 -1.5 14 / 36 (39%) 6 / 7 (86%) 3 / 7 (43%) 0.857 0.429 0.00036 0 0.0011 0.0013 0 0.003 1.9 2 / 11 (18%) 3 / 11 (27%) 0.182 0.273
CITRULLINE-DEG-PWY~L-citrulline degradation 0.63 0.87 1 0.51 1 1 0.85 0.99 1 0.28 0.7 1 0.071 0.85 1 0.13 0.8 1 0.019 0.019 0.02 0.019 0.018 0.0027 0.02 0.019 0.005 0.074 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.019 0.019 0.0035 0.02 0.021 0.0037 0.074 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5084~2-oxoglutarate decarboxylation to succinyl-CoA 0.43 0.82 1 0.94 1 1 0.44 0.92 1 0.75 0.9 1 0.53 0.92 1 0.17 0.8 1 0.0016 0.00018 0 0.00039 0 0.001 0.00037 0 0.00099 -0.076 4 / 36 (11%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 8.1e-05 0 0.00027 8.1e-06 0 2.7e-05 -3.3 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
PWY-7183~pyrimidine nucleobases salvage I 0.17 0.8 1 0.58 1 1 0.93 0.99 1 0.17 0.68 1 0.59 0.92 1 0.31 0.88 1 0.012 0.012 0.011 0.011 0.011 0.0013 0.01 0.01 0.0024 -0.14 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.013 0.011 0.0044 0.012 0.013 0.0025 -0.12 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5026~indole-3-acetate biosynthesis V (bacteria and fungi) 0.48 0.82 1 0.36 1 1 0.55 0.99 1 0.47 0.81 1 0.42 0.92 1 0.54 0.88 1 0.00049 0.00029 0.00012 0.00012 0.00012 0.00014 0.00031 0.00012 0.00044 1.4 21 / 36 (58%) 4 / 7 (57%) 4 / 7 (57%) 0.571 0.571 0.00033 9.5e-05 0.00065 0.00032 0.00023 0.00034 -0.044 7 / 11 (64%) 6 / 11 (55%) 0.636 0.545
PWY-6385~peptidoglycan biosynthesis III (mycobacteria) 0.25 0.8 1 0.48 1 1 0.38 0.91 1 0.13 0.68 1 0.21 0.87 1 0.17 0.8 1 0.0098 0.0098 0.008 0.0076 0.0073 0.0018 0.009 0.0081 0.0036 0.24 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.0076 0.011 0.01 0.0096 0.0047 -0.14 11 / 11 (100%) 11 / 11 (100%) 1 1
COBALSYN-PWY~superpathway of adenosylcobalamin salvage from cobinamide I 0.83 0.93 1 0.92 1 1 0.65 0.99 1 0.56 0.85 1 0.52 0.92 1 0.76 0.93 1 0.0048 0.0048 0.0047 0.0047 0.0046 0.00071 0.0048 0.004 0.0022 0.03 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0047 0.0044 0.0018 0.005 0.0056 0.0019 0.089 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5653~NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde 0.62 0.86 1 0.6 1 1 0.98 0.99 1 0.34 0.71 1 0.17 0.85 1 0.41 0.88 1 0.0092 0.0092 0.0094 0.0086 0.0093 0.0023 0.0093 0.0083 0.0032 0.11 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0092 0.0096 0.003 0.0096 0.0099 0.0013 0.061 11 / 11 (100%) 11 / 11 (100%) 1 1
ARABCAT-PWY~L-arabinose degradation I 0.83 0.93 1 0.044 1 1 0.033 0.76 1 0.54 0.84 1 0.015 0.82 1 0.011 0.68 1 0.0042 0.0042 0.0029 0.0036 0.0039 0.0021 0.0056 0.0048 0.0029 0.64 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0045 0.0025 0.0057 0.0034 0.0025 0.0026 -0.4 11 / 11 (100%) 11 / 11 (100%) 1 1
SERSYN-PWY~L-serine biosynthesis I 0.2 0.8 1 0.51 1 1 0.29 0.91 1 0.13 0.68 1 0.2 0.86 1 0.14 0.8 1 0.011 0.011 0.0095 0.0087 0.0085 0.0014 0.01 0.0095 0.0034 0.2 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.012 0.012 0.0086 0.01 0.011 0.0033 -0.26 11 / 11 (100%) 11 / 11 (100%) 1 1
SORBDEG-PWY~D-sorbitol degradation II 0.72 0.89 1 0.16 1 1 0.48 0.97 1 0.98 1 1 0.82 0.98 1 0.26 0.87 1 0.0012 0.0012 0.00092 0.00083 0.00083 0.00043 0.0016 0.0012 0.0016 0.95 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.00076 0.00081 0.00047 0.0015 0.0016 0.00077 0.98 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5198~factor 420 biosynthesis 0.65 0.88 1 0.63 1 1 0.63 0.99 1 0.98 1 1 0.96 1 1 0.97 0.99 1 0.00022 2.4e-05 0 3.8e-05 0 1e-04 1.2e-05 0 3.2e-05 -1.7 4 / 36 (11%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 1.9e-05 0 6.3e-05 2.8e-05 0 9.4e-05 0.56 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
NAD-BIOSYNTHESIS-III~NAD biosynthesis III (from nicotinamide) 0.82 0.93 1 0.52 1 1 0.78 0.99 1 0.84 0.94 1 0.86 0.99 1 0.47 0.88 1 0.00019 1.6e-05 0 2.8e-05 0 7.5e-05 6.6e-06 0 1.8e-05 -2.1 3 / 36 (8.3%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 2.9e-05 0 9.5e-05 0 0 0 -Inf 1 / 11 (9.1%) 0 / 11 (0%) 0.0909 0
PWY-6620~guanine and guanosine salvage 0.052 0.8 1 0.55 1 1 0.42 0.91 1 0.93 0.98 1 0.38 0.92 1 0.61 0.89 1 0.0094 0.0094 0.0097 0.01 0.01 0.0015 0.0099 0.01 0.0011 -0.014 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0088 0.0088 0.0023 0.0091 0.0097 0.0017 0.048 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-40~putrescine biosynthesis I 0.12 0.8 1 0.0083 0.79 1 0.003 0.54 1 0.68 0.9 1 0.032 0.83 1 0.032 0.68 1 0.006 0.0058 0.0049 0.0076 0.0058 0.005 0.0043 0.0034 0.0032 -0.82 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0048 0.0043 0.0025 0.0066 0.0052 0.0034 0.46 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7969~5-hydroxybenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 0.48 0.82 1 0.62 1 1 0.32 0.91 1 0.75 0.9 1 0.7 0.93 1 0.87 0.96 1 0.0049 0.0049 0.0047 0.0051 0.0046 0.00092 0.0049 0.0042 0.0019 -0.058 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0046 0.0048 0.0017 0.0052 0.0051 0.002 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7226~guanosine deoxyribonucleotides de novo biosynthesis I 0.7 0.89 1 0.56 1 1 0.86 0.99 1 0.95 0.98 1 0.85 0.99 1 0.43 0.88 1 0.0017 0.0014 0.00066 0.0016 0.00076 0.0017 0.0011 0.00085 0.0012 -0.54 29 / 36 (81%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0012 0.00065 0.0017 0.0016 0.00016 0.0028 0.42 10 / 11 (91%) 7 / 11 (64%) 0.909 0.636
PWY-6317~D-galactose degradation I (Leloir pathway) 0.18 0.8 1 0.85 1 1 0.57 0.99 1 0.14 0.68 1 0.48 0.92 1 0.77 0.93 1 0.023 0.023 0.022 0.02 0.019 0.004 0.02 0.021 0.0057 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.024 0.024 0.01 0.025 0.026 0.0039 0.059 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6387~UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (meso-diaminopimelate containing) 0.43 0.82 1 0.72 1 1 0.78 0.99 1 0.23 0.68 1 0.42 0.92 1 0.46 0.88 1 0.017 0.017 0.017 0.016 0.015 0.0028 0.016 0.015 0.0042 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.018 0.017 0.0068 0.018 0.018 0.0025 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6964~ammonia assimilation cycle II 0.68 0.88 1 0.73 1 1 0.37 0.91 1 0.35 0.72 1 0.41 0.92 1 0.83 0.95 1 0.044 0.044 0.045 0.042 0.042 0.0064 0.041 0.042 0.0089 -0.035 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.045 0.047 0.015 0.047 0.045 0.0055 0.063 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6619~adenine and adenosine salvage VI 0.43 0.82 1 0.88 1 1 0.67 0.99 1 0.33 0.71 1 0.6 0.92 1 0.88 0.96 1 3e-04 0.00011 0 7.5e-05 0 0.00014 0.00012 0 0.00032 0.68 13 / 36 (36%) 2 / 7 (29%) 1 / 7 (14%) 0.286 0.143 0.00014 0 0.00018 8.7e-05 0 0.00012 -0.69 5 / 11 (45%) 5 / 11 (45%) 0.455 0.455
PWY-7663~gondoate biosynthesis (anaerobic) 0.89 0.95 1 0.93 1 1 0.13 0.88 1 0.53 0.84 1 0.99 1 1 0.22 0.82 1 0.0045 0.0045 0.0033 0.0035 0.0034 0.0031 0.004 0.0027 0.0043 0.19 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0039 0.0029 0.0043 0.0061 0.0042 0.0045 0.65 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6828~linezolid resistance 0.49 0.82 1 0.43 1 1 0.56 0.99 1 0.2 0.68 1 0.82 0.98 1 0.94 0.98 1 0.00024 0.00011 0 0.00012 0 3e-04 2.1e-05 0 3.7e-05 -2.5 16 / 36 (44%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 0.00012 8e-05 0.00022 0.00014 0 0.00021 0.22 7 / 11 (64%) 5 / 11 (45%) 0.636 0.455
PWY0-1296~purine ribonucleosides degradation 0.2 0.8 1 0.55 1 1 0.83 0.99 1 0.91 0.98 1 0.54 0.92 1 0.32 0.88 1 0.01 0.01 0.01 0.012 0.012 0.0027 0.011 0.011 0.0031 -0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0099 0.0098 0.0031 0.0095 0.0092 0.0029 -0.06 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6578~8-amino-7-oxononanoate biosynthesis III 0.98 0.99 1 0.12 1 1 0.27 0.91 1 0.93 0.98 1 0.082 0.85 1 0.19 0.82 1 0.00033 0.00016 0 0.00017 0.00016 2e-04 8.1e-05 0 0.00021 -1.1 17 / 36 (47%) 4 / 7 (57%) 1 / 7 (14%) 0.571 0.143 0.00019 2.8e-05 0.00026 0.00016 5.9e-05 0.00022 -0.25 6 / 11 (55%) 6 / 11 (55%) 0.545 0.545
PWY0-1182~trehalose degradation II (cytosolic) 0.41 0.82 1 0.22 1 1 0.088 0.88 1 0.37 0.73 1 0.35 0.92 1 0.33 0.88 1 0.002 0.0014 0.00059 0.0015 0.00096 0.0014 0.00085 0.00048 0.0012 -0.82 25 / 36 (69%) 6 / 7 (86%) 5 / 7 (71%) 0.857 0.714 0.00099 0.00052 0.0013 0.002 8e-04 0.0033 1 7 / 11 (64%) 7 / 11 (64%) 0.636 0.636
ASPARAGINE-DEG1-PWY-1~L-asparagine degradation III (mammalian) 0.35 0.82 1 0.67 1 1 0.71 0.99 1 0.49 0.82 1 0.69 0.93 1 0.63 0.89 1 0.00039 0.00022 7.7e-05 3e-04 8.6e-05 4e-04 0.00028 4.5e-05 0.00039 -0.1 20 / 36 (56%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00019 0 0.00036 0.00015 7.7e-05 0.00019 -0.34 5 / 11 (45%) 6 / 11 (55%) 0.455 0.545
PWY-6282~palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate) 0.87 0.95 1 0.92 1 1 0.13 0.88 1 0.53 0.84 1 0.99 1 1 0.22 0.82 1 0.0045 0.0045 0.0033 0.0035 0.0034 0.0029 0.004 0.0027 0.0042 0.19 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0039 0.0029 0.0043 0.0061 0.0042 0.0045 0.65 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-46~putrescine biosynthesis III 0.87 0.95 1 0.18 1 1 0.057 0.84 1 0.83 0.94 1 0.051 0.85 1 0.017 0.68 1 0.0014 0.0012 0.00075 0.0012 0.00048 0.0019 0.001 0.00016 0.0021 -0.26 31 / 36 (86%) 7 / 7 (100%) 4 / 7 (57%) 1 0.571 0.001 0.0014 0.00072 0.0015 0.0017 0.00089 0.58 9 / 11 (82%) 11 / 11 (100%) 0.818 1
PWY-2941~L-lysine biosynthesis II 0.17 0.8 1 0.11 1 1 0.022 0.68 1 0.17 0.68 1 0.078 0.85 1 0.012 0.68 1 0.0018 0.0015 0.00093 0.0018 0.002 0.0014 0.0012 0.00031 0.0013 -0.58 31 / 36 (86%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 0.0012 8e-04 0.0013 0.0019 0.001 0.0021 0.66 8 / 11 (73%) 11 / 11 (100%) 0.727 1
PWY-7509~cardiolipin and phosphatidylethanolamine biosynthesis (Xanthomonas) 0.66 0.88 1 0.99 1 1 0.27 0.91 1 0.41 0.75 1 0.64 0.92 1 0.45 0.88 1 0.0029 0.0029 0.0029 0.0025 0.0027 0.00082 0.0026 0.0019 0.0015 0.057 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0028 0.0028 0.0014 0.0035 0.0035 0.0011 0.32 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6759~hydrogen production III 0.61 0.85 1 0.69 1 1 0.8 0.99 1 0.63 0.89 1 0.37 0.92 1 0.3 0.88 1 0.031 0.031 0.031 0.032 0.033 0.0063 0.032 0.036 0.011 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.03 0.031 0.0085 0.03 0.03 0.0075 0 11 / 11 (100%) 11 / 11 (100%) 1 1
GLYSYN-THR-PWY~glycine biosynthesis IV 0.5 0.83 1 0.55 1 1 0.55 0.99 1 0.22 0.68 1 0.72 0.94 1 0.84 0.96 1 0.011 0.011 0.0098 0.011 0.0095 0.0036 0.0099 0.0098 0.0037 -0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.012 0.0098 0.0068 0.012 0.01 0.0033 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6839~2-aminoethylphosphonate biosynthesis 0.058 0.8 1 0.89 1 1 0.79 0.99 1 0.12 0.68 1 0.96 1 1 0.82 0.95 1 0.00042 0.00014 0 3e-04 5.6e-05 0.00047 0.00028 0 0.00035 -0.1 12 / 36 (33%) 4 / 7 (57%) 3 / 7 (43%) 0.571 0.429 4.3e-05 0 0.00011 4.9e-05 0 0.00011 0.19 2 / 11 (18%) 3 / 11 (27%) 0.182 0.273
PWY-7965~2-methyladeninyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 0.48 0.82 1 0.62 1 1 0.32 0.91 1 0.75 0.9 1 0.7 0.93 1 0.87 0.96 1 0.0049 0.0049 0.0047 0.0051 0.0046 0.00092 0.0049 0.0042 0.0019 -0.058 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0046 0.0048 0.0017 0.0052 0.0051 0.002 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1535~D-serine degradation 0.72 0.89 1 0.48 1 1 0.24 0.91 1 0.73 0.9 1 0.37 0.92 1 0.18 0.8 1 0.00018 0.00011 7.8e-05 0.00016 6.4e-05 0.00026 0.00018 0.00013 0.00023 0.17 21 / 36 (58%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 8.4e-05 9.5e-05 7.3e-05 5.1e-05 0 6.8e-05 -0.72 7 / 11 (64%) 5 / 11 (45%) 0.636 0.455
PWY-6543~4-aminobenzoate biosynthesis 0.16 0.8 1 0.84 1 1 0.49 0.97 1 0.075 0.68 1 0.9 0.99 1 0.63 0.89 1 0.0023 0.0022 0.0015 0.0011 0.0012 0.00071 0.0011 0.0011 0.00082 0 34 / 36 (94%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0028 0.0018 0.0043 0.003 0.0027 0.0024 0.1 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1546~muropeptide degradation 0.12 0.8 1 0.16 1 1 0.035 0.76 1 0.2 0.68 1 0.47 0.92 1 0.11 0.8 1 0.00045 1e-04 0 0.00024 0 0.00046 7.2e-05 0 0.00018 -1.7 8 / 36 (22%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 1.7e-05 0 5.6e-05 0.00011 0 0.00026 2.7 1 / 11 (9.1%) 3 / 11 (27%) 0.0909 0.273
PWY-5989~stearate biosynthesis II (bacteria and plants) 0.95 0.97 1 0.76 1 1 0.13 0.88 1 0.65 0.89 1 0.74 0.95 1 0.13 0.8 1 0.0047 0.0042 0.0029 0.0032 0.0038 0.0025 0.0038 0.0026 0.0039 0.25 32 / 36 (89%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0035 0.0021 0.0043 0.0057 0.0035 0.0046 0.7 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-6788~cellulose degradation II (fungi) 0.39 0.82 1 0.46 1 1 0.59 0.99 1 0.21 0.68 1 0.08 0.85 1 0.4 0.88 1 0.0084 0.0059 0.0041 0.0047 0 0.0063 0.0059 0.0042 0.0079 0.33 25 / 36 (69%) 3 / 7 (43%) 5 / 7 (71%) 0.429 0.714 0.007 0.0035 0.0078 0.0055 0.0041 0.004 -0.35 8 / 11 (73%) 9 / 11 (82%) 0.727 0.818
PWYQT-4429~CO2 fixation into oxaloacetate (anaplerotic) 0.19 0.8 1 0.62 1 1 0.25 0.91 1 0.13 0.68 1 0.52 0.92 1 0.2 0.82 1 0.0034 0.003 0.0018 0.0017 0.00078 0.0017 0.0019 0.0015 0.0017 0.16 32 / 36 (89%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0046 0.0018 0.0079 0.003 0.0026 0.0031 -0.62 11 / 11 (100%) 9 / 11 (82%) 1 0.818
GALACT-GLUCUROCAT-PWY~superpathway of hexuronide and hexuronate degradation 0.099 0.8 1 0.088 1 1 0.017 0.64 1 0.35 0.72 1 0.091 0.85 1 0.12 0.8 1 0.003 0.0028 0.0026 0.0034 0.0032 0.0017 0.0021 0.0018 0.0018 -0.7 34 / 36 (94%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0019 0.001 0.0017 0.0038 0.0032 0.003 1 11 / 11 (100%) 10 / 11 (91%) 1 0.909
PWY-5122~geranyl diphosphate biosynthesis 0.98 0.99 1 0.15 1 1 0.075 0.88 1 0.58 0.87 1 0.17 0.85 1 0.13 0.8 1 0.0012 0.0011 0.00077 0.001 0.00072 0.00083 0.00079 0.00084 0.00085 -0.34 32 / 36 (89%) 6 / 7 (86%) 5 / 7 (71%) 0.857 0.714 0.001 0.00076 0.001 0.0014 0.00098 0.0014 0.49 10 / 11 (91%) 11 / 11 (100%) 0.909 1
PWY-5891~menaquinol-11 biosynthesis 0.26 0.8 1 0.67 1 1 0.17 0.91 1 0.18 0.68 1 0.52 0.92 1 0.23 0.82 1 0.0015 0.00074 6.1e-05 0.00078 0.00061 0.00087 8e-04 0.00012 0.0011 0.037 18 / 36 (50%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00041 0 0.00095 0.001 0 0.0018 1.3 4 / 11 (36%) 5 / 11 (45%) 0.364 0.455
PWY-5493~reductive monocarboxylic acid cycle 0.93 0.96 1 0.63 1 1 0.23 0.91 1 0.48 0.81 1 0.54 0.92 1 0.81 0.95 1 0.034 0.034 0.034 0.033 0.034 0.007 0.032 0.032 0.012 -0.044 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.033 0.034 0.0092 0.036 0.034 0.0049 0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
XYLCAT-PWY~D-xylose degradation I 0.27 0.8 1 0.74 1 1 0.98 0.99 1 0.07 0.68 1 0.72 0.94 1 0.94 0.98 1 0.0051 0.0051 0.0039 0.0034 0.003 0.0021 0.004 0.004 0.0031 0.23 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0061 0.0043 0.0082 0.0059 0.0053 0.0041 -0.048 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1295~pyrimidine ribonucleosides degradation 0.29 0.82 1 0.46 1 1 0.96 0.99 1 0.85 0.94 1 0.056 0.85 1 0.25 0.85 1 0.0067 0.0067 0.0063 0.007 0.0061 0.0018 0.0076 0.008 0.0028 0.12 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0061 0.0059 0.0021 0.0064 0.0064 0.0015 0.069 11 / 11 (100%) 11 / 11 (100%) 1 1
GLNSYN-PWY~L-glutamine biosynthesis I 0.69 0.89 1 0.9 1 1 0.69 0.99 1 0.33 0.71 1 0.19 0.85 1 0.42 0.88 1 0.047 0.047 0.048 0.045 0.046 0.0075 0.046 0.05 0.0093 0.032 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.048 0.048 0.013 0.049 0.049 0.0046 0.03 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7219~adenosine ribonucleotides de novo biosynthesis 0.45 0.82 1 0.52 1 1 0.48 0.97 1 0.25 0.69 1 0.47 0.92 1 0.53 0.88 1 0.016 0.016 0.016 0.015 0.015 0.0026 0.015 0.014 0.0039 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.017 0.015 0.0051 0.017 0.018 0.0032 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5382~hydrogen oxidation II (aerobic NAD) 0.38 0.82 1 0.4 1 1 0.087 0.88 1 0.39 0.74 1 0.47 0.92 1 0.15 0.8 1 6e-04 2e-04 0 0.00022 1.6e-05 0.00042 0.00011 0 2e-04 -1 12 / 36 (33%) 4 / 7 (57%) 2 / 7 (29%) 0.571 0.286 9.5e-05 0 0.00022 0.00035 0 0.00073 1.9 2 / 11 (18%) 4 / 11 (36%) 0.182 0.364
PWY-5970~fatty acids biosynthesis (yeast) 0.29 0.82 1 0.43 1 1 0.76 0.99 1 0.11 0.68 1 0.086 0.85 1 0.51 0.88 1 0.0038 0.0033 0.0028 0.0019 0.0022 0.0018 0.0027 0.0024 0.0028 0.51 31 / 36 (86%) 5 / 7 (71%) 6 / 7 (86%) 0.714 0.857 0.0033 0.002 0.0041 0.0044 0.0031 0.0033 0.42 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-7971~adenosylcobinamide-GDP salvage from cobinamide I 0.18 0.8 1 0.61 1 1 0.86 0.99 1 0.17 0.68 1 0.34 0.92 1 0.5 0.88 1 0.0026 0.0026 0.0022 0.002 0.0019 9e-04 0.0023 0.0016 0.0016 0.2 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0028 0.0027 0.0013 0.003 0.0031 0.0013 0.1 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6758~hydrogen production II 0.38 0.82 1 0.4 1 1 0.087 0.88 1 0.39 0.74 1 0.47 0.92 1 0.15 0.8 1 6e-04 2e-04 0 0.00022 1.6e-05 0.00042 0.00011 0 2e-04 -1 12 / 36 (33%) 4 / 7 (57%) 2 / 7 (29%) 0.571 0.286 9.5e-05 0 0.00022 0.00035 0 0.00073 1.9 2 / 11 (18%) 4 / 11 (36%) 0.182 0.364
PWY-6197~chlorinated phenols degradation 0.083 0.8 1 0.58 1 1 0.86 0.99 1 0.67 0.9 1 0.23 0.88 1 0.63 0.89 1 0.0014 0.0014 0.0012 0.0018 0.002 0.0011 0.002 0.0018 0.0014 0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.00098 0.001 0.00041 0.0012 0.0011 0.00063 0.29 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7909~formaldehyde oxidation VII (THF pathway) 0.37 0.82 1 0.91 1 1 0.34 0.91 1 0.38 0.74 1 0.63 0.92 1 0.97 0.99 1 0.00087 0.00041 0 0.00042 0.00012 0.00051 0.00033 0.00018 4e-04 -0.35 17 / 36 (47%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 2e-04 0 0.00042 0.00066 0 0.0013 1.7 4 / 11 (36%) 4 / 11 (36%) 0.364 0.364
PWY-4861~UDP-α-D-galacturonate biosynthesis I (from UDP-D-glucuronate) 0.27 0.8 1 1 1 1 0.27 0.91 1 0.12 0.68 1 0.14 0.85 1 0.35 0.88 1 0.00015 1.7e-05 0 0 0 0 0 0 0 NA 4 / 36 (11%) 0 / 7 (0%) 0 / 7 (0%) 0 0 2.4e-05 0 6e-05 3.1e-05 0 7.4e-05 0.37 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
PWY-7195~pyrimidine ribonucleosides salvage III 0.22 0.8 1 0.78 1 1 0.93 0.99 1 0.054 0.68 1 0.58 0.92 1 0.5 0.88 1 0.0018 0.0012 0.00079 0.00085 0 0.0012 0.00097 0 0.0013 0.19 25 / 36 (69%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 0.0015 0.00087 0.0021 0.0015 0.0012 0.0013 0 10 / 11 (91%) 9 / 11 (82%) 0.909 0.818
OANTIGEN-PWY~O-antigen building blocks biosynthesis (E. coli) 0.41 0.82 1 0.57 1 1 0.92 0.99 1 0.42 0.75 1 0.55 0.92 1 0.5 0.88 1 0.0035 0.0034 0.0029 0.0024 0.0025 0.0013 0.0032 0.0029 0.0024 0.42 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0037 0.0032 0.003 0.0038 0.0034 0.0025 0.038 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5154~L-arginine biosynthesis III (via N-acetyl-L-citrulline) 0.2 0.8 1 0.084 1 1 0.7 0.99 1 0.15 0.68 1 0.082 0.85 1 0.66 0.9 1 0.0014 0.00091 0.00043 0.0013 0.0013 0.00054 0.00076 0.001 0.00068 -0.77 23 / 36 (64%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 8e-04 0.00036 0.00091 0.00088 0 0.0022 0.14 8 / 11 (73%) 3 / 11 (27%) 0.727 0.273
PWY-6122~5-aminoimidazole ribonucleotide biosynthesis II 0.93 0.97 1 0.86 1 1 0.98 0.99 1 0.41 0.75 1 0.23 0.88 1 0.37 0.88 1 0.021 0.021 0.021 0.021 0.021 0.0036 0.021 0.021 0.0039 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.022 0.02 0.011 0.021 0.02 0.005 -0.067 11 / 11 (100%) 11 / 11 (100%) 1 1
GLUTSYN-PWY~L-glutamate biosynthesis I 0.41 0.82 1 0.71 1 1 0.55 0.99 1 0.26 0.69 1 0.33 0.92 1 0.49 0.88 1 0.091 0.091 0.093 0.086 0.085 0.01 0.084 0.085 0.018 -0.034 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.094 0.1 0.026 0.095 0.094 0.011 0.015 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-2301~myo-inositol biosynthesis 0.45 0.82 1 0.53 1 1 0.94 0.99 1 0.99 1 1 0.27 0.9 1 0.58 0.88 1 0.002 0.0018 0.001 0.0011 9e-04 0.00089 0.00086 0.00042 0.00094 -0.36 32 / 36 (89%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0028 0.0011 0.0051 0.0019 0.0013 0.002 -0.56 9 / 11 (82%) 9 / 11 (82%) 0.818 0.818
PWY-6898~thiamine salvage III 0.15 0.8 1 0.48 1 1 0.99 0.99 1 0.13 0.68 1 0.13 0.85 1 0.41 0.88 1 0.0079 0.0079 0.0076 0.0066 0.0068 0.0013 0.0071 0.0067 0.002 0.11 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0084 0.0081 0.0038 0.0087 0.0079 0.0018 0.051 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1241~ADP-L-glycero-β-D-manno-heptose biosynthesis 0.38 0.82 1 0.33 1 1 0.66 0.99 1 0.62 0.89 1 0.65 0.92 1 1 1 1 0.00067 0.00024 0 0.00046 0 0.00077 0.00024 0 0.00051 -0.94 13 / 36 (36%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 0.00022 0 0.00045 0.00013 0 0.00026 -0.76 4 / 11 (36%) 3 / 11 (27%) 0.364 0.273
PWY-7964~adeninyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 0.48 0.82 1 0.62 1 1 0.32 0.91 1 0.75 0.9 1 0.7 0.93 1 0.87 0.96 1 0.0049 0.0049 0.0047 0.0051 0.0046 0.00092 0.0049 0.0042 0.0019 -0.058 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0046 0.0048 0.0017 0.0052 0.0051 0.002 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
NONMEVIPP-PWY~methylerythritol phosphate pathway I 0.45 0.82 1 0.44 1 1 0.31 0.91 1 0.25 0.69 1 0.91 0.99 1 0.84 0.96 1 0.014 0.014 0.014 0.013 0.013 0.0022 0.012 0.012 0.0044 -0.12 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.015 0.016 0.0059 0.015 0.015 0.0022 0 11 / 11 (100%) 11 / 11 (100%) 1 1
OXIDATIVEPENT-PWY~pentose phosphate pathway (oxidative branch) I 0.34 0.82 1 0.59 1 1 0.79 0.99 1 0.57 0.86 1 0.35 0.92 1 0.42 0.88 1 0.0033 0.0029 0.0017 0.0015 0.0011 0.0013 0.0023 0.0024 0.0019 0.62 32 / 36 (89%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 0.0037 0.0016 0.0065 0.0034 0.0026 0.0032 -0.12 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-5384~sucrose degradation IV (sucrose phosphorylase) 0.091 0.8 1 0.87 1 1 0.84 0.99 1 0.15 0.68 1 0.25 0.9 1 0.24 0.84 1 0.0062 0.0061 0.0058 0.0035 0.0032 0.0021 0.0039 0.0023 0.0037 0.16 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.008 0.0069 0.008 0.0071 0.0076 0.0032 -0.17 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1586~peptidoglycan maturation (meso-diaminopimelate containing) 0.14 0.8 1 0.29 1 1 0.95 0.99 1 0.24 0.69 1 0.23 0.88 1 0.89 0.97 1 0.0034 0.0027 0.0015 0.0039 0.0015 0.0044 0.0043 0.003 0.004 0.14 29 / 36 (81%) 6 / 7 (86%) 7 / 7 (100%) 0.857 1 0.0017 0.00081 0.0024 0.002 0.0016 0.0017 0.23 7 / 11 (64%) 9 / 11 (82%) 0.636 0.818
PWY-5785~di-transpoly-cis-undecaprenyl phosphate biosynthesis 0.37 0.82 1 0.75 1 1 0.89 0.99 1 0.26 0.69 1 0.59 0.92 1 0.78 0.93 1 0.0017 0.0016 0.00093 0.001 0.00097 0.00085 0.00095 0.00053 0.00097 -0.074 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0023 0.00076 0.0042 0.0017 0.0015 0.0015 -0.44 11 / 11 (100%) 11 / 11 (100%) 1 1
TRESYN-PWY~trehalose biosynthesis I 0.6 0.85 1 0.54 1 1 0.19 0.91 1 0.67 0.9 1 0.79 0.97 1 0.67 0.9 1 0.00097 0.00051 5.6e-05 0.00045 0.00033 0.00072 0.00024 9.4e-05 0.00032 -0.91 19 / 36 (53%) 4 / 7 (57%) 4 / 7 (57%) 0.571 0.571 0.00029 3.1e-05 0.00069 0.00095 0 0.002 1.7 6 / 11 (55%) 5 / 11 (45%) 0.545 0.455
PWY0-881~superpathway of fatty acid biosynthesis I (E. coli) 0.56 0.84 1 0.85 1 1 0.87 0.99 1 0.62 0.89 1 0.52 0.92 1 0.39 0.88 1 0.0026 0.0015 0.00029 0.00079 4e-04 0.0012 0.00082 3e-04 0.001 0.054 21 / 36 (58%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 0.002 0.00029 0.0041 0.002 0 0.0033 0 7 / 11 (64%) 5 / 11 (45%) 0.636 0.455
PWY-6587~pyruvate fermentation to ethanol III 0.48 0.82 1 0.13 1 1 0.34 0.91 1 0.74 0.9 1 0.55 0.92 1 0.76 0.93 1 0.0017 0.0011 0.00076 0.0017 0.0013 0.0019 0.00088 0.00064 0.0013 -0.95 24 / 36 (67%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 0.0011 0.00076 0.0013 0.00094 0.00043 0.0011 -0.23 7 / 11 (64%) 7 / 11 (64%) 0.636 0.636
PWY-2622~trehalose biosynthesis IV 0.46 0.82 1 0.014 0.94 1 0.13 0.88 1 0.79 0.91 1 0.23 0.88 1 0.9 0.97 1 0.0037 0.0037 0.0031 0.0047 0.0044 0.003 0.0032 0.003 0.0017 -0.55 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0037 0.0029 0.0017 0.0035 0.0031 0.002 -0.08 11 / 11 (100%) 11 / 11 (100%) 1 1
COA-PWY-1~superpathway of coenzyme A biosynthesis III (mammals) 0.27 0.8 1 0.72 1 1 0.85 0.99 1 0.16 0.68 1 0.32 0.92 1 0.49 0.88 1 0.0083 0.0083 0.0072 0.0069 0.0071 0.00094 0.0075 0.0064 0.0033 0.12 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0091 0.0074 0.0056 0.0089 0.0087 0.0029 -0.032 11 / 11 (100%) 11 / 11 (100%) 1 1
MET-SAM-PWY~superpathway of S-adenosyl-L-methionine biosynthesis 0.4 0.82 1 0.6 1 1 0.33 0.91 1 0.16 0.68 1 0.42 0.92 1 0.18 0.81 1 0.00091 0.00038 0 3e-04 0 7e-04 0.00038 0 6e-04 0.34 15 / 36 (42%) 2 / 7 (29%) 3 / 7 (43%) 0.286 0.429 0.00047 0.00025 0.00076 0.00034 0 0.00087 -0.47 6 / 11 (55%) 4 / 11 (36%) 0.545 0.364
PWY-6124~inosine-5-phosphate biosynthesis II 0.31 0.82 1 0.52 1 1 0.32 0.91 1 0.17 0.68 1 0.86 0.99 1 0.83 0.95 1 0.011 0.011 0.01 0.01 0.0097 0.0014 0.0095 0.01 0.0036 -0.074 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.012 0.01 0.0062 0.013 0.013 0.003 0.12 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1325~superpathway of L-asparagine biosynthesis 0.35 0.82 1 0.34 1 1 0.33 0.91 1 0.24 0.69 1 0.77 0.97 1 0.82 0.95 1 0.01 0.01 0.01 0.0097 0.0091 0.0023 0.0086 0.0087 0.0015 -0.17 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.012 0.0027 0.011 0.011 0.0027 0 11 / 11 (100%) 11 / 11 (100%) 1 1
P21-PWY~pentose phosphate pathway (partial) 0.18 0.8 1 0.87 1 1 0.5 0.98 1 0.17 0.68 1 0.41 0.92 1 0.78 0.93 1 0.021 0.021 0.021 0.019 0.018 0.0033 0.019 0.019 0.007 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.023 0.026 0.0074 0.023 0.024 0.0032 0 11 / 11 (100%) 11 / 11 (100%) 1 1
FASYN-ELONG-PWY~fatty acid elongation -- saturated 0.48 0.82 1 0.97 1 1 0.42 0.91 1 0.21 0.68 1 0.75 0.96 1 0.4 0.88 1 0.0056 0.0056 0.0041 0.0037 0.0047 0.0027 0.0041 0.0026 0.0038 0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0063 0.0037 0.0095 0.0071 0.0049 0.0049 0.17 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6608~guanosine nucleotides degradation III 0.47 0.82 1 0.72 1 1 0.56 0.99 1 0.92 0.98 1 0.63 0.92 1 0.47 0.88 1 0.004 0.004 0.0039 0.0047 0.0051 0.0016 0.0049 0.0057 0.0031 0.06 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0039 0.0036 0.0014 0.0032 0.0035 0.0018 -0.29 11 / 11 (100%) 11 / 11 (100%) 1 1
GLUTSYNIII-PWY~L-glutamate biosynthesis III 0.12 0.8 1 0.61 1 1 0.3 0.91 1 0.028 0.68 1 0.58 0.92 1 0.54 0.88 1 0.002 0.0014 0.00036 0.0016 0.0012 0.0013 0.0016 0.00043 0.0021 0 25 / 36 (69%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.00076 0.00011 0.0017 0.0018 7.5e-05 0.004 1.2 6 / 11 (55%) 6 / 11 (55%) 0.545 0.545
PWY-7211~superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis 0.62 0.86 1 0.97 1 1 0.78 0.99 1 0.83 0.93 1 0.64 0.92 1 0.72 0.91 1 0.0015 0.00085 0.00014 0.00093 0.00046 0.0013 0.00078 0.00055 0.00092 -0.25 21 / 36 (58%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 0.00064 0.00016 0.0012 0.0011 9.5e-05 0.002 0.78 6 / 11 (55%) 6 / 11 (55%) 0.545 0.545
PWY0-1319~CDP-diacylglycerol biosynthesis II 0.21 0.8 1 0.5 1 1 0.42 0.91 1 0.52 0.84 1 0.52 0.92 1 0.72 0.91 1 0.00096 0.00085 0.00076 0.0011 0.001 0.001 0.001 0.00086 0.00093 -0.14 32 / 36 (89%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.00065 0.00048 5e-04 0.00077 0.00071 0.00053 0.24 10 / 11 (91%) 9 / 11 (82%) 0.909 0.818
PENTOSE-P-PWY~pentose phosphate pathway 0.72 0.89 1 0.87 1 1 0.55 0.99 1 0.85 0.94 1 0.58 0.92 1 0.41 0.88 1 0.0031 0.0028 0.0023 0.0021 0.0017 0.0018 0.0021 0.0024 0.0017 0 33 / 36 (92%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0033 0.0018 0.0055 0.0033 0.0026 0.003 0 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-5966~fatty acid biosynthesis initiation II 0.33 0.82 1 0.86 1 1 0.68 0.99 1 0.092 0.68 1 0.31 0.92 1 0.97 0.99 1 0.0059 0.0052 0.0034 0.0034 0.0031 0.0033 0.0036 0.0024 0.0039 0.082 32 / 36 (89%) 5 / 7 (71%) 6 / 7 (86%) 0.714 0.857 0.0063 0.0027 0.011 0.0063 0.0044 0.005 0 10 / 11 (91%) 11 / 11 (100%) 0.909 1
PWY-5938~pyruvate fermentation to (R)-acetoin I 0.91 0.96 1 0.78 1 1 0.77 0.99 1 0.74 0.9 1 0.93 1 1 0.9 0.97 1 0.00048 0.00013 0 0.00013 0 0.00029 6.7e-05 0 0.00012 -0.96 10 / 36 (28%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 0.00014 0 0.00026 0.00018 0 0.00044 0.36 3 / 11 (27%) 3 / 11 (27%) 0.273 0.273
PWY-6125~superpathway of guanosine nucleotides de novo biosynthesis II 0.73 0.89 1 0.66 1 1 0.9 0.99 1 0.95 0.98 1 0.96 1 1 0.41 0.88 1 0.0016 0.001 0.00035 0.0011 0.00056 0.0014 0.00077 0.00059 0.00084 -0.51 23 / 36 (64%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 9e-04 4e-04 0.0014 0.0012 0 0.0023 0.42 8 / 11 (73%) 5 / 11 (45%) 0.727 0.455
POLYISOPRENSYN-PWY~polyisoprenoid biosynthesis (E. coli) 0.63 0.86 1 0.31 1 1 0.24 0.91 1 0.27 0.7 1 0.18 0.85 1 0.54 0.88 1 0.0012 0.00086 0.00052 0.00068 0.00055 0.00072 6e-04 0 0.00085 -0.18 26 / 36 (72%) 5 / 7 (71%) 3 / 7 (43%) 0.714 0.429 8e-04 0.00047 0.00086 0.0012 0.00084 0.0014 0.58 10 / 11 (91%) 8 / 11 (73%) 0.909 0.727
PWY-6549~L-glutamine biosynthesis III 0.23 0.8 1 0.68 1 1 0.37 0.91 1 0.33 0.71 1 0.65 0.92 1 0.56 0.88 1 0.0012 0.00038 0 0.00012 0 0.00027 0.00024 0 5e-04 1 12 / 36 (33%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 0.00074 0 0.0016 0.00029 0 0.00043 -1.4 4 / 11 (36%) 4 / 11 (36%) 0.364 0.364
ASPARAGINE-DEG1-PWY~L-asparagine degradation I 0.66 0.88 1 0.35 1 1 0.13 0.88 1 0.76 0.9 1 0.86 0.99 1 0.51 0.88 1 0.0086 0.0086 0.0078 0.0085 0.0078 0.0022 0.0075 0.0079 0.0027 -0.18 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0083 0.0063 0.0061 0.0095 0.0087 0.0046 0.19 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5807~heptaprenyl diphosphate biosynthesis 0.8 0.93 1 0.72 1 1 0.82 0.99 1 0.77 0.9 1 0.98 1 1 0.93 0.98 1 0.00093 0.00088 0.00071 0.00081 0.00048 0.00069 7e-04 0.00074 0.00056 -0.21 34 / 36 (94%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.00099 0.00052 0.001 0.00092 9e-04 0.00071 -0.11 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY0-501~lipoate biosynthesis and incorporation I 0.24 0.8 1 0.78 1 1 0.51 0.99 1 0.21 0.68 1 0.64 0.92 1 0.57 0.88 1 0.0011 0.00056 9.1e-05 0.00068 0.00071 7e-04 0.00073 2e-04 0.00095 0.1 19 / 36 (53%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00035 0 8e-04 0.00058 0 0.0013 0.73 5 / 11 (45%) 5 / 11 (45%) 0.455 0.455
PWY-4341~L-glutamate biosynthesis V 0.55 0.84 1 0.5 1 1 0.31 0.91 1 0.31 0.71 1 0.6 0.92 1 0.93 0.98 1 0.045 0.045 0.046 0.043 0.043 0.0045 0.04 0.038 0.0093 -0.1 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.047 0.049 0.016 0.048 0.049 0.0066 0.03 11 / 11 (100%) 11 / 11 (100%) 1 1
HOMOSER-THRESYN-PWY~L-threonine biosynthesis 0.56 0.84 1 0.83 1 1 0.7 0.99 1 0.33 0.71 1 0.65 0.92 1 0.97 0.99 1 0.0081 0.0081 0.008 0.0072 0.0064 0.0017 0.007 0.0077 0.0024 -0.041 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0087 0.008 0.0058 0.0086 0.0089 0.0026 -0.017 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5030~L-histidine degradation III 0.1 0.8 1 0.51 1 1 0.21 0.91 1 0.0061 0.53 1 0.27 0.9 1 0.18 0.8 1 0.0015 0.00079 0.00016 0.00083 0.00053 0.00066 0.00092 0.00032 0.0015 0.15 19 / 36 (53%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 0.00047 0 0.0012 0.001 0 0.0021 1.1 3 / 11 (27%) 4 / 11 (36%) 0.273 0.364
PWY-5097~L-lysine biosynthesis VI 0.91 0.96 1 0.67 1 1 0.35 0.91 1 0.39 0.74 1 0.47 0.92 1 0.88 0.96 1 0.018 0.018 0.018 0.017 0.017 0.0016 0.017 0.017 0.0043 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.018 0.018 0.0057 0.018 0.019 0.002 0 11 / 11 (100%) 11 / 11 (100%) 1 1
ANAEROFRUCAT-PWY~homolactic fermentation 0.73 0.89 1 0.96 1 1 0.7 0.99 1 0.32 0.71 1 0.34 0.92 1 0.64 0.89 1 0.014 0.014 0.014 0.013 0.014 0.002 0.014 0.015 0.0042 0.11 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.014 0.014 0.0063 0.015 0.014 0.0026 0.1 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7494~choline degradation IV 0.72 0.89 1 0.84 1 1 0.88 0.99 1 0.87 0.95 1 0.65 0.92 1 0.63 0.89 1 0.00073 0.00047 2e-04 5e-04 0.00026 0.00059 0.00051 0.00064 0.00051 0.029 23 / 36 (64%) 6 / 7 (86%) 4 / 7 (57%) 0.857 0.571 0.00039 0.00029 0.00045 5e-04 0 0.00096 0.36 8 / 11 (73%) 5 / 11 (45%) 0.727 0.455
PWY-5347~superpathway of L-methionine biosynthesis (transsulfuration) 0.48 0.82 1 0.59 1 1 0.28 0.91 1 0.18 0.68 1 0.43 0.92 1 0.13 0.8 1 0.001 4e-04 0 0.00035 0 0.00084 0.00045 0 0.00076 0.36 14 / 36 (39%) 2 / 7 (29%) 3 / 7 (43%) 0.286 0.429 0.00047 0.00026 0.00081 0.00034 0 0.00095 -0.47 6 / 11 (55%) 3 / 11 (27%) 0.545 0.273
PWY-7459~kojibiose degradation 0.07 0.8 1 0.12 1 1 0.012 0.64 1 0.36 0.73 1 0.35 0.92 1 0.032 0.68 1 0.00083 0.00081 0.00064 0.0011 0.00085 0.00065 0.0015 0.0011 0.0011 0.45 35 / 36 (97%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.00059 0.00052 0.00034 0.00039 0.00033 0.00035 -0.6 11 / 11 (100%) 10 / 11 (91%) 1 0.909
ASPARTATE-DEG1-PWY~L-aspartate degradation I 0.33 0.82 1 0.14 1 1 0.2 0.91 1 0.1 0.68 1 0.023 0.82 1 0.059 0.8 1 0.02 0.02 0.019 0.017 0.017 0.0047 0.021 0.023 0.0057 0.3 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.022 0.017 0.015 0.02 0.019 0.0069 -0.14 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6700~queuosine biosynthesis 0.31 0.82 1 0.74 1 1 0.58 0.99 1 0.76 0.9 1 0.5 0.92 1 0.94 0.98 1 0.0026 0.0026 0.0023 0.0027 0.003 0.00098 0.003 0.0027 0.0017 0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0021 0.002 0.0012 0.0028 0.0022 0.0018 0.42 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6922~L-Nδ-acetylornithine biosynthesis 0.41 0.82 1 0.31 1 1 0.11 0.88 1 0.19 0.68 1 0.24 0.9 1 0.15 0.8 1 0.0012 0.00037 0 0.00033 0.00016 0.00043 2e-04 0 0.00035 -0.72 11 / 36 (31%) 4 / 7 (57%) 2 / 7 (29%) 0.571 0.286 0.00025 0 0.00067 0.00063 0 0.0013 1.3 2 / 11 (18%) 3 / 11 (27%) 0.182 0.273
GOLPDLCAT-PWY~superpathway of glycerol degradation to 13-propanediol 0.24 0.8 1 0.78 1 1 0.84 0.99 1 0.22 0.68 1 0.68 0.93 1 0.62 0.89 1 0.00051 0.00011 0 0.00016 0 2e-04 0.00019 0 0.00035 0.25 8 / 36 (22%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 1e-04 0 0.00034 4.9e-05 0 0.00011 -1 1 / 11 (9.1%) 2 / 11 (18%) 0.0909 0.182
GLUTDEG-PWY~L-glutamate degradation II 0.41 0.82 1 0.63 1 1 0.82 0.99 1 0.78 0.91 1 0.33 0.92 1 0.66 0.9 1 0.0086 0.0086 0.0082 0.009 0.0086 0.0033 0.01 0.011 0.0056 0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0075 0.0073 0.0027 0.0085 0.0072 0.0036 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6284~superpathway of unsaturated fatty acids biosynthesis (E. coli) 0.84 0.93 1 0.9 1 1 0.14 0.88 1 0.49 0.82 1 0.99 1 1 0.17 0.8 1 0.0044 0.0044 0.0032 0.0033 0.0034 0.0026 0.0038 0.0027 0.004 0.2 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0039 0.0029 0.0043 0.006 0.0042 0.0044 0.62 11 / 11 (100%) 11 / 11 (100%) 1 1
P142-PWY~pyruvate fermentation to acetate I 0.26 0.8 1 0.76 1 1 0.28 0.91 1 0.74 0.9 1 0.37 0.92 1 0.94 0.98 1 0.017 0.017 0.017 0.017 0.018 0.0035 0.017 0.016 0.0046 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.015 0.013 0.0038 0.017 0.018 0.0043 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
FASYN-INITIAL-PWY~superpathway of fatty acid biosynthesis initiation (E. coli) 0.81 0.93 1 0.38 1 1 0.5 0.98 1 0.83 0.93 1 0.46 0.92 1 0.91 0.97 1 0.0013 0.00067 7.9e-05 0.00075 0.00033 0.0012 0.00043 0 0.00085 -0.8 18 / 36 (50%) 4 / 7 (57%) 3 / 7 (43%) 0.571 0.429 0.00052 0.00022 0.00076 9e-04 0 0.0018 0.79 7 / 11 (64%) 4 / 11 (36%) 0.636 0.364
PWY0-461~L-lysine degradation I 0.46 0.82 1 0.48 1 1 0.94 0.99 1 0.29 0.7 1 0.2 0.85 1 0.46 0.88 1 0.0051 0.005 0.0051 0.0047 0.0039 0.0032 0.0045 0.0054 0.0029 -0.063 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0055 0.0055 0.0026 0.0049 0.0048 0.0022 -0.17 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5890~menaquinol-10 biosynthesis 0.26 0.8 1 0.67 1 1 0.17 0.91 1 0.18 0.68 1 0.52 0.92 1 0.23 0.82 1 0.0015 0.00074 6.1e-05 0.00078 0.00061 0.00087 8e-04 0.00012 0.0011 0.037 18 / 36 (50%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00041 0 0.00095 0.001 0 0.0018 1.3 4 / 11 (36%) 5 / 11 (45%) 0.364 0.455
PWY-6744~hydrogen production I 0.56 0.84 1 0.96 1 1 0.86 0.99 1 0.82 0.93 1 0.72 0.94 1 0.62 0.89 1 0.00011 1.9e-05 0 2.5e-05 0 5.3e-05 2.1e-05 0 3.7e-05 -0.25 6 / 36 (17%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 2.2e-05 0 7.3e-05 9.9e-06 0 3.3e-05 -1.2 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
COA-PWY~coenzyme A biosynthesis I (prokaryotic) 0.27 0.8 1 0.94 1 1 0.94 0.99 1 0.15 0.68 1 0.45 0.92 1 0.64 0.89 1 0.0081 0.0081 0.0075 0.0068 0.0061 0.0015 0.0071 0.006 0.0029 0.062 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0089 0.0068 0.0052 0.0088 0.0082 0.0029 -0.016 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1312~acetate and ATP formation from acetyl-CoA I 0.91 0.96 1 0.98 1 1 0.95 0.99 1 0.34 0.71 1 0.3 0.92 1 0.35 0.88 1 0.013 0.013 0.013 0.013 0.013 0.0028 0.013 0.013 0.003 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.014 0.01 0.0064 0.013 0.013 0.0034 -0.11 11 / 11 (100%) 11 / 11 (100%) 1 1
METSYN-PWY~superpathway of L-homoserine and L-methionine biosynthesis 0.42 0.82 1 0.59 1 1 0.34 0.91 1 0.17 0.68 1 0.42 0.92 1 0.19 0.81 1 0.00091 0.00038 0 3e-04 0 7e-04 0.00039 0 0.00061 0.38 15 / 36 (42%) 2 / 7 (29%) 3 / 7 (43%) 0.286 0.429 0.00046 0.00025 0.00077 0.00035 0 0.00088 -0.39 6 / 11 (55%) 4 / 11 (36%) 0.545 0.364
PWY4FS-8~phosphatidylglycerol biosynthesis II (non-plastidic) 0.41 0.82 1 0.081 1 1 0.046 0.76 1 0.69 0.9 1 0.023 0.82 1 0.035 0.68 1 0.00095 0.00081 0.00076 0.00097 0.00098 0.00086 0.00074 6e-04 0.00095 -0.39 31 / 36 (86%) 7 / 7 (100%) 4 / 7 (57%) 1 0.571 0.00066 0.00054 5e-04 0.00091 0.001 0.00052 0.46 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY0-1314~fructose degradation 0.8 0.93 1 0.74 1 1 0.2 0.91 1 0.77 0.9 1 0.96 1 1 0.33 0.88 1 0.00041 0.00026 0.00013 0.00024 0.00014 0.00025 0.00034 0.00034 0.00036 0.5 23 / 36 (64%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00036 0.00013 0.00064 0.00012 1e-04 0.00015 -1.6 8 / 11 (73%) 6 / 11 (55%) 0.727 0.545
METHFORM-PWY~methyl-coenzyme M reduction to methane 0.4 0.82 1 0.5 1 1 0.58 0.99 1 0.83 0.93 1 1 1 1 0.96 0.99 1 0.00068 7.6e-05 0 0.00019 0 5e-04 7.5e-05 0 2e-04 -1.3 4 / 36 (11%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 3.8e-05 0 0.00013 4.1e-05 0 0.00014 0.11 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
GLUTAMATE-SYN2-PWY~L-glutamate biosynthesis II 0.31 0.82 1 0.91 1 1 0.32 0.91 1 0.37 0.73 1 0.48 0.92 1 0.4 0.88 1 0.00096 5e-04 7.6e-05 5e-04 0.00014 0.00064 0.00071 0 0.0012 0.51 19 / 36 (53%) 5 / 7 (71%) 3 / 7 (43%) 0.714 0.429 0.00016 7.2e-05 0.00026 0.00072 0 0.0016 2.2 6 / 11 (55%) 5 / 11 (45%) 0.545 0.455
PWY-7198~pyrimidine deoxyribonucleotides de novo biosynthesis IV 0.83 0.93 1 0.57 1 1 0.12 0.88 1 0.51 0.83 1 0.56 0.92 1 0.1 0.8 1 0.00093 0.00036 0 0.00066 0 0.0016 7e-04 0 0.0013 0.085 14 / 36 (39%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 0.00028 0.00018 5e-04 4.7e-05 0 0.00012 -2.6 6 / 11 (55%) 2 / 11 (18%) 0.545 0.182
PWY-5951~(RR)-butanediol biosynthesis 0.52 0.83 1 0.46 1 1 0.59 0.99 1 0.89 0.96 1 0.84 0.99 1 0.97 0.99 1 0.00014 3.1e-05 0 5.8e-05 0 0.00013 1.7e-05 0 3e-05 -1.8 8 / 36 (22%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 2.7e-05 0 6.8e-05 2.6e-05 0 6.8e-05 -0.054 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
ORN-AMINOPENTANOATE-CAT-PWY~L-ornithine degradation I (L-proline biosynthesis) 0.41 0.82 1 0.39 1 1 0.27 0.91 1 0.92 0.98 1 0.99 1 1 0.7 0.91 1 0.0011 0.00081 0.00056 0.0012 0.0011 0.0013 0.00076 9e-04 0.00061 -0.66 27 / 36 (75%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 0.00067 0.00048 0.00084 0.00076 0.00057 0.00085 0.18 8 / 11 (73%) 9 / 11 (82%) 0.727 0.818
PWY-6293~superpathway of L-cysteine biosynthesis (fungi) 0.19 0.8 1 0.63 1 1 0.68 0.99 1 0.11 0.68 1 0.26 0.9 1 0.56 0.88 1 0.0039 0.0026 0.00082 0.0011 0 0.002 0.0013 0.00058 0.002 0.24 24 / 36 (67%) 3 / 7 (43%) 4 / 7 (57%) 0.429 0.571 0.0041 0.0015 0.0093 0.0028 0.0015 0.0034 -0.55 8 / 11 (73%) 9 / 11 (82%) 0.727 0.818
PWY-5418~phenol degradation I (aerobic) 0.083 0.8 1 0.58 1 1 0.86 0.99 1 0.67 0.9 1 0.23 0.88 1 0.63 0.89 1 0.0014 0.0014 0.0012 0.0018 0.002 0.0011 0.002 0.0018 0.0014 0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.00098 0.001 0.00041 0.0012 0.0011 0.00063 0.29 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5483~pyruvate fermentation to acetate III 0.14 0.8 1 0.4 1 1 0.13 0.88 1 0.075 0.68 1 0.21 0.87 1 0.071 0.8 1 0.0036 0.0028 0.0025 0.002 0.0019 0.0021 0.0026 0.0013 0.0029 0.38 28 / 36 (78%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 0.0035 0.0028 0.0028 0.0027 0.0022 0.0023 -0.37 10 / 11 (91%) 9 / 11 (82%) 0.909 0.818
ARGSYN-PWY~L-arginine biosynthesis I (via L-ornithine) 0.4 0.82 1 0.87 1 1 0.79 0.99 1 0.24 0.69 1 0.63 0.92 1 0.9 0.97 1 0.019 0.019 0.02 0.017 0.017 0.0033 0.018 0.02 0.0074 0.082 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.02 0.02 0.0078 0.021 0.021 0.004 0.07 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7858~(5Z)-dodecenoate biosynthesis II 0.068 0.8 1 0.25 1 1 0.017 0.64 1 0.049 0.68 1 0.095 0.85 1 0.0054 0.68 1 0.00036 7.9e-05 0 1e-05 0 2.7e-05 8.1e-05 0 0.00012 3 8 / 36 (22%) 1 / 7 (14%) 3 / 7 (43%) 0.143 0.429 2e-04 0 0.00042 0 0 0 -Inf 4 / 11 (36%) 0 / 11 (0%) 0.364 0
COMPLETE-ARO-PWY~superpathway of aromatic amino acid biosynthesis 0.95 0.97 1 1 1 1 0.7 0.99 1 0.76 0.9 1 0.91 0.99 1 0.52 0.88 1 0.0017 0.00093 0.00055 0.001 0.00061 0.0012 0.001 0.00045 0.0012 0 20 / 36 (56%) 4 / 7 (57%) 4 / 7 (57%) 0.571 0.571 0.00095 0.00063 0.0014 0.00079 0 0.00099 -0.27 7 / 11 (64%) 5 / 11 (45%) 0.636 0.455
PWY-4985~mimosine biosynthesis 0.11 0.8 1 0.97 1 1 0.7 0.99 1 0.061 0.68 1 0.64 0.92 1 1 1 1 0.0017 0.001 0.00025 3e-04 0 0.00052 0.00042 0 0.00093 0.49 22 / 36 (61%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 0.0019 0.00029 0.0042 0.001 0.00045 0.0013 -0.93 9 / 11 (82%) 8 / 11 (73%) 0.818 0.727
PWY0-1305~L-glutamate degradation IX (via 4-aminobutanoate) 0.16 0.8 1 0.26 1 1 0.16 0.91 1 0.11 0.68 1 0.14 0.85 1 0.054 0.8 1 0.0028 0.0027 0.0018 0.0013 0.0012 0.0013 0.002 0.0018 0.0016 0.62 35 / 36 (97%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0038 0.002 0.0063 0.0029 0.0019 0.0029 -0.39 11 / 11 (100%) 10 / 11 (91%) 1 0.909
GLUTAMINDEG-PWY~L-glutamine degradation I 0.059 0.8 1 0.25 1 1 0.95 0.99 1 0.071 0.68 1 0.025 0.82 1 0.16 0.8 1 0.014 0.014 0.014 0.012 0.013 0.0021 0.013 0.013 0.0031 0.12 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.015 0.014 0.0039 0.016 0.016 0.0034 0.093 11 / 11 (100%) 11 / 11 (100%) 1 1
BRANCHED-CHAIN-AA-SYN-PWY~superpathway of branched chain amino acid biosynthesis 0.54 0.84 1 0.6 1 1 0.67 0.99 1 0.28 0.7 1 0.55 0.92 1 0.56 0.88 1 0.022 0.022 0.022 0.021 0.021 0.0024 0.021 0.02 0.0059 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.023 0.024 0.0084 0.023 0.023 0.0045 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7309~acrylonitrile degradation II 0.075 0.8 1 0.16 1 1 0.14 0.88 1 0.19 0.68 1 0.27 0.9 1 0.15 0.8 1 0.00035 0.00024 0.00012 0.00044 0.00028 0.00058 0.00027 0.00022 0.00033 -0.7 24 / 36 (67%) 6 / 7 (86%) 5 / 7 (71%) 0.857 0.714 0.00015 3.3e-05 2e-04 0.00017 8.9e-05 2e-04 0.18 6 / 11 (55%) 7 / 11 (64%) 0.545 0.636
PWY-6510~methanol oxidation to formaldehyde II 0.36 0.82 1 0.57 1 1 0.83 0.99 1 0.22 0.68 1 0.88 0.99 1 0.46 0.88 1 0.00089 0.00084 0.00087 0.00079 0.00072 0.00057 0.00065 0.00062 0.00047 -0.28 34 / 36 (94%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.001 0.00097 6e-04 0.00083 0.00068 0.00056 -0.27 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6163~chorismate biosynthesis from 3-dehydroquinate 0.76 0.9 1 0.97 1 1 0.93 0.99 1 0.41 0.75 1 0.55 0.92 1 0.72 0.91 1 0.011 0.011 0.011 0.011 0.0097 0.0024 0.011 0.012 0.0045 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.011 0.0049 0.011 0.012 0.002 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5939~pyruvate fermentation to (R)-acetoin II 0.039 0.8 1 0.19 1 1 0.1 0.88 1 0.027 0.68 1 0.038 0.84 1 0.024 0.68 1 0.00092 0.00041 0 3e-05 0 7.9e-05 0.00029 0.00015 0.00041 3.3 16 / 36 (44%) 1 / 7 (14%) 5 / 7 (71%) 0.143 0.714 0.00071 0.00024 0.0011 0.00042 0 8e-04 -0.76 6 / 11 (55%) 4 / 11 (36%) 0.545 0.364
PWY-7400~L-arginine biosynthesis IV (archaebacteria) 0.45 0.82 1 1 1 1 0.68 0.99 1 0.26 0.69 1 0.71 0.94 1 1 1 1 0.019 0.019 0.019 0.017 0.016 0.0035 0.018 0.019 0.0074 0.082 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.019 0.02 0.0078 0.02 0.021 0.0037 0.074 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1315~L-lactaldehyde degradation (anaerobic) 0.65 0.88 1 0.43 1 1 0.21 0.91 1 0.54 0.84 1 0.71 0.94 1 0.91 0.97 1 0.015 0.015 0.013 0.015 0.015 0.0048 0.014 0.014 0.0047 -0.1 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.014 0.013 0.0053 0.015 0.015 0.0035 0.1 11 / 11 (100%) 11 / 11 (100%) 1 1
PRPP-PWY~superpathway of histidine purine and pyrimidine biosynthesis 0.73 0.89 1 0.89 1 1 0.93 0.99 1 0.8 0.92 1 0.89 0.99 1 0.83 0.95 1 0.003 0.0023 0.0011 0.0014 0.0014 0.0011 0.0015 0.00054 0.0016 0.1 28 / 36 (78%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0033 0.00069 0.0069 0.0024 0.0017 0.0026 -0.46 8 / 11 (73%) 8 / 11 (73%) 0.727 0.727
ILEUSYN-PWY~L-isoleucine biosynthesis I (from threonine) 0.65 0.88 1 0.64 1 1 0.72 0.99 1 0.32 0.71 1 0.52 0.92 1 0.52 0.88 1 0.023 0.023 0.023 0.022 0.023 0.0028 0.022 0.021 0.0064 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.024 0.024 0.0086 0.024 0.023 0.0046 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-66~GDP-L-fucose biosynthesis I (from GDP-D-mannose) 0.084 0.8 1 0.95 1 1 0.42 0.91 1 0.23 0.68 1 0.88 0.99 1 0.41 0.88 1 0.0033 0.0032 0.0029 0.0037 0.004 0.0012 0.004 0.0039 0.0026 0.11 35 / 36 (97%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0025 0.0024 0.0015 0.003 0.0026 0.0015 0.26 10 / 11 (91%) 11 / 11 (100%) 0.909 1
PWY-922~mevalonate pathway I 0.61 0.85 1 0.89 1 1 0.7 0.99 1 0.6 0.88 1 0.77 0.97 1 0.71 0.91 1 0.00034 9.4e-05 0 6.1e-05 0 0.00014 7.6e-05 0 0.00017 0.32 10 / 36 (28%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 0.00016 0 0.00039 6.5e-05 0 0.00012 -1.3 3 / 11 (27%) 3 / 11 (27%) 0.273 0.273
PWY-6630~superpathway of L-tyrosine biosynthesis 0.28 0.82 1 0.19 1 1 0.52 0.99 1 0.51 0.83 1 0.24 0.88 1 0.91 0.97 1 0.0035 0.0034 0.0026 0.0021 0.0019 0.0016 0.003 0.0027 0.0017 0.51 35 / 36 (97%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0042 0.0025 0.006 0.0037 0.0035 0.0023 -0.18 10 / 11 (91%) 11 / 11 (100%) 0.909 1
PWY-5108~L-isoleucine biosynthesis V 0.39 0.82 1 0.9 1 1 0.62 0.99 1 0.18 0.68 1 0.5 0.92 1 0.61 0.89 1 0.0012 0.00061 0.00016 0.00051 0.00037 0.00055 0.00074 0.00025 0.0012 0.54 19 / 36 (53%) 6 / 7 (86%) 4 / 7 (57%) 0.857 0.571 4e-04 0 0.00078 0.00081 0 0.0016 1 5 / 11 (45%) 4 / 11 (36%) 0.455 0.364
THREONINE-DEG2-PWY~L-threonine degradation II 0.41 0.82 1 0.71 1 1 0.64 0.99 1 0.086 0.68 1 0.96 1 1 0.2 0.82 1 0.0022 0.0022 0.0016 0.002 0.0015 0.0015 0.0017 0.0017 0.0011 -0.23 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0026 0.0023 0.0017 0.0023 0.0011 0.0026 -0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1597~prenylated FMNH2 biosynthesis 0.48 0.82 1 0.45 1 1 0.75 0.99 1 0.26 0.69 1 0.44 0.92 1 0.74 0.93 1 0.0013 0.0013 0.0012 0.001 0.00094 0.00051 0.0015 0.0012 0.0015 0.58 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0013 0.0014 0.00056 0.0014 0.0015 5e-04 0.11 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7392~taxadiene biosynthesis (engineered) 0.95 0.97 1 0.69 1 1 0.71 0.99 1 0.67 0.9 1 0.6 0.92 1 0.65 0.9 1 0.0012 0.00093 0.00056 0.00079 0.00082 0.00064 0.00077 0.00054 0.00082 -0.037 28 / 36 (78%) 6 / 7 (86%) 5 / 7 (71%) 0.857 0.714 0.00082 0.00061 0.00089 0.0012 0.00052 0.0017 0.55 10 / 11 (91%) 7 / 11 (64%) 0.909 0.636
PWY-6753~S-methyl-5-thioadenosine degradation III 0.21 0.8 1 0.18 1 1 0.42 0.91 1 0.48 0.81 1 0.39 0.92 1 0.68 0.91 1 0.00017 2.4e-05 0 6.4e-05 0 0.00014 2e-05 0 5.3e-05 -1.7 5 / 36 (14%) 2 / 7 (29%) 1 / 7 (14%) 0.286 0.143 1.9e-05 0 6.3e-05 6e-06 0 2e-05 -1.7 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
PWY-5783~octaprenyl diphosphate biosynthesis 0.56 0.84 1 0.88 1 1 0.71 0.99 1 0.69 0.9 1 0.79 0.97 1 0.74 0.93 1 0.0031 0.0031 0.0021 0.0021 0.0021 0.0012 0.002 0.0018 0.0012 -0.07 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.004 0.0021 0.0069 0.0036 0.0029 0.0031 -0.15 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-8015~glycine degradation (Stickland reaction) 0.17 0.8 1 0.11 1 1 0.43 0.91 1 0.18 0.68 1 0.039 0.84 1 0.75 0.93 1 0.0017 0.0017 0.0012 0.0016 0.0012 0.0013 0.0012 0.00084 0.0016 -0.42 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0024 0.0024 0.0012 0.0013 0.001 0.0011 -0.88 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7806~glyphosate degradation II 0.59 0.85 1 0.095 1 1 0.095 0.88 1 0.66 0.9 1 0.15 0.85 1 0.06 0.8 1 0.00078 5e-04 0.00019 0.00067 0.00042 9e-04 0.00022 8.1e-05 0.00029 -1.6 23 / 36 (64%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00052 2.8e-05 0.00068 0.00054 0.00036 0.00065 0.054 6 / 11 (55%) 8 / 11 (73%) 0.545 0.727
PWY-6173~histamine biosynthesis 0.85 0.94 1 0.55 1 1 0.5 0.99 1 0.63 0.89 1 0.63 0.92 1 0.96 0.99 1 0.00038 0.00014 0 8.6e-05 0 0.00015 3.8e-05 0 7.2e-05 -1.2 13 / 36 (36%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 0.00011 0 0.00019 0.00026 0 0.00057 1.2 5 / 11 (45%) 3 / 11 (27%) 0.455 0.273
PWY-6970~acetyl-CoA biosynthesis II (NADP-dependent pyruvate dehydrogenase) 0.89 0.95 1 0.38 1 1 0.35 0.91 1 0.64 0.89 1 0.21 0.87 1 0.2 0.82 1 0.0017 0.00069 0 0.00054 0.00042 0.00081 0.00029 0 0.00069 -0.9 15 / 36 (42%) 4 / 7 (57%) 2 / 7 (29%) 0.571 0.286 0.00077 0 0.0015 0.00095 0 0.0018 0.3 4 / 11 (36%) 5 / 11 (45%) 0.364 0.455
PWY-5123~trans trans-farnesyl diphosphate biosynthesis 0.15 0.8 1 0.11 1 1 0.012 0.64 1 0.049 0.68 1 0.078 0.85 1 0.014 0.68 1 0.00085 0.00038 0 0.00044 0.00034 0.00048 0.00023 0 4e-04 -0.94 16 / 36 (44%) 5 / 7 (71%) 2 / 7 (29%) 0.714 0.286 0.00019 0 0.00049 0.00063 0.00011 0.0012 1.7 3 / 11 (27%) 6 / 11 (55%) 0.273 0.545
PWY-7790~UMP biosynthesis II 0.26 0.8 1 0.39 1 1 0.8 0.99 1 0.22 0.68 1 0.076 0.85 1 0.39 0.88 1 0.024 0.024 0.025 0.021 0.02 0.0044 0.022 0.023 0.0055 0.067 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.024 0.024 0.0085 0.026 0.025 0.0035 0.12 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5005~biotin biosynthesis II 0.68 0.89 1 0.42 1 1 0.65 0.99 1 0.59 0.87 1 0.35 0.92 1 0.57 0.88 1 0.00039 0.00015 0 0.00013 0 0.00018 9.9e-05 0 0.00026 -0.39 14 / 36 (39%) 3 / 7 (43%) 1 / 7 (14%) 0.429 0.143 0.00019 0 0.00025 0.00016 0 0.00022 -0.25 5 / 11 (45%) 5 / 11 (45%) 0.455 0.455
PWY-6901~superpathway of glucose and xylose degradation 0.6 0.85 1 0.89 1 1 0.8 0.99 1 0.75 0.9 1 0.74 0.95 1 0.67 0.9 1 0.0031 0.0029 0.0022 0.0019 0.0018 0.0015 0.0022 0.0024 0.0018 0.21 33 / 36 (92%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0033 0.002 0.0057 0.0034 0.0024 0.0031 0.043 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
METHANOGENESIS-PWY~methanogenesis from H2 and CO2 0.52 0.83 1 0.41 1 1 0.93 0.99 1 0.94 0.98 1 0.91 0.99 1 0.44 0.88 1 0.00037 3.1e-05 0 8.1e-05 0 0.00021 2.4e-05 0 6.3e-05 -1.8 3 / 36 (8.3%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 3.4e-05 0 0.00011 0 0 0 -Inf 1 / 11 (9.1%) 0 / 11 (0%) 0.0909 0
PWY0-781~aspartate superpathway 0.2 0.8 1 0.053 1 1 0.024 0.68 1 0.14 0.68 1 0.081 0.85 1 0.026 0.68 1 0.0019 0.0016 0.001 0.0022 0.0013 0.0022 0.0012 0.00091 0.0011 -0.87 30 / 36 (83%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 0.0014 0.00064 0.0019 0.0017 0.0019 0.0014 0.28 8 / 11 (73%) 10 / 11 (91%) 0.727 0.909
GLUCUROCAT-PWY~superpathway of β-D-glucuronosides degradation 0.079 0.8 1 0.49 1 1 0.14 0.88 1 0.36 0.73 1 0.53 0.92 1 0.54 0.88 1 0.0039 0.0038 0.0038 0.0047 0.004 0.0026 0.0042 0.0045 0.0032 -0.16 35 / 36 (97%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0024 0.0024 0.0017 0.0043 0.005 0.0031 0.84 11 / 11 (100%) 10 / 11 (91%) 1 0.909
PWY-5676~acetyl-CoA fermentation to butanoate II 0.86 0.95 1 0.25 1 1 0.75 0.99 1 0.26 0.69 1 0.11 0.85 1 0.32 0.88 1 0.0015 0.0014 0.001 0.0014 0.0011 0.001 0.0018 0.0018 0.0016 0.36 35 / 36 (97%) 6 / 7 (86%) 7 / 7 (100%) 0.857 1 0.0012 0.00089 0.00096 0.0015 0.0012 0.001 0.32 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-3821~D-galactose detoxification 0.92 0.96 1 0.77 1 1 0.39 0.91 1 0.52 0.84 1 0.58 0.92 1 0.43 0.88 1 0.0011 0.00073 0.00055 0.00068 0.00045 0.00081 0.00074 0 0.0011 0.12 23 / 36 (64%) 4 / 7 (57%) 3 / 7 (43%) 0.571 0.429 0.00063 0.00048 0.00084 0.00087 0.00064 0.00077 0.47 8 / 11 (73%) 8 / 11 (73%) 0.727 0.727
ARGSYNBSUB-PWY~L-arginine biosynthesis II (acetyl cycle) 0.52 0.83 1 0.99 1 1 0.81 0.99 1 0.27 0.7 1 0.42 0.92 1 0.58 0.88 1 0.021 0.021 0.022 0.02 0.018 0.0032 0.02 0.022 0.0066 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.022 0.022 0.007 0.022 0.023 0.0033 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-4121~glutathionylspermidine biosynthesis 0.16 0.8 1 0.2 1 1 0.096 0.88 1 0.097 0.68 1 0.13 0.85 1 0.15 0.8 1 0.00081 0.00029 0 0.00042 0.00011 0.00061 0.00027 0 0.00054 -0.64 13 / 36 (36%) 5 / 7 (71%) 2 / 7 (29%) 0.714 0.286 0.00012 0 0.00024 4e-04 0 0.00084 1.7 3 / 11 (27%) 3 / 11 (27%) 0.273 0.273
BSUBPOLYAMSYN-PWY~spermidine biosynthesis I 0.27 0.8 1 0.32 1 1 0.38 0.91 1 0.15 0.68 1 0.63 0.92 1 0.7 0.91 1 0.00066 0.00055 0.00051 0.00047 0.00031 0.00047 0.00021 0.00019 2e-04 -1.2 30 / 36 (83%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 0.00065 0.00069 4e-04 0.00072 0.00058 0.00056 0.15 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-5686~UMP biosynthesis I 0.19 0.8 1 0.3 1 1 0.98 0.99 1 0.17 0.68 1 0.058 0.85 1 0.27 0.88 1 0.024 0.024 0.025 0.021 0.02 0.0041 0.023 0.022 0.0052 0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.024 0.024 0.0085 0.026 0.026 0.0036 0.12 11 / 11 (100%) 11 / 11 (100%) 1 1
P124-PWY~Bifidobacterium shunt 0.46 0.82 1 0.62 1 1 0.63 0.99 1 0.34 0.71 1 0.29 0.91 1 0.46 0.88 1 0.011 0.011 0.011 0.0095 0.009 0.0019 0.011 0.012 0.0035 0.21 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.012 0.013 0.0069 0.011 0.011 0.0016 -0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-1001~cellulose biosynthesis 0.27 0.8 1 0.094 1 1 0.2 0.91 1 0.33 0.71 1 0.13 0.85 1 0.07 0.8 1 0.0019 0.0012 0.00012 0.0021 0.00012 0.0027 0.0013 2.7e-05 0.0018 -0.69 22 / 36 (61%) 6 / 7 (86%) 4 / 7 (57%) 0.857 0.571 0.001 0 0.0017 0.00071 3e-04 0.001 -0.49 5 / 11 (45%) 7 / 11 (64%) 0.455 0.636
PWY-7968~5-methylbenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 0.48 0.82 1 0.62 1 1 0.32 0.91 1 0.75 0.9 1 0.7 0.93 1 0.87 0.96 1 0.0049 0.0049 0.0047 0.0051 0.0046 0.00092 0.0049 0.0042 0.0019 -0.058 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0046 0.0048 0.0017 0.0052 0.0051 0.002 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7197~pyrimidine deoxyribonucleotide phosphorylation 0.47 0.82 1 0.81 1 1 0.53 0.99 1 0.21 0.68 1 0.95 1 1 0.41 0.88 1 0.00043 0.00029 0.00018 0.00031 0.00022 0.00041 0.00026 6.1e-05 0.00032 -0.25 24 / 36 (67%) 4 / 7 (57%) 4 / 7 (57%) 0.571 0.571 0.00039 0.00026 4e-04 2e-04 9.4e-05 0.00027 -0.96 9 / 11 (82%) 7 / 11 (64%) 0.818 0.636
DENOVOPURINE2-PWY~superpathway of purine nucleotides de novo biosynthesis II 0.81 0.93 1 0.77 1 1 0.86 0.99 1 0.48 0.81 1 0.55 0.92 1 0.42 0.88 1 0.0015 0.001 0.00043 0.00079 0.00052 0.00097 0.00085 0.00063 9e-04 0.11 24 / 36 (67%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 0.00092 0.00041 0.0014 0.0013 0.00016 0.0024 0.5 8 / 11 (73%) 7 / 11 (64%) 0.727 0.636
PWY0-823~L-arginine degradation III (arginine decarboxylase/agmatinase pathway) 0.12 0.8 1 0.0083 0.79 1 0.003 0.54 1 0.68 0.9 1 0.032 0.83 1 0.032 0.68 1 0.006 0.0058 0.0049 0.0076 0.0058 0.005 0.0043 0.0034 0.0032 -0.82 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0048 0.0043 0.0025 0.0066 0.0052 0.0034 0.46 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7111~pyruvate fermentation to isobutanol (engineered) 0.39 0.82 1 0.97 1 1 0.76 0.99 1 0.22 0.68 1 0.35 0.92 1 0.28 0.88 1 0.024 0.024 0.025 0.022 0.023 0.0043 0.023 0.025 0.0084 0.064 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.026 0.027 0.01 0.024 0.025 0.0057 -0.12 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1298~superpathway of pyrimidine deoxyribonucleosides degradation 0.3 0.82 1 0.42 1 1 0.68 0.99 1 0.39 0.74 1 0.52 0.92 1 0.78 0.93 1 0.0028 0.0028 0.0026 0.0027 0.0026 0.001 0.0033 0.0038 0.00091 0.29 35 / 36 (97%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0022 0.0019 0.0014 0.0031 0.0025 0.0019 0.49 10 / 11 (91%) 11 / 11 (100%) 0.909 1
HISTSYN-PWY~L-histidine biosynthesis 0.49 0.83 1 0.35 1 1 0.9 0.99 1 0.26 0.69 1 0.056 0.85 1 0.41 0.88 1 0.0095 0.0095 0.0092 0.0083 0.0079 0.0017 0.0093 0.0089 0.0025 0.16 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0095 0.0092 0.0042 0.01 0.0099 0.0025 0.074 11 / 11 (100%) 11 / 11 (100%) 1 1
ALANINE-DEG3-PWY~L-alanine degradation III 0.023 0.8 1 0.51 1 1 0.66 0.99 1 0.016 0.68 1 0.12 0.85 1 0.36 0.88 1 0.0072 0.0072 0.0064 0.004 0.0046 0.0017 0.0048 0.0039 0.0022 0.26 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0095 0.0076 0.01 0.0086 0.0072 0.0034 -0.14 11 / 11 (100%) 11 / 11 (100%) 1 1
MALTOSECAT-PWY~maltose degradation 0.043 0.8 1 0.097 1 1 0.019 0.64 1 0.036 0.68 1 0.1 0.85 1 0.034 0.68 1 0.00048 0.00017 0 3e-04 0.00028 0.00035 0.00018 0 0.00023 -0.74 13 / 36 (36%) 5 / 7 (71%) 3 / 7 (43%) 0.714 0.429 5.6e-05 0 0.00013 2e-04 0 0.00037 1.8 2 / 11 (18%) 3 / 11 (27%) 0.182 0.273
PWY-4261~glycerol degradation I 0.42 0.82 1 0.21 1 1 0.4 0.91 1 0.49 0.82 1 0.21 0.87 1 0.27 0.88 1 0.0014 0.0011 0.00064 0.0014 0.0011 0.0013 0.0011 0.00062 0.0017 -0.35 27 / 36 (75%) 6 / 7 (86%) 4 / 7 (57%) 0.857 0.571 0.0011 0.00053 0.0015 0.00079 0.00041 0.00073 -0.48 8 / 11 (73%) 9 / 11 (82%) 0.727 0.818
PWY-6470~peptidoglycan biosynthesis V (β-lactam resistance) 0.037 0.8 1 1 1 1 0.52 0.99 1 0.043 0.68 1 0.15 0.85 1 0.37 0.88 1 0.0062 0.0058 0.0036 0.0025 0.0012 0.0024 0.0035 0.0014 0.0042 0.49 34 / 36 (94%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 0.0089 0.0057 0.012 0.0063 0.005 0.0054 -0.5 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6376~desferrioxamine B biosynthesis 0.46 0.82 1 0.48 1 1 0.94 0.99 1 0.29 0.7 1 0.2 0.85 1 0.46 0.88 1 0.0051 0.005 0.0051 0.0047 0.0039 0.0032 0.0045 0.0054 0.0029 -0.063 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0055 0.0055 0.0026 0.0049 0.0048 0.0022 -0.17 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7388~octanoyl-[acyl-carrier protein] biosynthesis (mitochondria yeast) 0.44 0.82 1 0.58 1 1 0.42 0.91 1 0.15 0.68 1 0.37 0.92 1 0.26 0.87 1 0.013 0.013 0.012 0.011 0.0093 0.0036 0.013 0.014 0.005 0.24 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.014 0.011 0.01 0.012 0.015 0.0049 -0.22 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7221~guanosine ribonucleotides de novo biosynthesis 0.99 0.99 1 0.3 1 1 0.88 0.99 1 0.68 0.9 1 0.36 0.92 1 0.8 0.95 1 0.0012 0.00096 0.00068 0.00089 0.00052 0.00066 0.00063 0.00063 0.00044 -0.5 29 / 36 (81%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0011 0.00087 0.0011 0.001 0.00047 0.0015 -0.14 9 / 11 (82%) 7 / 11 (64%) 0.818 0.636
PWY-7003~glycerol degradation to butanol 0.94 0.97 1 0.98 1 1 0.61 0.99 1 0.99 1 1 0.77 0.97 1 0.54 0.88 1 0.0015 0.00059 0 0.00047 0 0.00073 0.00065 0 0.0012 0.47 14 / 36 (39%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 0.00047 0 7e-04 0.00075 0 0.00098 0.67 4 / 11 (36%) 5 / 11 (45%) 0.364 0.455
ASPARAGINESYN-PWY~L-asparagine biosynthesis II 0.35 0.82 1 0.34 1 1 0.33 0.91 1 0.24 0.69 1 0.77 0.97 1 0.82 0.95 1 0.01 0.01 0.01 0.0097 0.0091 0.0023 0.0086 0.0087 0.0015 -0.17 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.012 0.0027 0.011 0.011 0.0027 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6527~stachyose degradation 0.82 0.93 1 0.98 1 1 0.49 0.97 1 0.66 0.9 1 0.67 0.93 1 0.38 0.88 1 0.0017 0.0011 0.00068 8e-04 0.00064 0.00092 0.001 0 0.0014 0.32 22 / 36 (61%) 4 / 7 (57%) 3 / 7 (43%) 0.571 0.429 0.001 0.00083 0.0017 0.0013 7e-04 0.0013 0.38 7 / 11 (64%) 8 / 11 (73%) 0.636 0.727
PWY-7176~UTP and CTP de novo biosynthesis 0.46 0.82 1 0.13 1 1 0.4 0.91 1 0.49 0.82 1 0.24 0.9 1 0.96 0.99 1 0.00098 0.00082 0.00062 0.00095 0.00069 0.00055 6e-04 0.00047 0.00049 -0.66 30 / 36 (83%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 8e-04 0.00051 0.00088 9e-04 0.00048 0.0012 0.17 10 / 11 (91%) 7 / 11 (64%) 0.909 0.636
PWY-6012-1~acyl carrier protein activation 0.4 0.82 1 0.59 1 1 0.53 0.99 1 0.2 0.68 1 0.38 0.92 1 0.34 0.88 1 0.003 0.003 0.0026 0.0024 0.0018 0.00088 0.0028 0.0027 0.0014 0.22 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0034 0.0022 0.0031 0.003 0.0027 0.0017 -0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7356~thiamine salvage IV (yeast) 0.59 0.85 1 0.68 1 1 0.69 0.99 1 0.53 0.84 1 0.73 0.95 1 0.82 0.95 1 0.0045 0.0041 0.0036 0.0034 0.0031 0.002 0.0039 0.0045 0.0027 0.2 33 / 36 (92%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0048 0.0028 0.0059 0.0039 0.0031 0.0025 -0.3 10 / 11 (91%) 11 / 11 (100%) 0.909 1
PWY-4821~UDP-α-D-xylose biosynthesis 0.48 0.82 1 0.55 1 1 0.95 0.99 1 0.75 0.9 1 0.23 0.88 1 0.44 0.88 1 0.0015 0.00038 0 8.6e-05 0 0.00015 0 0 0 -Inf 9 / 36 (25%) 3 / 7 (43%) 0 / 7 (0%) 0.429 0 0.00094 0 0.003 0.00026 0 0.00074 -1.9 3 / 11 (27%) 3 / 11 (27%) 0.273 0.273
LARABITOLUTIL-PWY~xylitol degradation 0.48 0.82 1 0.7 1 1 0.96 0.99 1 0.22 0.68 1 0.44 0.92 1 0.72 0.91 1 0.0034 0.0028 0.0015 0.0019 0.001 0.0023 0.0023 0.0014 0.0027 0.28 30 / 36 (83%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 0.0035 0.001 0.0071 0.0031 0.0019 0.0029 -0.18 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
GLUTATHIONESYN-PWY~glutathione biosynthesis 0.91 0.96 1 0.92 1 1 0.81 0.99 1 0.57 0.86 1 0.78 0.97 1 0.48 0.88 1 0.0015 0.00098 0.00018 4e-04 0.00019 5e-04 0.00045 0.00036 0.00044 0.17 23 / 36 (64%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 5e-04 0.00023 0.00076 0.0022 0 0.0068 2.1 6 / 11 (55%) 5 / 11 (45%) 0.545 0.455
RHAMCAT-PWY~L-rhamnose degradation I 0.4 0.82 1 0.91 1 1 0.64 0.99 1 0.24 0.69 1 0.92 1 1 0.51 0.88 1 0.0011 0.00082 0.00032 0.00062 0.00079 0.00033 0.00071 0.00082 0.00045 0.2 26 / 36 (72%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.00044 0.00021 6e-04 0.0014 0 0.0022 1.7 8 / 11 (73%) 4 / 11 (36%) 0.727 0.364
PWY3O-355~stearate biosynthesis III (fungi) 0.3 0.82 1 0.66 1 1 0.81 0.99 1 0.11 0.68 1 0.13 0.85 1 0.47 0.88 1 0.0054 0.0047 0.0034 0.0028 0.0027 0.0027 0.0033 0.0026 0.0035 0.24 31 / 36 (86%) 5 / 7 (71%) 6 / 7 (86%) 0.714 0.857 0.0054 0.0026 0.0089 0.0059 0.0044 0.0045 0.13 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
P121-PWY~adenine and adenosine salvage I 0.12 0.8 1 0.38 1 1 0.19 0.91 1 0.97 1 1 0.96 1 1 0.55 0.88 1 0.0071 0.0071 0.0072 0.0078 0.008 0.0016 0.007 0.0075 0.0018 -0.16 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0066 0.0065 0.0023 0.0072 0.0071 0.0015 0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
ASPARTATESYN-PWY~L-aspartate biosynthesis 0.33 0.82 1 0.14 1 1 0.2 0.91 1 0.1 0.68 1 0.023 0.82 1 0.059 0.8 1 0.02 0.02 0.019 0.017 0.017 0.0047 0.021 0.023 0.0057 0.3 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.022 0.017 0.015 0.02 0.019 0.0069 -0.14 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY66-409~superpathway of purine nucleotide salvage 0.89 0.95 1 0.32 1 1 0.21 0.91 1 0.64 0.89 1 0.18 0.85 1 0.17 0.8 1 0.0013 0.00088 0.00043 0.00068 4e-04 0.00054 0.00045 0.00063 0.00044 -0.6 25 / 36 (69%) 6 / 7 (86%) 4 / 7 (57%) 0.857 0.571 0.00082 0.00048 0.00086 0.0013 0.00036 0.0021 0.66 7 / 11 (64%) 8 / 11 (73%) 0.636 0.727
PWY-6628~superpathway of L-phenylalanine biosynthesis 0.54 0.84 1 0.75 1 1 0.97 0.99 1 0.31 0.71 1 0.43 0.92 1 0.83 0.95 1 0.011 0.011 0.01 0.0092 0.0081 0.0027 0.01 0.0096 0.0051 0.12 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.0086 0.0076 0.011 0.011 0.0027 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7208~superpathway of pyrimidine nucleobases salvage 0.4 0.82 1 0.048 1 1 0.12 0.88 1 0.33 0.71 1 0.065 0.85 1 0.34 0.88 1 0.00099 0.00077 0.00052 0.00087 0.00066 0.00046 0.00053 0.00049 0.00052 -0.72 28 / 36 (78%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 0.00075 0.00033 0.00097 0.00088 0.00051 0.0012 0.23 9 / 11 (82%) 7 / 11 (64%) 0.818 0.636
PWY-6277~superpathway of 5-aminoimidazole ribonucleotide biosynthesis 0.032 0.8 1 0.64 1 1 0.31 0.91 1 1 1 1 0.4 0.92 1 0.85 0.96 1 0.014 0.014 0.014 0.016 0.017 0.0036 0.015 0.016 0.0026 -0.093 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.013 0.013 0.0031 0.014 0.013 0.0027 0.11 11 / 11 (100%) 11 / 11 (100%) 1 1
ETOH-ACETYLCOA-ANA-PWY~ethanol degradation I 0.66 0.88 1 0.84 1 1 0.95 0.99 1 0.42 0.75 1 0.86 0.99 1 0.92 0.98 1 0.0033 0.0033 0.0021 0.0029 0.0019 0.0026 0.0029 0.0014 0.0028 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0041 0.0025 0.006 0.0032 0.0026 0.0025 -0.36 11 / 11 (100%) 11 / 11 (100%) 1 1
PROSYN-PWY~L-proline biosynthesis I 0.15 0.8 1 0.91 1 1 0.99 1 1 0.12 0.68 1 0.47 0.92 1 0.56 0.88 1 0.011 0.011 0.01 0.0092 0.0093 0.00073 0.0097 0.0091 0.0041 0.076 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.012 0.011 0.0044 0.011 0.012 0.0015 -0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
GLUCONEO-PWY~gluconeogenesis I 0.34 0.82 1 0.41 1 1 0.032 0.76 1 0.99 1 1 0.99 1 1 0.074 0.8 1 0.0075 0.0075 0.0074 0.0075 0.0077 0.0014 0.0068 0.0066 0.002 -0.14 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0067 0.0068 0.0029 0.0088 0.0091 0.0032 0.39 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7199~pyrimidine deoxyribonucleosides salvage 0.58 0.85 1 0.34 1 1 0.4 0.91 1 0.98 1 1 0.48 0.92 1 0.92 0.98 1 0.0012 0.00093 6e-04 0.0011 0.0012 0.00082 0.00074 0.00076 0.00062 -0.57 29 / 36 (81%) 6 / 7 (86%) 5 / 7 (71%) 0.857 0.714 0.00079 0.00053 0.00083 0.0011 0.00048 0.0015 0.48 10 / 11 (91%) 8 / 11 (73%) 0.909 0.727
RIBOKIN-PWY~ribose phosphorylation 0.41 0.82 1 0.78 1 1 0.84 0.99 1 0.99 1 1 0.86 0.99 1 0.69 0.91 1 0.00065 0.00056 0.00036 0.00081 0.00048 0.001 0.00084 0.00039 0.0012 0.052 31 / 36 (86%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.00042 0.00036 0.00027 0.00038 0.00028 3e-04 -0.14 10 / 11 (91%) 9 / 11 (82%) 0.909 0.818
GLUTAMATE-DEG1-PWY~L-glutamate degradation I 0.058 0.8 1 0.13 1 1 0.0093 0.64 1 0.17 0.68 1 0.24 0.9 1 0.053 0.8 1 0.0025 0.0025 0.0023 0.0029 0.0033 0.00092 0.002 0.002 0.0017 -0.54 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0016 0.0015 0.001 0.0034 0.0035 0.0022 1.1 11 / 11 (100%) 11 / 11 (100%) 1 1
FOLSYN-PWY~superpathway of tetrahydrofolate biosynthesis and salvage 0.33 0.82 1 0.66 1 1 0.15 0.88 1 0.18 0.68 1 0.88 0.99 1 0.27 0.88 1 0.00084 0.00021 0 0.00022 0 0.00034 0.00016 0 0.00027 -0.46 9 / 36 (25%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 9.6e-05 0 0.00032 0.00035 0 0.00083 1.9 1 / 11 (9.1%) 2 / 11 (18%) 0.0909 0.182
PWY-4101~D-sorbitol degradation I 0.086 0.8 1 0.42 1 1 0.34 0.91 1 0.12 0.68 1 0.32 0.92 1 0.24 0.84 1 0.014 0.014 0.014 0.011 0.01 0.0037 0.013 0.013 0.0081 0.24 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.015 0.015 0.0039 0.014 0.014 0.0027 -0.1 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5831~CDP-abequose biosynthesis 0.72 0.89 1 0.9 1 1 0.66 0.99 1 0.4 0.75 1 0.95 1 1 1 1 1 0.00028 4.6e-05 0 9.2e-06 0 2.4e-05 3.9e-06 0 1e-05 -1.2 6 / 36 (17%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 2.9e-05 0 7.1e-05 0.00011 0 0.00037 1.9 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
PWY-5344~L-homocysteine biosynthesis 0.08 0.8 1 0.72 1 1 0.85 0.99 1 0.14 0.68 1 0.19 0.85 1 0.41 0.88 1 0.023 0.023 0.023 0.019 0.019 0.003 0.02 0.02 0.0062 0.074 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.024 0.025 0.0078 0.025 0.025 0.0038 0.059 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7247~β-D-glucuronide and D-glucuronate degradation 0.076 0.8 1 0.77 1 1 0.25 0.91 1 0.48 0.81 1 0.96 1 1 0.61 0.89 1 0.0074 0.0074 0.0068 0.0085 0.0084 0.0033 0.0083 0.0092 0.0047 -0.034 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0055 0.006 0.0019 0.0079 0.0072 0.004 0.52 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1477~ethanolamine utilization 0.42 0.82 1 0.79 1 1 0.74 0.99 1 0.34 0.71 1 0.37 0.92 1 0.73 0.91 1 0.0032 0.0031 0.0022 0.0024 0.0019 0.002 0.0025 0.0024 0.0022 0.059 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0041 0.0023 0.0059 0.0029 0.0025 0.0024 -0.5 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5490~paraoxon degradation 0.2 0.8 1 0.35 1 1 0.41 0.91 1 0.21 0.68 1 0.56 0.92 1 0.53 0.88 1 0.00052 8.6e-05 0 0.00016 0 0.00035 0.00027 0 0.00066 0.75 6 / 36 (17%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 7.9e-06 0 2.6e-05 5.4e-06 0 1.8e-05 -0.55 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
PWY-7229~superpathway of adenosine nucleotides de novo biosynthesis I 0.77 0.91 1 0.6 1 1 0.46 0.93 1 0.69 0.9 1 0.82 0.98 1 0.87 0.96 1 0.0073 0.0073 0.006 0.0073 0.0067 0.0023 0.0068 0.008 0.0024 -0.1 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0074 0.0054 0.0056 0.0075 0.0061 0.0033 0.019 11 / 11 (100%) 11 / 11 (100%) 1 1
LACTOSECAT-PWY~lactose and galactose degradation I 0.13 0.8 1 0.36 1 1 0.038 0.76 1 0.13 0.68 1 0.4 0.92 1 0.033 0.68 1 0.00084 0.00047 0.00026 0.00024 0 0.00035 0.00046 0 0.00062 0.94 20 / 36 (56%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 0.00076 0.00048 0.0012 0.00033 0.00018 0.00044 -1.2 8 / 11 (73%) 6 / 11 (55%) 0.727 0.545
PWY-6827~gellan degradation 0.7 0.89 1 0.91 1 1 0.36 0.91 1 0.5 0.82 1 0.61 0.92 1 0.2 0.82 1 0.00016 1.4e-05 0 8.1e-06 0 2.1e-05 1.1e-05 0 2.9e-05 0.44 3 / 36 (8.3%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 3.3e-05 0 0.00011 0 0 0 -Inf 1 / 11 (9.1%) 0 / 11 (0%) 0.0909 0
PWY-6057~dimethyl sulfide degradation III (oxidation) 1 1 1 0.64 1 1 0.25 0.91 1 0.75 0.9 1 0.44 0.92 1 0.14 0.8 1 0.00021 1.8e-05 0 1.6e-05 0 4.2e-05 3.4e-05 0 9.1e-05 1.1 3 / 36 (8.3%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 2.6e-05 0 8.5e-05 0 0 0 -Inf 1 / 11 (9.1%) 0 / 11 (0%) 0.0909 0
PWY0-662~PRPP biosynthesis 0.36 0.82 1 0.65 1 1 0.81 0.99 1 0.21 0.68 1 0.56 0.92 1 0.28 0.88 1 0.025 0.025 0.026 0.024 0.025 0.0067 0.023 0.022 0.0082 -0.061 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.027 0.025 0.0093 0.025 0.026 0.0044 -0.11 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY4LZ-257~superpathway of fermentation (Chlamydomonas reinhardtii) 0.25 0.8 1 0.74 1 1 0.86 0.99 1 0.36 0.73 1 0.86 0.99 1 0.83 0.95 1 0.0019 0.00031 0 0.00075 0 0.0019 0.00054 0 0.0013 -0.47 6 / 36 (17%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 0.00012 0 4e-04 8.9e-05 0 0.00029 -0.43 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
PWY-7581~N-acetylneuraminate and N-acetylmannosamine degradation II 0.24 0.8 1 0.42 1 1 0.086 0.88 1 0.073 0.68 1 0.19 0.85 1 0.062 0.8 1 0.00064 0.00016 0 0.00011 0.00014 0.00012 6e-05 0 0.00011 -0.87 9 / 36 (25%) 4 / 7 (57%) 2 / 7 (29%) 0.571 0.286 2.5e-05 0 8.4e-05 0.00039 0 0.00087 4 1 / 11 (9.1%) 2 / 11 (18%) 0.0909 0.182
PWY-7686~L-malate degradation II 0.076 0.8 1 0.0086 0.79 1 0.0015 0.54 0.81 0.94 0.98 1 0.051 0.85 1 0.0061 0.68 1 0.0069 0.0069 0.0069 0.0079 0.0081 0.002 0.0059 0.0048 0.002 -0.42 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0063 0.0067 0.0017 0.0076 0.007 0.002 0.27 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7179-1~purine deoxyribonucleosides degradation II 0.58 0.85 1 0.12 1 1 0.42 0.91 1 0.35 0.72 1 0.075 0.85 1 0.4 0.88 1 0.0036 0.0036 0.0033 0.0035 0.0032 0.0021 0.0029 0.0024 0.0022 -0.27 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.004 0.0039 0.0022 0.0036 0.0037 0.0015 -0.15 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1309~chitobiose degradation 0.53 0.84 1 0.77 1 1 0.93 0.99 1 0.91 0.98 1 0.53 0.92 1 0.41 0.88 1 0.007 0.002 0 0.0034 0 0.0066 0.0016 0 0.0021 -1.1 10 / 36 (28%) 2 / 7 (29%) 3 / 7 (43%) 0.286 0.429 0.0016 0 0.0041 0.0015 0 0.0036 -0.093 3 / 11 (27%) 2 / 11 (18%) 0.273 0.182
PWY-5853~demethylmenaquinol-6 biosynthesis I 0.55 0.84 1 0.56 1 1 0.91 0.99 1 0.85 0.94 1 0.52 0.92 1 0.9 0.97 1 0.0027 0.0026 0.0015 0.0016 9e-04 0.0012 0.0021 0.0026 0.0017 0.39 34 / 36 (94%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0031 0.00097 0.0052 0.003 0.0034 0.0025 -0.047 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
DTDPRHAMSYN-PWY~dTDP-L-rhamnose biosynthesis 0.11 0.8 1 0.62 1 1 0.068 0.88 1 0.93 0.98 1 0.61 0.92 1 0.39 0.88 1 0.01 0.01 0.01 0.011 0.011 0.0019 0.01 0.01 0.002 -0.14 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0087 0.0085 0.0028 0.011 0.011 0.0037 0.34 11 / 11 (100%) 11 / 11 (100%) 1 1
ACETATEUTIL-PWY~superpathway of acetate utilization and formation 0.16 0.8 1 0.63 1 1 0.24 0.91 1 0.06 0.68 1 0.25 0.9 1 0.23 0.82 1 0.002 0.0013 0.00064 0.0014 0.0014 0.001 0.0018 0.00082 0.0022 0.36 24 / 36 (67%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 0.00076 9.4e-05 0.0012 0.0016 0.00034 0.0025 1.1 6 / 11 (55%) 6 / 11 (55%) 0.545 0.545
PWY-7167~choline degradation III 0.21 0.8 1 0.84 1 1 0.89 0.99 1 0.49 0.81 1 0.76 0.97 1 0.61 0.89 1 0.0011 0.00024 0 0.00059 0 0.0014 0.00049 0 0.0011 -0.27 8 / 36 (22%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 5.6e-05 0 0.00012 3.1e-05 0 8e-05 -0.85 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
N2FIX-PWY~nitrogen fixation I (ferredoxin) 0.26 0.8 1 0.46 1 1 0.97 0.99 1 0.2 0.68 1 0.92 0.99 1 0.48 0.88 1 0.009 0.009 0.0088 0.0084 0.0077 0.0027 0.0076 0.0062 0.0037 -0.14 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.01 0.0088 0.003 0.0092 0.0096 0.0033 -0.12 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-541~cyclopropane fatty acid (CFA) biosynthesis 0.65 0.88 1 0.35 1 1 0.11 0.88 1 0.63 0.89 1 0.13 0.85 1 0.021 0.68 1 0.0036 0.0036 0.0032 0.004 0.0035 0.0023 0.0046 0.0044 0.0025 0.2 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0035 0.0028 0.0014 0.0029 0.0028 0.0012 -0.27 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7761~NAD salvage pathway II (PNC IV cycle) 0.31 0.82 1 0.013 0.94 1 0.048 0.76 1 0.36 0.73 1 0.02 0.82 1 0.15 0.8 1 0.00098 0.00046 0 0.00066 0.00075 0.00061 3e-04 0 0.00048 -1.1 17 / 36 (47%) 5 / 7 (71%) 3 / 7 (43%) 0.714 0.429 0.00039 0 0.00056 0.00052 0 0.00095 0.42 5 / 11 (45%) 4 / 11 (36%) 0.455 0.364
PWY-1042~glycolysis IV (plant cytosol) 0.29 0.82 1 1 1 1 0.43 0.91 1 0.7 0.9 1 0.1 0.85 1 0.61 0.89 1 0.015 0.015 0.014 0.015 0.014 0.0029 0.015 0.017 0.0032 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.014 0.013 0.004 0.015 0.015 0.0022 0.1 11 / 11 (100%) 11 / 11 (100%) 1 1
GLYCOLYSIS-E-D~superpathway of glycolysis and the Entner-Doudoroff pathway 0.27 0.8 1 0.9 1 1 0.38 0.91 1 0.12 0.68 1 0.61 0.92 1 0.48 0.88 1 0.0021 0.00065 0 0.00062 0.00027 7e-04 0.00079 0 0.0014 0.35 11 / 36 (31%) 4 / 7 (57%) 3 / 7 (43%) 0.571 0.429 0.00029 0 0.00086 0.00095 0 0.0022 1.7 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
HSERMETANA-PWY~L-methionine biosynthesis III 0.094 0.8 1 0.69 1 1 0.88 0.99 1 0.14 0.68 1 0.37 0.92 1 0.58 0.88 1 0.011 0.011 0.012 0.0087 0.0091 0.0031 0.0097 0.012 0.0054 0.16 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.013 0.013 0.0056 0.013 0.012 0.0036 0 11 / 11 (100%) 11 / 11 (100%) 1 1
GLYCOCAT-PWY~glycogen degradation I 0.76 0.9 1 0.21 1 1 0.011 0.64 1 0.79 0.91 1 0.42 0.92 1 0.031 0.68 1 0.014 0.014 0.014 0.013 0.013 0.0027 0.011 0.0084 0.0056 -0.24 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.013 0.014 0.006 0.018 0.019 0.0073 0.47 11 / 11 (100%) 11 / 11 (100%) 1 1
PYRIDOXSYN-PWY~pyridoxal 5-phosphate biosynthesis I 0.22 0.8 1 0.83 1 1 0.35 0.91 1 0.13 0.68 1 0.84 0.99 1 0.42 0.88 1 0.0026 0.00066 0 0.00072 0 0.00092 0.00097 0 0.0017 0.43 9 / 36 (25%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 2e-04 0 0.00068 0.00087 0 0.0023 2.1 1 / 11 (9.1%) 2 / 11 (18%) 0.0909 0.182
PHOSPHONOTASE-PWY~2-aminoethylphosphonate degradation I 0.79 0.92 1 0.18 1 1 0.85 0.99 1 0.97 1 1 0.11 0.85 1 0.53 0.88 1 0.00034 5.7e-05 0 5.3e-05 0 0.00014 8.3e-05 0 2e-04 0.65 6 / 36 (17%) 1 / 7 (14%) 2 / 7 (29%) 0.143 0.286 3.8e-05 0 0.00013 6.2e-05 0 0.00017 0.71 1 / 11 (9.1%) 2 / 11 (18%) 0.0909 0.182
PWY-5838~superpathway of menaquinol-8 biosynthesis I 0.21 0.8 1 0.67 1 1 0.26 0.91 1 0.29 0.71 1 0.85 0.99 1 0.56 0.88 1 0.00075 6.3e-05 0 0.00015 0 0.00039 9.5e-05 0 0.00025 -0.66 3 / 36 (8.3%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 0 0 0 5.1e-05 0 0.00017 Inf 0 / 11 (0%) 1 / 11 (9.1%) 0 0.0909
PWY-5100~pyruvate fermentation to acetate and lactate II 0.93 0.97 1 0.53 1 1 0.74 0.99 1 0.44 0.77 1 0.73 0.95 1 0.96 0.99 1 0.011 0.011 0.011 0.011 0.012 0.0039 0.01 0.012 0.0051 -0.14 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.011 0.0032 0.011 0.011 0.0025 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6285~superpathway of fatty acids biosynthesis (E. coli) 0.87 0.95 1 0.93 1 1 0.14 0.88 1 0.55 0.85 1 1 1 1 0.23 0.82 1 0.0044 0.0044 0.0032 0.0033 0.0037 0.0026 0.0038 0.0026 0.004 0.2 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0039 0.0029 0.0042 0.006 0.0042 0.0044 0.62 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6019~pseudouridine degradation 0.23 0.8 1 0.32 1 1 0.64 0.99 1 0.44 0.77 1 0.78 0.97 1 0.97 0.99 1 0.0014 0.00019 0 0.00055 0 0.0014 0.00034 0 0.00091 -0.69 5 / 36 (14%) 2 / 7 (29%) 1 / 7 (14%) 0.286 0.143 4.8e-05 0 0.00016 1.2e-05 0 4e-05 -2 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
MALATE-ASPARTATE-SHUTTLE-PWY~L-aspartate degradation II 0.5 0.83 1 0.74 1 1 0.91 0.99 1 0.87 0.95 1 0.54 0.92 1 0.52 0.88 1 0.0028 0.0028 0.0019 0.0028 0.0033 0.0016 0.0033 0.002 0.0033 0.24 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0021 0.0013 0.0016 0.003 0.0017 0.0038 0.51 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6807~xyloglucan degradation II (exoglucanase) 0.66 0.88 1 1 1 1 0.22 0.91 1 0.34 0.71 1 0.79 0.97 1 0.39 0.88 1 0.008 0.00067 0 0 0 0 0 0 0 NA 3 / 36 (8.3%) 0 / 7 (0%) 0 / 7 (0%) 0 0 0.00029 0 0.00095 0.0019 0 0.0052 2.7 1 / 11 (9.1%) 2 / 11 (18%) 0.0909 0.182
FUC-RHAMCAT-PWY~superpathway of fucose and rhamnose degradation 0.032 0.8 1 0.52 1 1 0.14 0.88 1 0.02 0.68 1 0.5 0.92 1 0.13 0.8 1 0.001 2e-04 0 0.00042 0 0.00064 4e-04 0 0.00069 -0.07 7 / 36 (19%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 0 0 0 0.00012 0 0.00034 Inf 0 / 11 (0%) 2 / 11 (18%) 0 0.182
PHOSLIPSYN-PWY~superpathway of phospholipid biosynthesis I (bacteria) 0.23 0.8 1 0.87 1 1 0.34 0.91 1 0.34 0.71 1 0.77 0.97 1 0.59 0.88 1 9e-04 7.5e-05 0 0.00016 0 0.00042 0.00013 0 0.00036 -0.3 3 / 36 (8.3%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 0 0 0 6e-05 0 2e-04 Inf 0 / 11 (0%) 1 / 11 (9.1%) 0 0.0909
GALACTUROCAT-PWY~D-galacturonate degradation I 0.048 0.8 1 0.12 1 1 0.026 0.71 1 0.19 0.68 1 0.25 0.9 1 0.12 0.8 1 0.0034 0.0034 0.003 0.0044 0.0039 0.0021 0.0029 0.0025 0.002 -0.6 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0024 0.002 0.0014 0.0042 0.0055 0.0029 0.81 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5659~GDP-mannose biosynthesis 0.43 0.82 1 0.95 1 1 0.72 0.99 1 0.4 0.75 1 0.52 0.92 1 0.57 0.88 1 0.0029 0.0026 0.0021 0.0021 0.0018 0.002 0.0026 0.0013 0.0028 0.31 32 / 36 (89%) 6 / 7 (86%) 5 / 7 (71%) 0.857 0.714 0.0028 0.0028 0.0018 0.0026 0.0021 0.0022 -0.11 10 / 11 (91%) 11 / 11 (100%) 0.909 1
PWY-5194~siroheme biosynthesis 0.34 0.82 1 0.032 1 1 0.11 0.88 1 0.41 0.75 1 0.096 0.85 1 0.16 0.8 1 0.00049 0.00044 3e-04 0.00057 0.00042 0.00033 0.00025 3e-04 0.00012 -1.2 32 / 36 (89%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.00049 0.00036 0.00051 0.00042 3e-04 0.00037 -0.22 9 / 11 (82%) 10 / 11 (91%) 0.818 0.909
PWY0-1313~acetate conversion to acetyl-CoA 0.69 0.89 1 0.44 1 1 0.12 0.88 1 0.62 0.89 1 0.23 0.88 1 0.071 0.8 1 0.0035 0.0033 0.0033 0.0031 0.0031 0.0014 0.003 0.0045 0.0023 -0.047 34 / 36 (94%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0031 0.0025 0.0025 0.0038 0.0045 0.0023 0.29 10 / 11 (91%) 11 / 11 (100%) 0.909 1
PWY-5669~phosphatidylethanolamine biosynthesis I 0.66 0.88 1 0.99 1 1 0.27 0.91 1 0.41 0.75 1 0.64 0.92 1 0.45 0.88 1 0.0029 0.0029 0.0029 0.0025 0.0027 0.00082 0.0026 0.0019 0.0015 0.057 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0028 0.0028 0.0014 0.0035 0.0035 0.0011 0.32 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5156~superpathway of fatty acid biosynthesis II (plant) 0.98 0.99 1 0.82 1 1 0.1 0.88 1 0.92 0.98 1 0.18 0.85 1 0.072 0.8 1 0.0045 0.0042 0.0029 0.0032 0.0037 0.0024 0.0037 0.0026 0.0038 0.21 33 / 36 (92%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0037 0.0029 0.0042 0.0055 0.0035 0.0044 0.57 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-7970~benzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 0.48 0.82 1 0.62 1 1 0.32 0.91 1 0.75 0.9 1 0.7 0.93 1 0.87 0.96 1 0.0049 0.0049 0.0047 0.0051 0.0046 0.00092 0.0049 0.0042 0.0019 -0.058 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0046 0.0048 0.0017 0.0052 0.0051 0.002 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7205~CMP phosphorylation 0.83 0.93 1 0.97 1 1 0.6 0.99 1 0.39 0.74 1 0.51 0.92 1 0.11 0.8 1 0.00065 0.00058 0.00043 0.00057 0.00042 0.00042 0.00048 0.00048 0.00026 -0.25 32 / 36 (89%) 6 / 7 (86%) 7 / 7 (100%) 0.857 1 0.00061 0.00044 0.00052 0.00063 0.00035 0.00084 0.047 11 / 11 (100%) 8 / 11 (73%) 1 0.727
GLUGLNSYN-PWY~L-glutamate biosynthesis IV 0.81 0.93 1 0.32 1 1 0.092 0.88 1 0.45 0.79 1 0.9 0.99 1 0.41 0.88 1 0.038 0.038 0.039 0.036 0.039 0.007 0.033 0.032 0.014 -0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.038 0.045 0.014 0.043 0.042 0.013 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6617~adenosine nucleotides degradation III 0.14 0.8 1 0.37 1 1 0.23 0.91 1 0.1 0.68 1 0.42 0.92 1 0.49 0.88 1 0.001 0.00046 0 0.00067 0.00029 0.00091 0.00052 5.4e-05 0.00078 -0.37 16 / 36 (44%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00023 0 0.00051 0.00052 0 0.0011 1.2 4 / 11 (36%) 3 / 11 (27%) 0.364 0.273
PWY-5148~acyl-CoA hydrolysis 0.18 0.8 1 0.37 1 1 0.61 0.99 1 0.34 0.71 1 0.27 0.9 1 0.44 0.88 1 0.00027 8.2e-05 0 0.00013 0 2e-04 0.00018 0.00016 0.00019 0.47 11 / 36 (31%) 3 / 7 (43%) 4 / 7 (57%) 0.429 0.571 2.6e-05 0 5.8e-05 5.1e-05 0 0.00012 0.97 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
GDPRHAMSYN-PWY~GDP-D-rhamnose biosynthesis 0.52 0.83 1 0.14 1 1 0.15 0.88 1 0.53 0.84 1 0.12 0.85 1 0.25 0.85 1 0.0011 0.00036 0 0.00041 0.00014 0.00059 0.00015 0 4e-04 -1.5 12 / 36 (33%) 4 / 7 (57%) 1 / 7 (14%) 0.571 0.143 0.00028 0 0.00054 0.00054 0 0.001 0.95 4 / 11 (36%) 3 / 11 (27%) 0.364 0.273
PWY-6406~salicylate biosynthesis I 0.22 0.8 1 0.22 1 1 0.69 0.99 1 0.52 0.84 1 0.9 0.99 1 0.31 0.88 1 8e-04 6.7e-05 0 0.00022 0 0.00058 0.00011 0 0.00028 -1 3 / 36 (8.3%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 1.1e-05 0 3.6e-05 0 0 0 -Inf 1 / 11 (9.1%) 0 / 11 (0%) 0.0909 0
PLPSAL-PWY~pyridoxal 5-phosphate salvage I 0.48 0.82 1 0.67 1 1 0.26 0.91 1 0.65 0.89 1 0.84 0.99 1 0.4 0.88 1 0.0011 0.00075 0.00047 0.00071 0.00049 0.00066 0.00092 0.00066 0.00095 0.37 25 / 36 (69%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 0.00047 0.00026 0.00068 0.00095 0.00068 0.001 1 7 / 11 (64%) 8 / 11 (73%) 0.636 0.727
PWY-7242~D-fructuronate degradation 0.56 0.84 1 0.83 1 1 0.24 0.91 1 0.86 0.94 1 0.96 1 1 0.73 0.92 1 0.0024 0.002 0.0013 0.0021 0.0012 0.0024 0.0018 0.00091 0.0017 -0.22 30 / 36 (83%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0014 0.0014 0.0011 0.0028 0.0032 0.0025 1 9 / 11 (82%) 9 / 11 (82%) 0.818 0.818
PWY-6164~3-dehydroquinate biosynthesis I 0.34 0.82 1 0.8 1 1 0.88 0.99 1 0.18 0.68 1 0.55 0.92 1 0.59 0.88 1 0.019 0.019 0.018 0.017 0.017 0.0024 0.017 0.017 0.0055 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.021 0.019 0.012 0.02 0.019 0.0046 -0.07 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-724~superpathway of L-lysine L-threonine and L-methionine biosynthesis II 0.13 0.8 1 0.77 1 1 0.83 0.99 1 0.13 0.68 1 0.99 1 1 0.89 0.97 1 0.0094 0.0094 0.0097 0.0069 0.0064 0.0028 0.008 0.01 0.0044 0.21 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.011 0.0075 0.01 0.01 0.0031 -0.14 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7346~UDP-α-D-glucuronate biosynthesis (from UDP-glucose) 0.59 0.85 1 0.34 1 1 0.26 0.91 1 0.26 0.69 1 0.16 0.85 1 0.11 0.8 1 0.011 0.011 0.01 0.01 0.0097 0.0027 0.012 0.01 0.004 0.26 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.0099 0.0042 0.01 0.011 0.0045 -0.14 11 / 11 (100%) 11 / 11 (100%) 1 1
DAPLYSINESYN-PWY~L-lysine biosynthesis I 0.44 0.82 1 0.94 1 1 0.97 0.99 1 0.69 0.9 1 0.84 0.99 1 0.71 0.91 1 0.0032 0.0027 0.0016 0.0015 0.0016 0.0012 0.0017 0.0017 0.0015 0.18 31 / 36 (86%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.004 0.0015 0.0078 0.0029 0.0015 0.0028 -0.46 9 / 11 (82%) 10 / 11 (91%) 0.818 0.909
HISDEG-PWY~L-histidine degradation I 0.026 0.8 1 0.17 1 1 0.46 0.93 1 0.041 0.68 1 0.12 0.85 1 0.38 0.88 1 0.00024 5.3e-05 0 8.8e-05 0 0.00013 0.00017 0.00011 0.00022 0.95 8 / 36 (22%) 3 / 7 (43%) 4 / 7 (57%) 0.429 0.571 0 0 0 1.1e-05 0 3.6e-05 Inf 0 / 11 (0%) 1 / 11 (9.1%) 0 0.0909
PWY-7518~atromentin biosynthesis 0.6 0.85 1 0.97 1 1 0.53 0.99 1 0.37 0.73 1 0.94 1 1 0.5 0.88 1 0.00076 0.00059 0.00046 0.00055 0.00033 6e-04 0.00058 0.00047 0.00067 0.077 28 / 36 (78%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 0.00069 0.00056 0.00077 0.00053 0.00045 0.00053 -0.38 10 / 11 (91%) 8 / 11 (73%) 0.909 0.727
PWY-2161~folate polyglutamylation 0.21 0.8 1 0.71 1 1 0.51 0.99 1 0.2 0.68 1 0.28 0.91 1 0.25 0.86 1 0.013 0.013 0.013 0.011 0.012 0.0038 0.012 0.014 0.0058 0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.015 0.016 0.0073 0.013 0.013 0.0027 -0.21 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7432~L-phenylalanine biosynthesis III (cytosolic plants) 0.56 0.84 1 0.88 1 1 0.36 0.91 1 0.15 0.68 1 0.47 0.92 1 0.11 0.8 1 0.00095 0.00071 0.00052 0.00074 0.00038 0.00088 0.00071 0.00066 8e-04 -0.06 27 / 36 (75%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 0.00081 0.00057 0.0011 0.00059 0.00044 0.00054 -0.46 10 / 11 (91%) 8 / 11 (73%) 0.909 0.727
PWY66-162~ethanol degradation IV 0.22 0.8 1 0.37 1 1 1 1 1 0.44 0.78 1 0.67 0.93 1 0.2 0.82 1 0.0015 0.00013 0 0.00036 0 0.00096 0.00028 0 0.00073 -0.36 3 / 36 (8.3%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 9.4e-06 0 3.1e-05 0 0 0 -Inf 1 / 11 (9.1%) 0 / 11 (0%) 0.0909 0
PWY-622~starch biosynthesis 0.12 0.8 1 0.62 1 1 0.56 0.99 1 0.092 0.68 1 0.26 0.9 1 0.34 0.88 1 0.0083 0.0062 0.002 0.0021 0.00074 0.0029 0.0027 0.002 0.0038 0.36 27 / 36 (75%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 0.01 0.0041 0.022 0.007 0.0053 0.0077 -0.51 9 / 11 (82%) 9 / 11 (82%) 0.818 0.818
PWY0-1545~cardiolipin biosynthesis III 0.56 0.84 1 0.99 1 1 0.34 0.91 1 0.73 0.9 1 0.98 1 1 0.39 0.88 1 0.00033 0.00013 0 0.00013 0 0.00022 0.00017 0 4e-04 0.39 14 / 36 (39%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 6.4e-05 0 0.00013 0.00017 0 0.00029 1.4 3 / 11 (27%) 5 / 11 (45%) 0.273 0.455
PWY-7685~L-malate degradation I 0.55 0.84 1 0.17 1 1 0.55 0.99 1 0.3 0.71 1 0.057 0.85 1 0.16 0.8 1 0.00013 1e-05 0 0 0 0 7.7e-06 0 2e-05 Inf 3 / 36 (8.3%) 0 / 7 (0%) 1 / 7 (14%) 0 0.143 8.8e-06 0 2.9e-05 2.1e-05 0 6.8e-05 1.3 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
PWY-6612~superpathway of tetrahydrofolate biosynthesis 0.32 0.82 1 0.66 1 1 0.094 0.88 1 0.18 0.68 1 0.88 0.99 1 0.16 0.8 1 0.00075 0.00021 0 0.00021 0 0.00034 0.00016 0 0.00029 -0.39 10 / 36 (28%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 9.4e-05 0 0.00031 0.00035 0 0.00079 1.9 1 / 11 (9.1%) 3 / 11 (27%) 0.0909 0.273
PWY-621~sucrose degradation III (sucrose invertase) 0.096 0.8 1 0.27 1 1 0.21 0.91 1 0.09 0.68 1 0.09 0.85 1 0.11 0.8 1 0.015 0.015 0.015 0.011 0.011 0.0052 0.014 0.018 0.0081 0.35 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.017 0.016 0.011 0.015 0.015 0.0038 -0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-2781~cis-zeatin biosynthesis 0.37 0.82 1 0.21 1 1 0.42 0.91 1 0.15 0.68 1 0.82 0.98 1 0.62 0.89 1 0.012 0.012 0.012 0.012 0.012 0.0016 0.011 0.01 0.0025 -0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.013 0.013 0.0045 0.013 0.013 0.0023 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-283~benzoate degradation II (aerobic and anaerobic) 0.83 0.93 1 0.59 1 1 0.21 0.91 1 0.99 1 1 0.58 0.92 1 0.34 0.88 1 0.0021 0.00023 0 0.00012 0 0.00031 0 0 0 -Inf 4 / 36 (11%) 1 / 7 (14%) 0 / 7 (0%) 0.143 0 7.8e-05 0 0.00026 0.00061 0 0.0014 3 1 / 11 (9.1%) 2 / 11 (18%) 0.0909 0.182
PWY-6910~hydroxymethylpyrimidine salvage 0.92 0.96 1 0.58 1 1 0.79 0.99 1 0.46 0.79 1 0.6 0.92 1 0.5 0.88 1 0.011 0.011 0.011 0.011 0.012 0.0029 0.011 0.011 0.0042 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.011 0.0041 0.011 0.01 0.0021 0 11 / 11 (100%) 11 / 11 (100%) 1 1
GLYSYN-PWY~glycine biosynthesis I 0.13 0.8 1 0.9 1 1 0.19 0.91 1 0.18 0.68 1 0.19 0.85 1 0.053 0.8 1 0.014 0.014 0.014 0.013 0.014 0.003 0.013 0.014 0.0031 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.015 0.015 0.0042 0.014 0.013 0.0027 -0.1 11 / 11 (100%) 11 / 11 (100%) 1 1
GLUAMCAT-PWY~N-acetylglucosamine degradation I 0.3 0.82 1 0.97 1 1 0.53 0.99 1 0.72 0.9 1 0.18 0.85 1 0.38 0.88 1 0.013 0.013 0.013 0.013 0.013 0.0025 0.014 0.014 0.0034 0.11 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.012 0.011 0.0028 0.013 0.013 0.0041 0.12 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5895~menaquinol-13 biosynthesis 0.26 0.8 1 0.67 1 1 0.17 0.91 1 0.18 0.68 1 0.52 0.92 1 0.23 0.82 1 0.0015 0.00074 6.1e-05 0.00078 0.00061 0.00087 8e-04 0.00012 0.0011 0.037 18 / 36 (50%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00041 0 0.00095 0.001 0 0.0018 1.3 4 / 11 (36%) 5 / 11 (45%) 0.364 0.455
PWY-6050~dimethyl sulfoxide degradation 0.56 0.84 1 0.39 1 1 0.96 0.99 1 0.61 0.89 1 0.36 0.92 1 0.77 0.93 1 0.00081 0.00043 9.7e-05 0.00064 0.00024 0.0011 0.00055 0 0.0012 -0.22 19 / 36 (53%) 5 / 7 (71%) 3 / 7 (43%) 0.714 0.429 0.00044 9.4e-05 0.00072 0.00019 0 3e-04 -1.2 6 / 11 (55%) 5 / 11 (45%) 0.545 0.455
PWY-6130~glycerol degradation III 0.52 0.83 1 0.025 1 1 0.96 0.99 1 0.44 0.78 1 0.026 0.82 1 0.32 0.88 1 0.002 0.0019 0.0017 0.0021 0.0012 0.0017 0.0016 0.0012 0.0016 -0.39 34 / 36 (94%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 0.0023 0.0024 7e-04 0.0015 0.0014 8e-04 -0.62 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6535~4-aminobutanoate degradation I 0.15 0.8 1 0.69 1 1 0.76 0.99 1 0.22 0.68 1 0.086 0.85 1 0.14 0.8 1 0.00044 3.7e-05 0 0.00011 0 0.00029 8e-05 0 0.00019 -0.46 3 / 36 (8.3%) 1 / 7 (14%) 2 / 7 (29%) 0.143 0.286 0 0 0 0 0 0 NA 0 / 11 (0%) 0 / 11 (0%) 0 0
PWY18C3-24~methylsalicylate degradation 0.71 0.89 1 0.19 1 1 0.81 0.99 1 0.088 0.68 1 0.07 0.85 1 0.38 0.88 1 0.0019 0.0018 0.0016 0.0016 0.0017 0.0016 0.0021 0.0017 0.0019 0.39 35 / 36 (97%) 6 / 7 (86%) 7 / 7 (100%) 0.857 1 0.0016 0.0016 0.0012 0.0019 0.0016 0.00084 0.25 11 / 11 (100%) 11 / 11 (100%) 1 1
GLYCLEAV-PWY~glycine cleavage 0.47 0.82 1 0.59 1 1 0.66 0.99 1 0.82 0.93 1 0.12 0.85 1 0.15 0.8 1 0.0022 0.002 0.00089 0.0022 0.0022 0.0016 0.0025 0.0017 0.0022 0.18 33 / 36 (92%) 6 / 7 (86%) 7 / 7 (100%) 0.857 1 0.0017 0.00078 0.0026 0.0019 0.00064 0.0033 0.16 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-6139~CMP-N-acetylneuraminate biosynthesis II (bacteria) 0.37 0.82 1 0.21 1 1 0.44 0.92 1 0.48 0.81 1 0.15 0.85 1 0.94 0.98 1 0.00074 0.00025 0 0.00034 1e-04 5e-04 0.00018 0 0.00032 -0.92 12 / 36 (33%) 4 / 7 (57%) 2 / 7 (29%) 0.571 0.286 0.00012 0 0.00019 0.00035 0 0.0012 1.5 5 / 11 (45%) 1 / 11 (9.1%) 0.455 0.0909
PWY-7184~pyrimidine deoxyribonucleotides de novo biosynthesis I 0.72 0.89 1 0.85 1 1 0.57 0.99 1 0.84 0.94 1 0.62 0.92 1 0.51 0.88 1 0.00093 0.00044 0 0.00074 0 0.0016 0.00065 5.1e-05 0.0012 -0.19 17 / 36 (47%) 3 / 7 (43%) 4 / 7 (57%) 0.429 0.571 0.00038 0 0.00062 0.00018 0 0.00028 -1.1 5 / 11 (45%) 5 / 11 (45%) 0.455 0.455
PWY-8004~Entner-Doudoroff pathway I 0.66 0.88 1 0.23 1 1 0.69 0.99 1 0.85 0.94 1 0.1 0.85 1 0.29 0.88 1 0.0018 0.00025 0 0.00015 0 0.00041 0.00052 0 0.001 1.8 5 / 36 (14%) 1 / 7 (14%) 2 / 7 (29%) 0.143 0.286 3e-05 0 1e-04 0.00036 0 0.0012 3.6 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
PWY-3801~sucrose degradation II (sucrose synthase) 0.14 0.8 1 0.85 1 1 0.89 0.99 1 0.068 0.68 1 0.88 0.99 1 0.82 0.95 1 0.0051 0.0051 0.0038 0.0035 0.0032 0.0013 0.0035 0.0023 0.0021 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0066 0.0049 0.0071 0.0055 0.0045 0.0031 -0.26 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6519~8-amino-7-oxononanoate biosynthesis I 0.24 0.8 1 0.84 1 1 0.22 0.91 1 0.17 0.68 1 0.93 1 1 0.41 0.88 1 0.0028 0.0011 0 0.0014 0.00045 0.0019 0.0013 0.00011 0.0018 -0.11 15 / 36 (42%) 4 / 7 (57%) 4 / 7 (57%) 0.571 0.571 0.00058 0 0.0017 0.0015 0 0.0033 1.4 3 / 11 (27%) 4 / 11 (36%) 0.273 0.364
PWY4FS-7~phosphatidylglycerol biosynthesis I (plastidic) 0.41 0.82 1 0.081 1 1 0.046 0.76 1 0.69 0.9 1 0.023 0.82 1 0.035 0.68 1 0.00095 0.00081 0.00076 0.00097 0.00098 0.00086 0.00074 6e-04 0.00095 -0.39 31 / 36 (86%) 7 / 7 (100%) 4 / 7 (57%) 1 0.571 0.00066 0.00054 5e-04 0.00091 0.001 0.00052 0.46 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY0-162~superpathway of pyrimidine ribonucleotides de novo biosynthesis 0.41 0.82 1 0.83 1 1 0.95 0.99 1 0.76 0.9 1 0.65 0.92 1 0.96 0.99 1 0.004 0.0038 0.0025 0.0021 0.003 0.0014 0.0023 0.0017 0.0016 0.13 34 / 36 (94%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0051 0.0014 0.0094 0.0044 0.0034 0.0039 -0.21 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-5674~nitrate reduction IV (dissimilatory) 0.32 0.82 1 0.85 1 1 0.33 0.91 1 0.53 0.84 1 0.69 0.93 1 0.32 0.88 1 0.00055 0.00017 0 0.00033 0 0.00072 0.00033 0 0.00068 0 11 / 36 (31%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 8.9e-05 0 0.00016 3.6e-05 0 9.1e-05 -1.3 3 / 11 (27%) 2 / 11 (18%) 0.273 0.182
PWY-3282~superpathway of ammonia assimilation (plants) 0.79 0.92 1 0.6 1 1 0.26 0.91 1 0.42 0.76 1 0.68 0.93 1 0.81 0.95 1 0.033 0.033 0.032 0.031 0.032 0.0052 0.029 0.029 0.009 -0.096 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.033 0.037 0.013 0.036 0.038 0.0098 0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6545~pyrimidine deoxyribonucleotides de novo biosynthesis III 0.9 0.96 1 0.67 1 1 0.088 0.88 1 0.53 0.84 1 0.58 0.92 1 0.052 0.8 1 0.0013 0.00028 0 0.00051 0 0.0013 0.00054 0 0.0011 0.082 8 / 36 (22%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 0.00026 0 0.00058 0 0 0 -Inf 4 / 11 (36%) 0 / 11 (0%) 0.364 0
PWY-6610~adenine salvage 0.45 0.82 1 0.11 1 1 0.61 0.99 1 0.25 0.69 1 0.47 0.92 1 0.59 0.88 1 0.0057 0.0057 0.0058 0.0056 0.0058 0.0016 0.0049 0.0052 0.0021 -0.19 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0062 0.0065 0.0013 0.0057 0.0056 0.0019 -0.12 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6590~superpathway of Clostridium acetobutylicum acidogenic fermentation 0.93 0.96 1 0.75 1 1 0.83 0.99 1 0.46 0.8 1 0.5 0.92 1 0.58 0.88 1 6e-04 0.00035 0.00022 0.00044 0 0.00081 0.00039 0.00034 0.00047 -0.17 21 / 36 (58%) 3 / 7 (43%) 4 / 7 (57%) 0.429 0.571 0.00029 0.00028 0.00029 0.00032 0.00016 0.00035 0.14 7 / 11 (64%) 7 / 11 (64%) 0.636 0.636
PWY-6348~phosphate acquisition 0.65 0.88 1 0.18 1 1 0.012 0.64 1 0.77 0.9 1 0.41 0.92 1 0.038 0.72 1 0.0026 0.0023 0.0015 0.0014 0.0019 0.00095 0.00077 0.00048 0.00058 -0.86 33 / 36 (92%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0027 0.0018 0.0049 0.0035 0.0028 0.0032 0.37 9 / 11 (82%) 10 / 11 (91%) 0.818 0.909
PWY-6389~pyruvate fermentation to (S)-acetoin 0.76 0.9 1 0.31 1 1 0.52 0.99 1 0.22 0.68 1 0.13 0.85 1 0.29 0.88 1 0.0022 0.0017 0.001 0.0023 0.00024 0.0043 0.0019 0 0.0041 -0.28 28 / 36 (78%) 5 / 7 (71%) 3 / 7 (43%) 0.714 0.429 0.0015 0.0011 0.0012 0.0014 0.001 0.0012 -0.1 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
P23-PWY~reductive TCA cycle I 0.16 0.8 1 0.89 1 1 0.35 0.91 1 0.23 0.69 1 0.56 0.92 1 0.86 0.96 1 0.0013 0.00022 0 0.00042 0 0.00082 0.00038 0 0.00072 -0.14 6 / 36 (17%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 2.1e-05 0 7e-05 2e-04 0 0.00066 3.3 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
PWY-5297~siroheme amide biosynthesis 0.83 0.93 1 0.27 1 1 0.32 0.91 1 0.99 1 1 0.26 0.9 1 0.38 0.88 1 0.00026 4.3e-05 0 4.1e-05 0 7.3e-05 0 0 0 -Inf 6 / 36 (17%) 2 / 7 (29%) 0 / 7 (0%) 0.286 0 4.4e-05 0 1e-04 7e-05 0 0.00019 0.67 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
PWY3O-4106~NAD salvage pathway IV (from nicotinamide riboside) 0.84 0.93 1 0.47 1 1 0.22 0.91 1 0.7 0.9 1 0.15 0.85 1 0.082 0.8 1 0.00052 0.00023 0 0.00038 0 0.00093 0.00034 0.00013 0.00061 -0.16 16 / 36 (44%) 3 / 7 (43%) 4 / 7 (57%) 0.429 0.571 0.00022 0 0.00048 8.5e-05 0 0.00015 -1.4 5 / 11 (45%) 4 / 11 (36%) 0.455 0.364
PWY66-366~flavin biosynthesis IV (mammalian) 0.42 0.82 1 0.73 1 1 0.95 0.99 1 0.26 0.69 1 0.078 0.85 1 0.14 0.8 1 0.011 0.011 0.011 0.011 0.011 0.0019 0.011 0.011 0.0021 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.011 0.0019 0.012 0.011 0.0015 0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5981~CDP-diacylglycerol biosynthesis III 0.72 0.89 1 0.7 1 1 0.55 0.99 1 0.57 0.86 1 0.66 0.92 1 0.76 0.93 1 0.0099 0.0099 0.0098 0.01 0.0092 0.0015 0.01 0.011 0.0035 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0097 0.0088 0.0024 0.01 0.01 0.0021 0.044 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1587~N6-L-threonylcarbamoyladenosine37-modified tRNA biosynthesis 0.56 0.84 1 0.78 1 1 0.59 0.99 1 0.69 0.9 1 0.099 0.85 1 0.62 0.89 1 0.01 0.01 0.01 0.0099 0.01 0.0013 0.01 0.0095 0.0013 0.014 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0095 0.01 0.0029 0.01 0.0099 0.0018 0.074 11 / 11 (100%) 11 / 11 (100%) 1 1
MANNCAT-PWY~D-mannose degradation 0.58 0.85 1 0.35 1 1 0.18 0.91 1 0.69 0.9 1 0.87 0.99 1 0.62 0.89 1 0.007 0.007 0.0065 0.0074 0.0079 0.0037 0.0065 0.005 0.0037 -0.19 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0065 0.0064 0.0019 0.0074 0.0067 0.0026 0.19 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7335~UDP-N-acetyl-α-D-mannosaminouronate biosynthesis 0.35 0.82 1 0.34 1 1 0.47 0.96 1 0.27 0.7 1 0.33 0.92 1 0.48 0.88 1 0.0015 0.00047 0 0.00051 0 0.00078 0.0011 0.00014 0.0017 1.1 11 / 36 (31%) 3 / 7 (43%) 4 / 7 (57%) 0.429 0.571 0.00028 0 0.00088 0.00024 0 0.00057 -0.22 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
UDPNAGSYN-PWY~UDP-N-acetyl-D-glucosamine biosynthesis I 0.083 0.8 1 0.94 1 1 0.75 0.99 1 0.085 0.68 1 0.66 0.92 1 0.51 0.88 1 0.007 0.007 0.0055 0.0047 0.0046 0.00084 0.0051 0.0041 0.0027 0.12 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0088 0.0087 0.0069 0.0078 0.009 0.0039 -0.17 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7204~pyridoxal 5-phosphate salvage II (plants) 0.59 0.85 1 0.46 1 1 0.72 0.99 1 0.31 0.71 1 0.54 0.92 1 0.58 0.88 1 0.00077 0.00041 0.00019 0.00029 0 0.00054 0.00045 0 0.00075 0.63 19 / 36 (53%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 4e-04 0.00026 0.00069 0.00045 0.00048 0.00051 0.17 7 / 11 (64%) 6 / 11 (55%) 0.636 0.545
GLYCOGENSYNTH-PWY~glycogen biosynthesis I (from ADP-D-Glucose) 0.31 0.82 1 0.67 1 1 0.91 0.99 1 0.23 0.68 1 0.73 0.95 1 0.61 0.89 1 0.036 0.036 0.038 0.033 0.03 0.0087 0.032 0.039 0.013 -0.044 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.039 0.037 0.018 0.037 0.039 0.0079 -0.076 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1391~S-methyl-5-thioadenosine degradation IV 0.069 0.8 1 0.2 1 1 0.33 0.91 1 0.071 0.68 1 0.29 0.91 1 0.55 0.88 1 0.00024 6e-05 0 0.00013 8.1e-05 0.00021 9.5e-05 0 2e-04 -0.45 9 / 36 (25%) 4 / 7 (57%) 2 / 7 (29%) 0.571 0.286 2e-05 0 4.5e-05 3.5e-05 0 0.00012 0.81 2 / 11 (18%) 1 / 11 (9.1%) 0.182 0.0909
PWY-6381~bisucaberin biosynthesis 0.46 0.82 1 0.48 1 1 0.94 0.99 1 0.29 0.7 1 0.2 0.85 1 0.46 0.88 1 0.0051 0.005 0.0051 0.0047 0.0039 0.0032 0.0045 0.0054 0.0029 -0.063 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0055 0.0055 0.0026 0.0049 0.0048 0.0022 -0.17 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5910~superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) 0.44 0.82 1 0.28 1 1 0.083 0.88 1 0.85 0.94 1 0.42 0.92 1 0.13 0.8 1 0.00025 3.5e-05 0 5.9e-05 0 0.00016 0 0 0 -Inf 5 / 36 (14%) 1 / 7 (14%) 0 / 7 (0%) 0.143 0 9.1e-06 0 3e-05 6.8e-05 0 0.00014 2.9 1 / 11 (9.1%) 3 / 11 (27%) 0.0909 0.273
PWY-4381~fatty acid biosynthesis initiation I 0.13 0.8 1 0.36 1 1 0.46 0.93 1 0.15 0.68 1 0.13 0.85 1 0.17 0.8 1 0.009 0.009 0.0084 0.0075 0.0072 0.0011 0.0088 0.0088 0.0034 0.23 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0096 0.0095 0.003 0.0096 0.0089 0.0028 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7664~oleate biosynthesis IV (anaerobic) 0.88 0.95 1 0.92 1 1 0.14 0.88 1 0.54 0.84 1 0.99 1 1 0.23 0.82 1 0.0044 0.0044 0.0032 0.0034 0.0033 0.0029 0.0039 0.0027 0.0042 0.2 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0039 0.0029 0.0042 0.006 0.0042 0.0044 0.62 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY66-426~hydrogen sulfide biosynthesis II (mammalian) 0.031 0.8 1 0.062 1 1 0.14 0.88 1 0.077 0.68 1 0.14 0.85 1 0.27 0.87 1 0.0023 0.00019 0 0.00064 0 0.0012 0.00035 0 0.00092 -0.87 3 / 36 (8.3%) 2 / 7 (29%) 1 / 7 (14%) 0.286 0.143 0 0 0 0 0 0 NA 0 / 11 (0%) 0 / 11 (0%) 0 0
PWY-6595~superpathway of guanosine nucleotides degradation (plants) 0.84 0.93 1 0.3 1 1 0.65 0.99 1 0.97 1 1 0.44 0.92 1 0.7 0.91 1 0.0014 0.00049 0 7e-04 0 0.0012 0.00037 0 0.00084 -0.92 13 / 36 (36%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 0.00056 0 0.00081 0.00036 0 0.00058 -0.64 4 / 11 (36%) 4 / 11 (36%) 0.364 0.364
SAM-PWY~S-adenosyl-L-methionine biosynthesis 0.64 0.87 1 0.86 1 1 0.82 0.99 1 0.31 0.71 1 0.18 0.85 1 0.19 0.81 1 0.024 0.024 0.023 0.023 0.02 0.0069 0.024 0.022 0.0083 0.061 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.024 0.024 0.0055 0.024 0.024 0.0027 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7179~purine deoxyribonucleosides degradation I 0.62 0.86 1 0.11 1 1 0.39 0.91 1 0.37 0.73 1 0.064 0.85 1 0.35 0.88 1 0.0037 0.0037 0.0033 0.0036 0.0032 0.0023 0.003 0.0025 0.0024 -0.26 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0041 0.004 0.0023 0.0037 0.0037 0.0016 -0.15 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1275~lipoate biosynthesis and incorporation II 0.92 0.96 1 0.86 1 1 0.3 0.91 1 0.78 0.91 1 0.96 1 1 0.38 0.88 1 0.00039 8.6e-05 0 5.6e-05 0 7.6e-05 0.00011 0 0.00019 0.97 8 / 36 (22%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 0.00017 0 0.00048 5.3e-06 0 1.8e-05 -5 2 / 11 (18%) 1 / 11 (9.1%) 0.182 0.0909
PANTO-PWY~phosphopantothenate biosynthesis I 0.03 0.8 1 0.57 1 1 0.38 0.91 1 0.18 0.68 1 0.37 0.92 1 0.53 0.88 1 0.0029 0.0029 0.0029 0.0033 0.0031 0.0011 0.0038 0.0033 0.0017 0.2 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.002 0.0013 0.0014 0.0031 0.0025 0.0016 0.63 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7996~menaquinol-4 biosynthesis I 0.18 0.8 1 0.34 1 1 0.3 0.91 1 0.15 0.68 1 0.77 0.97 1 0.67 0.9 1 0.0057 0.0057 0.0057 0.005 0.0052 0.0016 0.0045 0.004 0.0021 -0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0063 0.0064 0.0019 0.0065 0.0064 0.0018 0.045 11 / 11 (100%) 11 / 11 (100%) 1 1
GLYCOLYSIS~glycolysis I (from glucose 6-phosphate) 0.74 0.9 1 0.48 1 1 0.7 0.99 1 0.59 0.87 1 0.029 0.83 1 0.44 0.88 1 0.011 0.011 0.012 0.011 0.011 0.0016 0.012 0.013 0.0034 0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.01 0.01 0.0036 0.012 0.012 0.0032 0.26 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-3001~superpathway of L-isoleucine biosynthesis I 0.87 0.95 1 0.77 1 1 0.78 0.99 1 0.4 0.75 1 0.21 0.88 1 0.6 0.89 1 0.018 0.018 0.017 0.017 0.016 0.0042 0.017 0.018 0.0057 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.018 0.016 0.0089 0.018 0.018 0.0042 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5695~inosine 5-phosphate degradation 0.34 0.82 1 0.75 1 1 0.71 0.99 1 0.95 0.98 1 0.87 0.99 1 0.97 0.99 1 0.0065 0.0065 0.0063 0.0071 0.0072 0.0016 0.0072 0.0063 0.0038 0.02 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0062 0.0055 0.0026 0.0061 0.0057 0.0016 -0.023 11 / 11 (100%) 11 / 11 (100%) 1 1
GLCMANNANAUT-PWY~superpathway of N-acetylglucosamine N-acetylmannosamine and N-acetylneuraminate degradation 0.38 0.82 1 0.89 1 1 0.83 0.99 1 1 1 1 0.63 0.92 1 0.66 0.9 1 0.0045 0.0045 0.0046 0.005 0.0044 0.0022 0.005 0.0056 0.0024 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0041 0.0047 0.0017 0.0043 0.0037 0.0023 0.069 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5849~menaquinol-6 biosynthesis 0.18 0.8 1 0.34 1 1 0.3 0.91 1 0.15 0.68 1 0.77 0.97 1 0.67 0.9 1 0.0057 0.0057 0.0057 0.005 0.0052 0.0016 0.0045 0.004 0.0021 -0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0063 0.0064 0.0019 0.0065 0.0064 0.0018 0.045 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5516~D-xylose degradation II 0.091 0.8 1 0.19 1 1 0.71 0.99 1 0.11 0.68 1 0.47 0.92 1 0.29 0.88 1 0.00085 0.00085 0.00082 8e-04 0.00079 0.00036 0.00061 0.00057 0.00029 -0.39 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0011 0.0011 0.00041 8e-04 8e-04 0.00032 -0.46 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1317~L-lactaldehyde degradation (aerobic) 0.2 0.8 1 0.14 1 1 0.093 0.88 1 0.095 0.68 1 0.19 0.85 1 0.22 0.82 1 0.0012 0.00045 0 0.00061 0.00037 0.00083 0.00024 0 0.00035 -1.3 14 / 36 (39%) 5 / 7 (71%) 3 / 7 (43%) 0.714 0.429 0.00029 0 0.00066 0.00064 0 0.0014 1.1 3 / 11 (27%) 3 / 11 (27%) 0.273 0.273
BIOTIN-BIOSYNTHESIS-PWY~biotin biosynthesis I 0.27 0.8 1 0.87 1 1 0.26 0.91 1 0.19 0.68 1 0.63 0.92 1 0.29 0.88 1 0.0026 0.001 0 0.0011 0.00037 0.0015 0.0012 0 0.0018 0.13 14 / 36 (39%) 4 / 7 (57%) 3 / 7 (43%) 0.571 0.429 0.00051 0 0.0015 0.0013 0 0.0029 1.3 3 / 11 (27%) 4 / 11 (36%) 0.273 0.364
P41-PWY~pyruvate fermentation to acetate and (S)-lactate I 0.44 0.82 1 0.61 1 1 1 1 1 0.45 0.79 1 0.23 0.88 1 0.39 0.88 1 0.0027 0.0027 0.0017 0.0019 0.0016 0.0016 0.0019 0.0014 0.0021 0 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0037 0.002 0.006 0.0025 0.0017 0.0023 -0.57 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5482~pyruvate fermentation to acetate II 0.45 0.82 1 0.59 1 1 0.95 0.99 1 0.42 0.75 1 0.26 0.9 1 0.43 0.88 1 0.0029 0.0028 0.0018 0.0021 0.0018 0.0017 0.002 0.0011 0.002 -0.07 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0038 0.0022 0.0061 0.0027 0.0017 0.0024 -0.49 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5886~4-hydroxyphenylpyruvate biosynthesis 0.6 0.85 1 0.97 1 1 0.53 0.99 1 0.37 0.73 1 0.94 1 1 0.5 0.88 1 0.00076 0.00059 0.00046 0.00055 0.00033 6e-04 0.00058 0.00047 0.00067 0.077 28 / 36 (78%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 0.00069 0.00056 0.00077 0.00053 0.00045 0.00053 -0.38 10 / 11 (91%) 8 / 11 (73%) 0.909 0.727
PWY-723~alkylnitronates degradation 0.64 0.87 1 0.19 1 1 0.81 0.99 1 0.5 0.82 1 0.51 0.92 1 0.21 0.82 1 0.00026 4.3e-05 0 2.4e-05 0 6.4e-05 1.3e-05 0 3.6e-05 -0.88 6 / 36 (17%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 6.5e-05 0 0.00018 5.3e-05 0 0.00015 -0.29 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
PWY-5851~demethylmenaquinol-9 biosynthesis 0.55 0.84 1 0.56 1 1 0.91 0.99 1 0.85 0.94 1 0.52 0.92 1 0.9 0.97 1 0.0027 0.0026 0.0015 0.0016 9e-04 0.0012 0.0021 0.0026 0.0017 0.39 34 / 36 (94%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0031 0.00097 0.0052 0.003 0.0034 0.0025 -0.047 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-6028~acetoin degradation 0.72 0.89 1 0.82 1 1 0.81 0.99 1 0.99 1 1 0.59 0.92 1 0.63 0.89 1 0.00036 8.9e-05 0 0.00013 0 0.00031 5.1e-05 0 8.7e-05 -1.3 9 / 36 (25%) 2 / 7 (29%) 3 / 7 (43%) 0.286 0.429 7.7e-05 0 0.00018 1e-04 0 0.00029 0.38 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
PWY-6536~4-aminobutanoate degradation III 0.16 0.8 1 0.63 1 1 0.7 0.99 1 0.2 0.68 1 0.066 0.85 1 0.11 0.8 1 0.00092 7.7e-05 0 0.00022 0 0.00058 0.00018 0 0.00045 -0.29 3 / 36 (8.3%) 1 / 7 (14%) 2 / 7 (29%) 0.143 0.286 0 0 0 0 0 0 NA 0 / 11 (0%) 0 / 11 (0%) 0 0
PWY0-845~superpathway of pyridoxal 5-phosphate biosynthesis and salvage 0.48 0.82 1 0.34 1 1 0.97 0.99 1 0.42 0.75 1 0.23 0.88 1 0.75 0.93 1 0.0022 5e-04 0 0.00039 0 0.00069 0.00081 0 0.0014 1.1 8 / 36 (22%) 2 / 7 (29%) 3 / 7 (43%) 0.286 0.429 0.00016 0 0.00054 7e-04 0 0.0019 2.1 1 / 11 (9.1%) 2 / 11 (18%) 0.0909 0.182
PWY-6353~purine nucleotides degradation II (aerobic) 0.42 0.82 1 0.65 1 1 0.81 0.99 1 0.86 0.94 1 0.89 0.99 1 0.79 0.94 1 0.0059 0.0059 0.0061 0.0065 0.0066 0.0015 0.0064 0.0059 0.0032 -0.022 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0058 0.0065 0.0022 0.0055 0.0052 0.0014 -0.077 11 / 11 (100%) 11 / 11 (100%) 1 1
P4-PWY~superpathway of L-lysine L-threonine and L-methionine biosynthesis I 0.52 0.83 1 0.92 1 1 0.72 0.99 1 0.63 0.89 1 0.7 0.94 1 0.4 0.88 1 0.0038 0.0027 0.0014 0.0015 0.00093 0.0016 0.0016 0.0012 0.002 0.093 26 / 36 (72%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.0038 0.0016 0.0085 0.0031 0.0017 0.0032 -0.29 8 / 11 (73%) 9 / 11 (82%) 0.727 0.818
ARGDEG-III-PWY~L-arginine degradation IV (arginine decarboxylase/agmatine deiminase pathway) 0.77 0.9 1 0.56 1 1 0.38 0.91 1 0.77 0.9 1 0.17 0.85 1 0.15 0.8 1 0.0068 0.0068 0.0063 0.007 0.0066 0.0019 0.0077 0.0065 0.003 0.14 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0069 0.0069 0.0031 0.0062 0.0054 0.0022 -0.15 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-701~L-methionine degradation II 0.72 0.89 1 0.48 1 1 0.24 0.91 1 0.73 0.9 1 0.37 0.92 1 0.18 0.8 1 0.00018 0.00011 7.8e-05 0.00016 6.4e-05 0.00026 0.00018 0.00013 0.00023 0.17 21 / 36 (58%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 8.4e-05 9.5e-05 7.3e-05 5.1e-05 0 6.8e-05 -0.72 7 / 11 (64%) 5 / 11 (45%) 0.636 0.455
ALACAT2-PWY~L-alanine degradation II (to D-lactate) 0.21 0.8 1 0.55 1 1 0.32 0.91 1 0.13 0.68 1 0.46 0.92 1 0.59 0.88 1 0.0012 0.00045 0 0.00053 0.00023 7e-04 0.00047 3.6e-05 0.00086 -0.17 14 / 36 (39%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 2e-04 0 0.00047 0.00066 0 0.0015 1.7 3 / 11 (27%) 2 / 11 (18%) 0.273 0.182
PWY0-1466~trehalose degradation VI (periplasmic) 0.6 0.85 1 0.27 1 1 0.13 0.88 1 0.44 0.78 1 0.39 0.92 1 0.4 0.88 1 0.0028 0.0019 0.00096 0.0017 0.001 0.0016 0.00094 0.00042 0.0013 -0.85 25 / 36 (69%) 6 / 7 (86%) 5 / 7 (71%) 0.857 0.714 0.0015 0.001 0.0022 0.0031 0.00091 0.0054 1 7 / 11 (64%) 7 / 11 (64%) 0.636 0.636
PWY-6897~thiamine salvage II 0.86 0.95 1 0.76 1 1 0.52 0.99 1 0.42 0.75 1 0.36 0.92 1 0.69 0.91 1 0.01 0.01 0.01 0.0098 0.0083 0.0027 0.0096 0.011 0.0028 -0.03 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.0094 0.0055 0.011 0.011 0.0029 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5964~guanylyl molybdenum cofactor biosynthesis 0.48 0.82 1 0.53 1 1 0.3 0.91 1 0.95 0.98 1 0.61 0.92 1 0.15 0.8 1 0.0016 0.0016 0.0016 0.002 0.0021 0.00073 0.002 0.0017 0.0014 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0017 0.0015 0.00075 0.0011 0.001 0.00068 -0.63 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5345~superpathway of L-methionine biosynthesis (by sulfhydrylation) 0.32 0.82 1 0.99 1 1 0.9 0.99 1 0.36 0.73 1 0.94 1 1 0.64 0.89 1 0.0052 0.0048 0.0043 0.0039 0.0038 0.0023 0.0042 0.0041 0.0032 0.11 33 / 36 (92%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0054 0.0055 0.0027 0.0053 0.0043 0.0028 -0.027 10 / 11 (91%) 11 / 11 (100%) 0.909 1
PWY-6892~thiazole biosynthesis I (facultative anaerobic bacteria) 0.83 0.93 1 0.66 1 1 0.088 0.88 1 0.7 0.9 1 0.56 0.92 1 0.11 0.8 1 6e-04 0.00035 0.00021 0.00041 0.00038 0.00038 0.00045 0.00016 0.00062 0.13 21 / 36 (58%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00046 0.00052 0.00039 0.00014 0 0.00022 -1.7 8 / 11 (73%) 4 / 11 (36%) 0.727 0.364
PWY-5489~methyl parathion degradation 0.2 0.8 1 0.35 1 1 0.41 0.91 1 0.21 0.68 1 0.56 0.92 1 0.53 0.88 1 0.00052 8.6e-05 0 0.00016 0 0.00035 0.00027 0 0.00066 0.75 6 / 36 (17%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 7.9e-06 0 2.6e-05 5.4e-06 0 1.8e-05 -0.55 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
PWY-6333~acetaldehyde biosynthesis I 0.32 0.82 1 0.46 1 1 0.38 0.91 1 0.21 0.68 1 0.19 0.85 1 0.17 0.8 1 0.028 0.028 0.027 0.025 0.026 0.005 0.028 0.035 0.012 0.16 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.029 0.032 0.0092 0.028 0.027 0.0045 -0.051 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7622~UDP-α-D-galactofuranose biosynthesis 0.2 0.8 1 0.63 1 1 0.7 0.99 1 0.12 0.68 1 0.56 0.92 1 0.54 0.88 1 0.023 0.023 0.021 0.02 0.018 0.0045 0.019 0.02 0.0058 -0.074 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.025 0.022 0.011 0.025 0.021 0.0075 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-1881~formate oxidation to CO2 0.21 0.8 1 0.77 1 1 0.13 0.88 1 0.018 0.68 1 0.26 0.9 1 0.056 0.8 1 0.00083 6e-04 2e-04 0.00062 0 0.0013 0.00053 0.00012 0.0011 -0.23 26 / 36 (72%) 3 / 7 (43%) 5 / 7 (71%) 0.429 0.714 0.00084 0.00053 0.0011 4e-04 0.00022 0.00042 -1.1 10 / 11 (91%) 8 / 11 (73%) 0.909 0.727
PWY-6893~thiamine diphosphate biosynthesis II (Bacillus) 0.22 0.8 1 0.44 1 1 0.017 0.64 1 0.062 0.68 1 0.17 0.85 1 0.0065 0.68 1 0.0014 0.0011 0.00058 0.001 0.00051 0.00095 0.0011 0.00043 0.0017 0.14 28 / 36 (78%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 7e-04 8.5e-05 0.0011 0.0014 0.001 0.0016 1 6 / 11 (55%) 10 / 11 (91%) 0.545 0.909
RIBOSYN2-PWY~flavin biosynthesis I (bacteria and plants) 0.76 0.9 1 0.96 1 1 0.36 0.91 1 0.65 0.89 1 0.46 0.92 1 0.78 0.94 1 0.0054 0.0054 0.0055 0.0051 0.005 0.0011 0.0052 0.0057 0.0016 0.028 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.005 0.0052 0.002 0.006 0.007 0.0021 0.26 11 / 11 (100%) 11 / 11 (100%) 1 1
ARGDEGRAD-PWY~L-arginine degradation V (arginine deiminase pathway) 0.24 0.8 1 0.8 1 1 0.048 0.76 1 0.25 0.69 1 0.6 0.92 1 0.076 0.8 1 0.0014 0.0012 0.0011 0.0011 0.00071 0.0011 0.0012 0.0016 0.00082 0.13 31 / 36 (86%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0018 0.0021 0.0013 0.00081 7e-04 0.00077 -1.2 10 / 11 (91%) 9 / 11 (82%) 0.909 0.818
PWY-6126~superpathway of adenosine nucleotides de novo biosynthesis II 0.81 0.93 1 0.79 1 1 0.84 0.99 1 0.93 0.98 1 0.98 1 1 0.71 0.91 1 0.0016 0.0011 0.00055 0.0012 0.00062 0.0015 0.00092 8e-04 0.001 -0.38 25 / 36 (69%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 0.001 6e-04 0.0014 0.0014 0.00018 0.0024 0.49 8 / 11 (73%) 7 / 11 (64%) 0.727 0.636
P185-PWY~formaldehyde assimilation III (dihydroxyacetone cycle) 0.63 0.87 1 0.93 1 1 0.87 0.99 1 0.42 0.75 1 0.63 0.92 1 0.65 0.9 1 0.0074 0.0074 0.0078 0.0069 0.0064 0.0014 0.0074 0.0082 0.0036 0.1 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0078 0.0095 0.0034 0.0074 0.0073 0.002 -0.076 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5852~demethylmenaquinol-8 biosynthesis I 0.55 0.84 1 0.56 1 1 0.91 0.99 1 0.85 0.94 1 0.52 0.92 1 0.9 0.97 1 0.0027 0.0026 0.0015 0.0016 9e-04 0.0012 0.0021 0.0026 0.0017 0.39 34 / 36 (94%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0031 0.00097 0.0052 0.003 0.0034 0.0025 -0.047 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-7796~pentose phosphate pathway (oxidative branch) II 0.056 0.8 1 0.02 1 1 0.19 0.91 1 0.0067 0.53 1 0.01 0.82 1 0.11 0.8 1 0.00053 0.00044 0.00037 0.00016 0 0.00026 0.00065 0.00048 0.00076 2 30 / 36 (83%) 3 / 7 (43%) 6 / 7 (86%) 0.429 0.857 0.00038 0.00038 0.00027 0.00054 5e-04 0.00042 0.51 10 / 11 (91%) 11 / 11 (100%) 0.909 1
HOMOSERSYN-PWY~L-homoserine biosynthesis 0.89 0.95 1 0.65 1 1 0.25 0.91 1 0.4 0.75 1 0.37 0.92 1 0.79 0.94 1 0.02 0.02 0.02 0.02 0.02 0.0025 0.019 0.019 0.004 -0.074 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.02 0.018 0.0065 0.021 0.021 0.0029 0.07 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6894~thiamine diphosphate biosynthesis I (E. coli) 0.22 0.8 1 0.44 1 1 0.017 0.64 1 0.062 0.68 1 0.17 0.85 1 0.0065 0.68 1 0.0014 0.0011 0.00058 0.001 0.00051 0.00095 0.0011 0.00043 0.0017 0.14 28 / 36 (78%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 7e-04 8.5e-05 0.0011 0.0014 0.001 0.0016 1 6 / 11 (55%) 10 / 11 (91%) 0.545 0.909
P441-PWY~superpathway of N-acetylneuraminate degradation 0.76 0.9 1 0.79 1 1 0.78 0.99 1 0.92 0.98 1 0.93 1 1 0.57 0.88 1 0.0059 0.0059 0.006 0.0063 0.0062 0.0026 0.0061 0.0054 0.0035 -0.047 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0061 0.0071 0.0032 0.0053 0.0041 0.0037 -0.2 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7181~pyrimidine deoxyribonucleosides degradation 0.44 0.82 1 0.35 1 1 0.6 0.99 1 0.77 0.9 1 0.34 0.92 1 0.98 0.99 1 0.0029 0.0029 0.0028 0.0027 0.0027 0.001 0.0034 0.0038 0.0013 0.33 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0023 0.0021 0.0014 0.0035 0.0028 0.0019 0.61 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7210~pyrimidine deoxyribonucleotides biosynthesis from CTP 0.22 0.8 1 0.76 1 1 0.38 0.91 1 0.19 0.68 1 0.74 0.95 1 0.32 0.88 1 0.00067 5.5e-05 0 8.8e-06 0 2.3e-05 0 0 0 -Inf 3 / 36 (8.3%) 1 / 7 (14%) 0 / 7 (0%) 0.143 0 0.00018 0 0.00049 0 0 0 -Inf 2 / 11 (18%) 0 / 11 (0%) 0.182 0
PWY-6349~CDP-archaeol biosynthesis 0.6 0.85 1 0.45 1 1 0.87 0.99 1 0.96 0.99 1 0.91 0.99 1 0.44 0.88 1 0.00019 1.6e-05 0 3.7e-05 0 9.8e-05 1.1e-05 0 2.8e-05 -1.8 3 / 36 (8.3%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 2.1e-05 0 6.9e-05 0 0 0 -Inf 1 / 11 (9.1%) 0 / 11 (0%) 0.0909 0
SER-GLYSYN-PWY~superpathway of L-serine and glycine biosynthesis I 0.29 0.82 1 0.69 1 1 0.41 0.91 1 0.22 0.68 1 0.33 0.92 1 0.25 0.86 1 0.0087 0.0087 0.008 0.0073 0.0071 0.0015 0.0081 0.0072 0.0033 0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.01 0.011 0.0076 0.0085 0.009 0.0031 -0.23 11 / 11 (100%) 11 / 11 (100%) 1 1
GLYCINE-SYN2-PWY~glycine biosynthesis II 0.47 0.82 1 0.59 1 1 0.66 0.99 1 0.82 0.93 1 0.12 0.85 1 0.15 0.8 1 0.0022 0.002 0.00089 0.0022 0.0022 0.0016 0.0025 0.0017 0.0022 0.18 33 / 36 (92%) 6 / 7 (86%) 7 / 7 (100%) 0.857 1 0.0017 0.00078 0.0026 0.0019 0.00064 0.0033 0.16 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-7997~demethylmenaquinol-4 biosynthesis 0.55 0.84 1 0.56 1 1 0.91 0.99 1 0.85 0.94 1 0.52 0.92 1 0.9 0.97 1 0.0027 0.0026 0.0015 0.0016 9e-04 0.0012 0.0021 0.0026 0.0017 0.39 34 / 36 (94%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0031 0.00097 0.0052 0.003 0.0034 0.0025 -0.047 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
ASPASN-PWY~superpathway of L-aspartate and L-asparagine biosynthesis 0.12 0.8 1 0.64 1 1 0.45 0.93 1 0.22 0.68 1 0.99 1 1 0.82 0.95 1 0.0029 0.0029 0.0024 0.0035 0.0026 0.0014 0.0032 0.0031 0.0016 -0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0023 0.0027 0.0014 0.0028 0.0017 0.0029 0.28 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6053~dimethylsulfoniopropanoate biosynthesis III (algae) 0.61 0.85 1 0.53 1 1 0.92 0.99 1 0.82 0.93 1 0.86 0.99 1 0.46 0.88 1 5e-04 9.7e-05 0 0.00019 0 0.00049 0.00014 0 0.00036 -0.44 7 / 36 (19%) 2 / 7 (29%) 1 / 7 (14%) 0.286 0.143 4.8e-05 0 9.6e-05 6.3e-05 0 0.00021 0.39 3 / 11 (27%) 1 / 11 (9.1%) 0.273 0.0909
PWY-6507~4-deoxy-L-threo-hex-4-enopyranuronate degradation 0.14 0.8 1 0.071 1 1 0.043 0.76 1 0.3 0.71 1 0.51 0.92 1 0.23 0.82 1 0.001 2e-04 0 0.00048 0 0.00082 0.00018 0 0.00041 -1.4 7 / 36 (19%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 7.7e-05 0 0.00026 0.00015 0 0.00043 0.96 1 / 11 (9.1%) 2 / 11 (18%) 0.0909 0.182
PWY-7228~superpathway of guanosine nucleotides de novo biosynthesis I 0.89 0.95 1 0.44 1 1 0.95 0.99 1 0.98 1 1 0.73 0.95 1 0.2 0.82 1 0.0014 0.0012 0.00084 0.0013 0.0011 0.00094 0.00093 0.001 0.00063 -0.48 32 / 36 (89%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0013 0.00072 0.0013 0.0014 0.00065 0.0019 0.11 11 / 11 (100%) 7 / 11 (64%) 1 0.636
PWY-7194~pyrimidine nucleobases salvage II 0.61 0.85 1 0.6 1 1 0.67 0.99 1 0.48 0.81 1 0.54 0.92 1 0.71 0.91 1 0.0013 0.0011 0.00064 9e-04 0.00057 0.00097 0.00078 0.00085 0.00076 -0.21 31 / 36 (86%) 6 / 7 (86%) 5 / 7 (71%) 0.857 0.714 0.0013 0.00067 0.0018 0.0012 0.00066 0.0013 -0.12 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-5731~atrazine degradation III 0.97 0.99 1 0.65 1 1 0.4 0.91 1 0.82 0.93 1 0.82 0.98 1 0.9 0.97 1 0.00053 0.00022 0 0.00019 0 3e-04 0.00015 0 0.00029 -0.34 15 / 36 (42%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 0.00017 0 0.00025 0.00034 0 0.00059 1 5 / 11 (45%) 4 / 11 (36%) 0.455 0.364
PWY-7791~UMP biosynthesis III 0.23 0.8 1 0.29 1 1 0.92 0.99 1 0.2 0.68 1 0.056 0.85 1 0.32 0.88 1 0.024 0.024 0.024 0.02 0.02 0.0045 0.022 0.022 0.0055 0.14 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.024 0.024 0.0085 0.026 0.025 0.0035 0.12 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6131~glycerol degradation II 0.68 0.88 1 0.057 1 1 0.54 0.99 1 0.61 0.89 1 0.04 0.84 1 0.37 0.88 1 0.0022 0.0022 0.002 0.002 0.0022 0.001 0.0033 0.0032 0.0025 0.72 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0017 0.0013 0.00092 0.0023 0.0022 0.00094 0.44 11 / 11 (100%) 11 / 11 (100%) 1 1
TYRSYN~L-tyrosine biosynthesis I 0.83 0.93 1 0.99 1 1 0.67 0.99 1 0.62 0.89 1 0.8 0.97 1 0.5 0.88 1 0.00088 0.00056 0.00031 0.00075 0.00036 0.00095 7e-04 0.00056 0.00076 -0.1 23 / 36 (64%) 4 / 7 (57%) 4 / 7 (57%) 0.571 0.571 0.00052 0.00025 0.00059 4e-04 0.00018 0.00041 -0.38 8 / 11 (73%) 7 / 11 (64%) 0.727 0.636
PWY-6609~adenine and adenosine salvage III 0.76 0.9 1 0.12 1 1 0.33 0.91 1 0.63 0.89 1 0.096 0.85 1 0.22 0.82 1 0.0032 0.0031 0.0028 0.003 0.0027 0.0019 0.0027 0.0024 0.0021 -0.15 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0034 0.0028 0.002 0.0031 0.0031 0.0013 -0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7227~adenosine deoxyribonucleotides de novo biosynthesis 0.7 0.89 1 0.56 1 1 0.86 0.99 1 0.95 0.98 1 0.85 0.99 1 0.43 0.88 1 0.0017 0.0014 0.00066 0.0016 0.00076 0.0017 0.0011 0.00085 0.0012 -0.54 29 / 36 (81%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0012 0.00065 0.0017 0.0016 0.00016 0.0028 0.42 10 / 11 (91%) 7 / 11 (64%) 0.909 0.636
NAD-BIOSYNTHESIS-II~NAD salvage pathway III (to nicotinamide riboside) 0.47 0.82 1 0.34 1 1 0.66 0.99 1 0.76 0.9 1 0.27 0.9 1 0.78 0.94 1 0.0043 0.004 0.0028 0.0023 0.0014 0.0022 0.0033 0.0039 0.0026 0.52 34 / 36 (94%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0043 0.0022 0.0063 0.0054 0.0045 0.004 0.33 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
ARGININE-SYN4-PWY~L-ornithine biosynthesis II 0.84 0.93 1 0.87 1 1 0.4 0.91 1 0.62 0.89 1 0.89 0.99 1 0.88 0.97 1 0.0011 0.00019 0 8.4e-05 0 0.00022 5.6e-05 0 0.00015 -0.58 6 / 36 (17%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 0.00013 0 0.00034 0.00041 0 0.001 1.7 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
PWY-7639~bis(guanylyl molybdenum cofactor) biosynthesis 0.48 0.82 1 0.53 1 1 0.3 0.91 1 0.95 0.98 1 0.61 0.92 1 0.15 0.8 1 0.0016 0.0016 0.0016 0.002 0.0021 0.00073 0.002 0.0017 0.0014 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0017 0.0015 0.00075 0.0011 0.001 0.00068 -0.63 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5142~acyl-[acyl-carrier protein] thioesterase pathway 0.24 0.8 1 0.92 1 1 0.96 0.99 1 0.4 0.75 1 0.17 0.85 1 0.19 0.81 1 0.0017 0.0016 0.0014 0.001 0.00099 0.00062 0.0016 0.00092 0.0016 0.68 34 / 36 (94%) 7 / 7 (100%) 5 / 7 (71%) 1 0.714 0.0019 0.0019 0.0014 0.0017 0.0015 0.001 -0.16 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-1722~formate assimilation into 510-methylenetetrahydrofolate 0.65 0.88 1 0.48 1 1 0.51 0.99 1 0.29 0.71 1 0.44 0.92 1 0.47 0.88 1 0.016 0.016 0.016 0.015 0.016 0.002 0.015 0.015 0.0029 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.016 0.016 0.0045 0.016 0.016 0.0022 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY3O-4107~NAD salvage pathway V (PNC V cycle) 0.16 0.8 1 0.61 1 1 0.46 0.93 1 0.1 0.68 1 0.28 0.9 1 0.3 0.88 1 0.0023 0.0017 0.00083 0.00068 0.00038 0.00082 0.00087 0.00063 0.001 0.36 27 / 36 (75%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 0.0029 0.0011 0.0065 0.0018 0.00099 0.0021 -0.69 9 / 11 (82%) 9 / 11 (82%) 0.818 0.818
SALVADEHYPOX-PWY~adenosine nucleotides degradation II 0.6 0.85 1 0.42 1 1 0.79 0.99 1 0.69 0.9 1 0.98 1 1 0.59 0.88 1 0.0079 0.0079 0.0076 0.0085 0.0089 0.0021 0.0081 0.0072 0.0041 -0.07 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0079 0.0084 0.0027 0.0074 0.0061 0.0019 -0.094 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5994~palmitate biosynthesis I (animals and fungi) 0.34 0.82 1 0.56 1 1 0.58 0.99 1 0.084 0.68 1 0.2 0.85 1 1 1 1 0.0046 0.0041 0.0033 0.0027 0.0025 0.0026 0.0032 0.0026 0.0035 0.25 32 / 36 (89%) 5 / 7 (71%) 6 / 7 (86%) 0.714 0.857 0.0043 0.0024 0.0062 0.0053 0.004 0.0039 0.3 10 / 11 (91%) 11 / 11 (100%) 0.909 1
CITRULBIO-PWY~L-citrulline biosynthesis 0.35 0.82 1 0.28 1 1 0.089 0.88 1 0.16 0.68 1 0.23 0.88 1 0.14 0.8 1 0.0013 4e-04 0 0.00041 0.00021 0.00058 0.00024 0 0.00045 -0.77 11 / 36 (31%) 4 / 7 (57%) 2 / 7 (29%) 0.571 0.286 0.00025 0 0.00068 0.00066 0 0.0014 1.4 2 / 11 (18%) 3 / 11 (27%) 0.182 0.273
PWY0-1301~melibiose degradation 0.72 0.89 1 0.97 1 1 0.71 0.99 1 0.3 0.71 1 0.31 0.92 1 0.49 0.88 1 0.057 0.057 0.054 0.054 0.053 0.016 0.055 0.045 0.021 0.026 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.058 0.054 0.025 0.06 0.058 0.02 0.049 11 / 11 (100%) 11 / 11 (100%) 1 1
PROUT-PWY~L-proline degradation 0.6 0.85 1 0.45 1 1 0.35 0.91 1 0.56 0.85 1 0.56 0.92 1 0.75 0.93 1 0.0019 0.00073 0 0.00074 0.00028 0.0011 0.00039 0 0.00061 -0.92 14 / 36 (39%) 4 / 7 (57%) 3 / 7 (43%) 0.571 0.429 0.00053 0 0.001 0.0011 0 0.0023 1.1 4 / 11 (36%) 3 / 11 (27%) 0.364 0.273
PWY-6614~tetrahydrofolate biosynthesis 0.92 0.96 1 0.99 1 1 0.19 0.91 1 0.56 0.85 1 0.49 0.92 1 0.32 0.88 1 0.0016 0.0016 0.0013 0.0015 0.0014 0.00099 0.0017 0.0024 0.0012 0.18 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0014 0.0011 0.00081 0.0019 0.0014 0.0011 0.44 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6646~fluoroacetate degradation 0.017 0.8 1 0.52 1 1 0.56 0.99 1 0.0062 0.53 1 0.51 0.92 1 0.54 0.88 1 0.0018 0.0016 0.0012 0.00075 0.00012 0.001 0.0011 4e-04 0.0013 0.55 32 / 36 (89%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 0.002 0.0023 0.0013 0.002 0.0012 0.0019 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6121~5-aminoimidazole ribonucleotide biosynthesis I 0.43 0.82 1 0.95 1 1 0.97 0.99 1 0.25 0.69 1 0.28 0.91 1 0.32 0.88 1 0.023 0.023 0.023 0.022 0.022 0.0026 0.022 0.022 0.0049 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.025 0.024 0.01 0.024 0.024 0.0041 -0.059 11 / 11 (100%) 11 / 11 (100%) 1 1
PANTOSYN-PWY~superpathway of coenzyme A biosynthesis I (bacteria) 0.9 0.96 1 0.51 1 1 0.98 0.99 1 0.56 0.85 1 0.19 0.85 1 0.61 0.89 1 0.004 0.004 0.0042 0.0038 0.0039 0.0012 0.0044 0.0046 0.002 0.21 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0038 0.0042 0.0016 0.0042 0.0043 0.0012 0.14 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1582~glycerol-3-phosphate to fumarate electron transfer 0.018 0.8 1 0.023 1 1 0.0073 0.64 1 0.033 0.68 1 0.037 0.84 1 0.017 0.68 1 0.0012 0.00052 0 0.0011 0.00049 0.0012 0.00071 0 0.0012 -0.63 15 / 36 (42%) 5 / 7 (71%) 3 / 7 (43%) 0.714 0.429 0.00015 0 0.00029 0.00039 0 0.00058 1.4 3 / 11 (27%) 4 / 11 (36%) 0.273 0.364
GLUCONSUPER-PWY~D-gluconate degradation 0.13 0.8 1 0.2 1 1 0.44 0.92 1 0.0091 0.62 1 0.0014 0.38 0.76 0.022 0.68 1 0.0014 0.0011 0.00032 0.00043 5.7e-05 0.00096 0.00064 0.00021 0.00078 0.57 30 / 36 (83%) 4 / 7 (57%) 6 / 7 (86%) 0.571 0.857 0.0017 0.00057 0.004 0.0013 0.00083 0.0014 -0.39 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-5892~menaquinol-12 biosynthesis 0.26 0.8 1 0.67 1 1 0.17 0.91 1 0.18 0.68 1 0.52 0.92 1 0.23 0.82 1 0.0015 0.00074 6.1e-05 0.00078 0.00061 0.00087 8e-04 0.00012 0.0011 0.037 18 / 36 (50%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00041 0 0.00095 0.001 0 0.0018 1.3 4 / 11 (36%) 5 / 11 (45%) 0.364 0.455
ARG%2bPOLYAMINE-SYN~superpathway of arginine and polyamine biosynthesis 0.43 0.82 1 0.039 1 1 0.061 0.88 1 0.52 0.84 1 0.023 0.82 1 0.062 0.8 1 0.0015 0.00075 0.00014 0.00098 0.00099 0.00092 0.00024 0 0.00064 -2 18 / 36 (50%) 5 / 7 (71%) 1 / 7 (14%) 0.714 0.143 0.00066 0.00029 0.00079 0.001 0.00029 0.0015 0.6 6 / 11 (55%) 6 / 11 (55%) 0.545 0.545
PWY0-1264~biotin-carboxyl carrier protein assembly 0.37 0.82 1 0.28 1 1 0.12 0.88 1 0.25 0.69 1 0.088 0.85 1 0.031 0.68 1 0.0087 0.0087 0.0078 0.008 0.0073 0.0027 0.0095 0.008 0.0046 0.25 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0092 0.0088 0.0028 0.008 0.0075 0.002 -0.2 11 / 11 (100%) 11 / 11 (100%) 1 1
GLYCEROLMETAB-PWY~glycerol degradation V 0.37 0.82 1 0.2 1 1 0.86 0.99 1 0.73 0.9 1 0.39 0.92 1 0.88 0.96 1 0.0027 0.0027 0.0023 0.0026 0.0021 0.0015 0.0041 0.0036 0.0035 0.66 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.002 0.0018 0.0011 0.0026 0.0025 0.0011 0.38 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1280~ethylene glycol degradation 0.26 0.8 1 0.21 1 1 0.15 0.9 1 0.11 0.68 1 0.11 0.85 1 0.17 0.8 1 0.001 0.00037 0 0.00041 0.00035 0.00042 0.00029 0 0.00053 -0.5 13 / 36 (36%) 5 / 7 (71%) 2 / 7 (29%) 0.714 0.286 0.00024 0 0.00055 0.00053 0 0.0012 1.1 3 / 11 (27%) 3 / 11 (27%) 0.273 0.273
PWY-3841~folate transformations II 0.91 0.96 1 0.9 1 1 0.64 0.99 1 0.44 0.78 1 0.39 0.92 1 0.74 0.93 1 0.0096 0.0096 0.0094 0.0092 0.0094 0.0012 0.0091 0.0094 0.0019 -0.016 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0098 0.0084 0.0054 0.0099 0.0099 0.0019 0.015 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-4981~L-proline biosynthesis II (from arginine) 0.17 0.8 1 0.44 1 1 0.19 0.91 1 0.21 0.68 1 0.7 0.93 1 0.72 0.91 1 0.00097 8e-05 0 0.00023 0 6e-04 0.00017 0 0.00045 -0.44 3 / 36 (8.3%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 0 0 0 9.4e-06 0 3.1e-05 Inf 0 / 11 (0%) 1 / 11 (9.1%) 0 0.0909
PWY0-1300~2-O-α-mannosyl-D-glycerate degradation 0.93 0.97 1 0.54 1 1 0.87 0.99 1 0.76 0.9 1 0.84 0.99 1 0.54 0.88 1 0.00021 4.6e-05 0 7.2e-05 0 0.00016 2.3e-05 0 4.7e-05 -1.6 8 / 36 (22%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 6.1e-05 0 0.00012 3e-05 0 9.9e-05 -1 3 / 11 (27%) 1 / 11 (9.1%) 0.273 0.0909
PWY-7200~superpathway of pyrimidine deoxyribonucleoside salvage 0.82 0.93 1 0.96 1 1 0.19 0.91 1 0.34 0.71 1 0.79 0.97 1 0.083 0.8 1 0.00044 6.2e-05 0 9.2e-05 0 0.00024 8.5e-05 0 0.00022 -0.11 5 / 36 (14%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 8.9e-05 0 0.00023 0 0 0 -Inf 3 / 11 (27%) 0 / 11 (0%) 0.273 0
ALANINE-SYN2-PWY~L-alanine biosynthesis II 0.023 0.8 1 0.51 1 1 0.66 0.99 1 0.016 0.68 1 0.12 0.85 1 0.36 0.88 1 0.0072 0.0072 0.0064 0.004 0.0046 0.0017 0.0048 0.0039 0.0022 0.26 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0095 0.0076 0.01 0.0086 0.0072 0.0034 -0.14 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7625~phosphatidylinositol biosynthesis II (eukaryotes) 0.41 0.82 1 0.68 1 1 0.74 0.99 1 0.66 0.9 1 0.6 0.92 1 0.87 0.96 1 0.0012 0.00097 5e-04 0.00043 0.00042 0.00029 0.00068 0.00024 9e-04 0.66 30 / 36 (83%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0015 4e-04 0.0034 0.00096 0.00062 0.00098 -0.64 9 / 11 (82%) 9 / 11 (82%) 0.818 0.818
P122-PWY~heterolactic fermentation 0.31 0.82 1 0.43 1 1 0.4 0.91 1 0.18 0.68 1 0.1 0.85 1 0.093 0.8 1 0.003 0.0022 0.001 0.0013 0.00077 0.0016 0.0016 0.00082 0.0018 0.3 26 / 36 (72%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 0.0031 0.0013 0.0063 0.0022 0.0013 0.0023 -0.49 9 / 11 (82%) 8 / 11 (73%) 0.818 0.727
TREDEGLOW-PWY~trehalose degradation I (low osmolarity) 0.87 0.95 1 0.78 1 1 0.69 0.99 1 0.41 0.75 1 0.89 0.99 1 0.65 0.9 1 0.0033 0.0033 0.0023 0.0029 0.0017 0.0025 0.0034 0.0021 0.0031 0.23 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0031 0.0023 0.0033 0.0036 0.0025 0.0024 0.22 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5512~UDP-N-acetyl-D-galactosamine biosynthesis I 0.088 0.8 1 0.22 1 1 0.074 0.88 1 0.045 0.68 1 0.12 0.85 1 0.074 0.8 1 0.00041 1e-04 0 0.00018 3.2e-05 3e-04 0.00016 0 0.00033 -0.17 9 / 36 (25%) 4 / 7 (57%) 2 / 7 (29%) 0.571 0.286 2.1e-05 0 6.9e-05 1e-04 0 0.00033 2.3 1 / 11 (9.1%) 2 / 11 (18%) 0.0909 0.182
PWY-6151~S-adenosyl-L-methionine cycle I 0.14 0.8 1 0.96 1 1 0.85 0.99 1 0.12 0.68 1 0.77 0.97 1 0.83 0.95 1 0.0086 0.0086 0.0082 0.0067 0.0051 0.0031 0.0069 0.0084 0.0035 0.042 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.01 0.008 0.0071 0.009 0.0086 0.0025 -0.15 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5350~thiosulfate disproportionation IV (rhodanese) 0.74 0.89 1 0.59 1 1 0.77 0.99 1 0.56 0.85 1 0.82 0.98 1 0.7 0.91 1 0.0096 0.0096 0.0092 0.01 0.0091 0.0045 0.0097 0.0092 0.0049 -0.044 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0096 0.01 0.0037 0.0092 0.0085 0.0026 -0.061 11 / 11 (100%) 11 / 11 (100%) 1 1
VALSYN-PWY~L-valine biosynthesis 0.67 0.88 1 0.62 1 1 0.74 0.99 1 0.32 0.71 1 0.54 0.92 1 0.51 0.88 1 0.023 0.023 0.023 0.022 0.023 0.0028 0.022 0.021 0.0065 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.024 0.024 0.0086 0.024 0.023 0.0046 0 11 / 11 (100%) 11 / 11 (100%) 1 1
THIOREDOX-PWY~thioredoxin pathway 0.33 0.82 1 0.88 1 1 0.7 0.99 1 0.24 0.69 1 0.3 0.92 1 0.26 0.86 1 0.028 0.028 0.029 0.026 0.023 0.0048 0.027 0.03 0.01 0.054 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.03 0.031 0.01 0.028 0.029 0.005 -0.1 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7842~UDP-yelosamine biosynthesis 1 1 1 0.0033 0.69 1 0.065 0.88 1 0.66 0.9 1 0.00018 0.098 0.098 0.01 0.68 1 0.00057 7.9e-05 0 0 0 0 0.00028 0.00011 0.00039 Inf 5 / 36 (14%) 0 / 7 (0%) 4 / 7 (57%) 0 0.571 0 0 0 7.8e-05 0 0.00026 Inf 0 / 11 (0%) 1 / 11 (9.1%) 0 0.0909
PWY-6698~oxalate degradation V 0.027 0.8 1 0.81 1 1 0.4 0.91 1 0.2 0.68 1 0.91 0.99 1 0.55 0.88 1 0.00076 0.00076 0.00061 0.0011 0.0011 0.00081 0.0011 0.00074 0.00078 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.00049 0.00051 0.00032 0.00063 0.00057 0.00041 0.36 11 / 11 (100%) 11 / 11 (100%) 1 1
ARO-PWY~chorismate biosynthesis I 0.65 0.88 1 0.97 1 1 0.9 0.99 1 0.38 0.74 1 0.59 0.92 1 0.62 0.89 1 0.011 0.011 0.011 0.011 0.0092 0.0025 0.011 0.011 0.0047 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.012 0.012 0.0066 0.011 0.011 0.0027 -0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6143~CMP-pseudaminate biosynthesis 0.032 0.8 1 0.53 1 1 0.83 0.99 1 0.023 0.68 1 0.63 0.92 1 0.67 0.9 1 0.00083 0.00016 0 3e-04 0 0.00043 0.00044 0 7e-04 0.55 7 / 36 (19%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 0 0 0 5.3e-05 0 0.00018 Inf 0 / 11 (0%) 1 / 11 (9.1%) 0 0.0909
ANAGLYCOLYSIS-PWY~glycolysis III (from glucose) 0.69 0.89 1 0.93 1 1 0.65 0.99 1 0.3 0.71 1 0.23 0.88 1 0.57 0.88 1 0.015 0.015 0.015 0.015 0.015 0.0022 0.015 0.017 0.004 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.016 0.016 0.006 0.016 0.015 0.0023 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-381~glycerol and glycerophosphodiester degradation 0.52 0.83 1 0.87 1 1 0.79 0.99 1 0.63 0.89 1 0.78 0.97 1 0.75 0.93 1 0.001 0.00039 0 0.00054 0 0.0011 0.00058 0 0.0011 0.1 14 / 36 (39%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 0.00028 0 0.00049 0.00029 0 0.00051 0.051 3 / 11 (27%) 5 / 11 (45%) 0.273 0.455
GLYSYN-ALA-PWY~glycine biosynthesis III 0.71 0.89 1 0.33 1 1 0.66 0.99 1 0.52 0.84 1 0.33 0.92 1 0.47 0.88 1 0.00067 0.00037 0.00012 0.00043 0.00035 0.00042 0.00025 5.4e-05 0.00037 -0.78 20 / 36 (56%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00049 0 0.00071 3e-04 0.00011 5e-04 -0.71 5 / 11 (45%) 6 / 11 (55%) 0.455 0.545
PWY-6613~tetrahydrofolate salvage from 510-methenyltetrahydrofolate 0.021 0.8 1 0.023 1 1 0.023 0.68 1 0.92 0.98 1 0.39 0.92 1 0.34 0.88 1 0.0094 0.0094 0.0094 0.011 0.011 0.0012 0.0089 0.0092 0.0012 -0.31 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.009 0.0088 0.002 0.0094 0.0097 0.0016 0.063 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6785~hydrogen production VIII 0.61 0.85 1 0.69 1 1 0.8 0.99 1 0.63 0.89 1 0.37 0.92 1 0.3 0.88 1 0.031 0.031 0.031 0.032 0.033 0.0063 0.032 0.036 0.011 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.03 0.031 0.0085 0.03 0.03 0.0075 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6588~pyruvate fermentation to acetone 0.26 0.8 1 0.0038 0.69 1 0.2 0.91 1 0.067 0.68 1 0.0059 0.81 1 0.21 0.82 1 0.0014 0.0011 0.0011 0.00055 0 0.00079 0.002 0.0018 0.0017 1.9 29 / 36 (81%) 3 / 7 (43%) 6 / 7 (86%) 0.429 0.857 0.00079 0.00058 0.00072 0.0014 0.0015 0.00066 0.83 9 / 11 (82%) 11 / 11 (100%) 0.818 1
PWY-6512~hydrogen oxidation III (anaerobic NADP) 0.69 0.89 1 0.58 1 1 0.74 0.99 1 0.91 0.98 1 0.95 1 1 0.33 0.88 1 0.0012 0.00065 8.7e-05 0.00069 0.00048 0.00085 0.00051 0.00061 0.00053 -0.44 19 / 36 (53%) 4 / 7 (57%) 4 / 7 (57%) 0.571 0.571 0.00055 0.00017 0.00099 0.00082 0 0.0017 0.58 7 / 11 (64%) 4 / 11 (36%) 0.636 0.364
PWY-43~putrescine biosynthesis II 0.77 0.9 1 0.56 1 1 0.38 0.91 1 0.77 0.9 1 0.17 0.85 1 0.15 0.8 1 0.0068 0.0068 0.0063 0.007 0.0066 0.0019 0.0077 0.0065 0.003 0.14 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0069 0.0069 0.0031 0.0062 0.0054 0.0022 -0.15 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5965~fatty acid biosynthesis initiation III 0.16 0.8 1 0.41 1 1 0.41 0.91 1 0.1 0.68 1 0.13 0.85 1 0.1 0.8 1 0.0044 0.0043 0.0027 0.002 0.0011 0.0022 0.0027 0.0021 0.0017 0.43 35 / 36 (97%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0062 0.0033 0.011 0.0049 0.0034 0.0046 -0.34 11 / 11 (100%) 10 / 11 (91%) 1 0.909
PROPIONMET-PWY~propanoyl CoA degradation I 0.13 0.8 1 0.11 1 1 0.065 0.88 1 0.042 0.68 1 0.15 0.85 1 0.19 0.81 1 0.0022 0.0011 0.00013 0.0015 0.00071 0.0016 0.00053 0.00026 0.00076 -1.5 18 / 36 (50%) 6 / 7 (86%) 4 / 7 (57%) 0.857 0.571 0.00068 0 0.0017 0.0017 0 0.0035 1.3 4 / 11 (36%) 4 / 11 (36%) 0.364 0.364
PWY-5121~superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP) 0.61 0.85 1 0.79 1 1 0.37 0.91 1 0.37 0.73 1 0.62 0.92 1 0.4 0.88 1 0.0078 0.0078 0.0082 0.0069 0.0076 0.0026 0.0073 0.0084 0.005 0.081 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0076 0.0076 0.0028 0.0089 0.0086 0.0021 0.23 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5278~sulfite oxidation III 0.32 0.82 1 0.73 1 1 0.43 0.92 1 0.32 0.71 1 0.13 0.85 1 0.078 0.8 1 0.012 0.012 0.012 0.011 0.011 0.0032 0.011 0.014 0.0043 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.013 0.015 0.0062 0.012 0.011 0.0039 -0.12 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5436~L-threonine degradation IV 0.41 0.82 1 0.87 1 1 0.94 0.99 1 0.35 0.72 1 0.82 0.99 1 0.81 0.95 1 0.0024 0.0024 0.0015 0.0016 0.0016 0.00095 0.0017 0.0014 0.0016 0.087 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0034 0.0015 0.006 0.0025 0.0017 0.0024 -0.44 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY66-428~L-threonine degradation V 0.98 0.99 1 0.6 1 1 0.74 0.99 1 0.7 0.9 1 0.62 0.92 1 0.88 0.97 1 0.00087 0.00051 7.2e-05 0.00053 7.1e-05 0.00074 0.00042 0 7e-04 -0.34 21 / 36 (58%) 5 / 7 (71%) 3 / 7 (43%) 0.714 0.429 0.00044 0.00019 0.00053 0.00063 0 0.001 0.52 8 / 11 (73%) 5 / 11 (45%) 0.727 0.455
PWY-5703~urea degradation I 0.21 0.8 1 0.65 1 1 0.57 0.99 1 0.13 0.68 1 0.57 0.92 1 0.2 0.82 1 0.0029 0.0023 0.00057 0.00086 0.00022 0.0012 0.0013 0.00054 0.0023 0.6 28 / 36 (78%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 0.0031 0.0011 0.0058 0.0029 0.00057 0.004 -0.096 10 / 11 (91%) 8 / 11 (73%) 0.909 0.727
PWY-7345~superpathway of anaerobic sucrose degradation 0.88 0.95 1 0.46 1 1 0.22 0.91 1 0.86 0.94 1 0.27 0.9 1 0.24 0.84 1 0.0014 0.00035 0 4e-04 0 0.00081 0.00049 0 0.00066 0.29 9 / 36 (25%) 2 / 7 (29%) 3 / 7 (43%) 0.286 0.429 0.00047 0 0.0012 0.00011 0 0.00025 -2.1 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
PWY0-1324~N-acetylneuraminate and N-acetylmannosamine degradation I 0.52 0.83 1 0.31 1 1 0.75 0.99 1 0.8 0.92 1 0.39 0.92 1 0.98 0.99 1 0.00088 0.00042 0 0.00063 0.00043 0.00079 0.00044 0 8e-04 -0.52 17 / 36 (47%) 4 / 7 (57%) 3 / 7 (43%) 0.571 0.429 4e-04 9.4e-05 0.00059 0.00029 0 0.00043 -0.46 6 / 11 (55%) 4 / 11 (36%) 0.545 0.364
PYRIDNUCSAL-PWY~NAD salvage pathway I (PNC VI cycle) 0.21 0.8 1 0.6 1 1 0.4 0.91 1 0.23 0.68 1 0.3 0.92 1 0.22 0.82 1 0.0025 0.0017 8e-04 0.00062 0.00032 0.00075 0.00084 0.00053 0.001 0.44 24 / 36 (67%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 0.0028 0.0011 0.0063 0.0017 0.001 0.0021 -0.72 8 / 11 (73%) 7 / 11 (64%) 0.727 0.636
PWY-2722~trehalose degradation IV 0.32 0.82 1 0.66 1 1 0.14 0.88 1 0.66 0.9 1 0.85 0.99 1 0.28 0.88 1 0.0011 0.00018 0 0.00039 0 0.001 0.00026 0 7e-04 -0.58 6 / 36 (17%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 2.4e-05 0 7.8e-05 0.00016 0 0.00037 2.7 1 / 11 (9.1%) 3 / 11 (27%) 0.0909 0.273
GLUTORN-PWY~L-ornithine biosynthesis I 0.48 0.82 1 0.74 1 1 0.88 0.99 1 0.26 0.69 1 0.42 0.92 1 0.72 0.91 1 0.015 0.015 0.016 0.014 0.014 0.0015 0.015 0.016 0.0055 0.1 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.015 0.016 0.0055 0.016 0.017 0.0023 0.093 11 / 11 (100%) 11 / 11 (100%) 1 1
PEPTIDOGLYCANSYN-PWY~peptidoglycan biosynthesis I (meso-diaminopimelate containing) 0.24 0.8 1 0.7 1 1 0.97 0.99 1 0.16 0.68 1 0.42 0.92 1 0.3 0.88 1 0.018 0.018 0.017 0.017 0.016 0.0028 0.016 0.016 0.0046 -0.087 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.019 0.019 0.0067 0.018 0.019 0.0026 -0.078 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY1-2~L-alanine degradation IV 0.45 0.82 1 0.7 1 1 0.59 0.99 1 0.7 0.9 1 0.7 0.94 1 0.21 0.82 1 0.0013 0.0013 9e-04 0.0014 0.0014 6e-04 0.0017 0.0012 0.0013 0.28 35 / 36 (97%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0011 0.00087 0.00086 0.0013 0.00043 0.0018 0.24 11 / 11 (100%) 10 / 11 (91%) 1 0.909
PWY-7560~methylerythritol phosphate pathway II 0.54 0.84 1 0.59 1 1 0.98 0.99 1 0.32 0.71 1 0.19 0.85 1 0.51 0.88 1 0.0074 0.0074 0.0078 0.0067 0.0078 0.0029 0.0074 0.0088 0.0039 0.14 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0075 0.0072 0.0031 0.0078 0.0079 0.0016 0.057 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5973~cis-vaccenate biosynthesis 0.76 0.9 1 0.85 1 1 0.32 0.91 1 0.89 0.96 1 0.98 1 1 0.31 0.88 1 0.0043 0.0042 0.0039 0.0032 0.0027 0.0018 0.0038 0.0026 0.003 0.25 35 / 36 (97%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.004 0.004 0.0025 0.0053 0.0048 0.0032 0.41 10 / 11 (91%) 11 / 11 (100%) 0.909 1
PWY-7234~inosine-5-phosphate biosynthesis III 0.13 0.8 1 0.79 1 1 0.4 0.91 1 0.081 0.68 1 0.86 0.99 1 0.35 0.88 1 0.0021 0.0019 0.0011 0.00082 0.00094 0.00061 0.0011 0.00091 0.0012 0.42 32 / 36 (89%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.003 0.0011 0.0054 0.0019 0.0011 0.0019 -0.66 11 / 11 (100%) 9 / 11 (82%) 1 0.818
PWY-2942~L-lysine biosynthesis III 0.0022 0.6 1 0.51 1 1 0.25 0.91 1 0.23 0.68 1 0.89 0.99 1 0.73 0.91 1 0.0063 0.0063 0.0058 0.0082 0.0086 0.0018 0.0076 0.0066 0.003 -0.11 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0048 0.0045 0.0015 0.0057 0.0054 0.0028 0.25 11 / 11 (100%) 11 / 11 (100%) 1 1
P283-PWY~hydrogen oxidation I (aerobic) 0.24 0.8 1 0.11 1 1 0.22 0.91 1 0.29 0.7 1 0.15 0.85 1 0.35 0.88 1 0.0014 0.00053 0 0.0012 0.00016 0.0028 0.00075 0 0.0019 -0.68 14 / 36 (39%) 4 / 7 (57%) 3 / 7 (43%) 0.571 0.429 0.00024 0 0.00058 0.00026 0 0.00062 0.12 4 / 11 (36%) 3 / 11 (27%) 0.364 0.273
PWY-7328~superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis 0.21 0.8 1 1 1 1 0.9 0.99 1 0.091 0.68 1 0.72 0.94 1 0.75 0.93 1 0.0052 0.0049 0.0038 0.0034 0.0027 0.0026 0.0034 0.0042 0.0024 0 34 / 36 (94%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0066 0.0035 0.0093 0.0052 0.0052 0.0033 -0.34 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5805~nonaprenyl diphosphate biosynthesis I 0.045 0.8 1 0.13 1 1 0.19 0.91 1 0.12 0.68 1 0.32 0.92 1 0.42 0.88 1 0.00041 8.1e-05 0 0.00024 0 0.00044 7.6e-05 0 0.00013 -1.7 7 / 36 (19%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 2.4e-05 0 7.9e-05 4.2e-05 0 0.00014 0.81 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
PWY-1269~CMP-3-deoxy-D-manno-octulosonate biosynthesis 0.44 0.82 1 0.62 1 1 0.8 0.99 1 0.38 0.73 1 0.67 0.93 1 0.86 0.96 1 0.0013 4e-04 0 0.00038 0 0.00055 0.00057 0 0.00085 0.58 11 / 36 (31%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 0.00021 0 0.00054 0.00048 0 0.00099 1.2 2 / 11 (18%) 3 / 11 (27%) 0.182 0.273
PWY-5941~glycogen degradation II 0.56 0.84 1 0.75 1 1 0.77 0.99 1 0.28 0.7 1 0.46 0.92 1 0.55 0.88 1 0.036 0.036 0.036 0.034 0.032 0.01 0.034 0.034 0.012 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.038 0.04 0.016 0.037 0.038 0.007 -0.038 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6765~hydrogen production IV 0.69 0.89 1 0.58 1 1 0.74 0.99 1 0.91 0.98 1 0.95 1 1 0.33 0.88 1 0.0012 0.00065 8.7e-05 0.00069 0.00048 0.00085 0.00051 0.00061 0.00053 -0.44 19 / 36 (53%) 4 / 7 (57%) 4 / 7 (57%) 0.571 0.571 0.00055 0.00017 0.00099 0.00082 0 0.0017 0.58 7 / 11 (64%) 4 / 11 (36%) 0.636 0.364
PWY-6606~guanosine nucleotides degradation II 0.82 0.93 1 0.28 1 1 0.62 0.99 1 0.99 1 1 0.43 0.92 1 0.67 0.9 1 0.0016 0.00059 0 0.00086 0 0.0014 0.00044 0 0.001 -0.97 13 / 36 (36%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 0.00066 0 0.00097 0.00044 0 0.00071 -0.58 4 / 11 (36%) 4 / 11 (36%) 0.364 0.364
PWY-5535~acetate and ATP formation from acetyl-CoA II 0.26 0.8 1 0.68 1 1 0.55 0.99 1 0.12 0.68 1 0.57 0.92 1 0.092 0.8 1 0.00095 0.00074 0.00034 0.00058 0.00034 0.00071 0.00038 0.00032 0.00043 -0.61 28 / 36 (78%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 0.001 0.00048 0.0011 8e-04 0.00022 0.0013 -0.32 10 / 11 (91%) 9 / 11 (82%) 0.909 0.818
PWY-5704~urea degradation II 0.88 0.95 1 0.92 1 1 0.62 0.99 1 0.74 0.9 1 0.88 0.99 1 0.53 0.88 1 0.004 0.004 0.0038 0.0041 0.0034 0.0014 0.0044 0.0046 0.0024 0.1 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0041 0.0043 0.002 0.0036 0.0028 0.0021 -0.19 11 / 11 (100%) 11 / 11 (100%) 1 1
1CMET2-PWY~N10-formyl-tetrahydrofolate biosynthesis 0.67 0.88 1 0.8 1 1 0.53 0.99 1 0.7 0.9 1 0.78 0.97 1 0.86 0.96 1 0.0052 0.0052 0.0054 0.0052 0.0055 0.00094 0.0052 0.005 0.0026 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.005 0.0049 0.0019 0.0053 0.0055 0.0016 0.084 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6717~(14)-β-D-xylan degradation 0.049 0.8 1 0.95 1 1 0.68 0.99 1 0.016 0.68 1 0.33 0.92 1 0.79 0.94 1 0.025 0.025 0.023 0.016 0.02 0.0089 0.016 0.013 0.0086 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.031 0.025 0.026 0.032 0.031 0.014 0.046 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6890~4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis 0.47 0.82 1 0.16 1 1 0.11 0.88 1 0.71 0.9 1 0.83 0.99 1 0.57 0.88 1 0.012 0.012 0.013 0.013 0.013 0.0039 0.012 0.013 0.0043 -0.12 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.012 0.011 0.0052 0.013 0.012 0.0023 0.12 11 / 11 (100%) 11 / 11 (100%) 1 1
LEUSYN-PWY~L-leucine biosynthesis 0.12 0.8 1 0.35 1 1 0.38 0.91 1 0.13 0.68 1 0.66 0.92 1 0.7 0.91 1 0.02 0.02 0.019 0.018 0.017 0.0021 0.017 0.016 0.0036 -0.082 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.022 0.019 0.0075 0.022 0.02 0.0039 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-1299~arginine dependent acid resistance 0.33 0.82 1 0.19 1 1 0.16 0.91 1 0.74 0.9 1 0.88 0.99 1 0.82 0.95 1 0.025 0.025 0.025 0.027 0.028 0.0045 0.024 0.025 0.0056 -0.17 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.025 0.026 0.0074 0.026 0.024 0.0049 0.057 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5364~sulfur reduction II (via polysulfide) 0.064 0.8 1 0.96 1 1 0.61 0.99 1 0.04 0.68 1 0.99 1 1 0.44 0.88 1 0.0013 0.00077 0.00019 0.00017 0 0.00027 2e-04 0 0.00044 0.23 22 / 36 (61%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 0.0014 0.00056 0.0031 0.00088 0.00057 0.0011 -0.67 9 / 11 (82%) 7 / 11 (64%) 0.818 0.636
TRYPDEG-PWY~L-tryptophan degradation II (via pyruvate) 0.72 0.89 1 0.48 1 1 0.24 0.91 1 0.73 0.9 1 0.37 0.92 1 0.18 0.8 1 0.00018 0.00011 7.8e-05 0.00016 6.4e-05 0.00026 0.00018 0.00013 0.00023 0.17 21 / 36 (58%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 8.4e-05 9.5e-05 7.3e-05 5.1e-05 0 6.8e-05 -0.72 7 / 11 (64%) 5 / 11 (45%) 0.636 0.455
PWY-6466~pyridoxal 5-phosphate biosynthesis II 0.094 0.8 1 0.78 1 1 0.91 0.99 1 0.079 0.68 1 0.58 0.92 1 0.75 0.93 1 0.01 0.01 0.0098 0.0077 0.0075 0.0031 0.0085 0.0075 0.0046 0.14 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.012 0.01 0.007 0.011 0.011 0.0032 -0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5332~sulfur reduction I 0.064 0.8 1 0.96 1 1 0.61 0.99 1 0.04 0.68 1 0.99 1 1 0.44 0.88 1 0.0013 0.00077 0.00019 0.00017 0 0.00027 2e-04 0 0.00044 0.23 22 / 36 (61%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 0.0014 0.00056 0.0031 0.00088 0.00057 0.0011 -0.67 9 / 11 (82%) 7 / 11 (64%) 0.818 0.636
SULFATE-CYS-PWY~superpathway of sulfate assimilation and cysteine biosynthesis 0.33 0.82 1 0.46 1 1 0.62 0.99 1 0.56 0.85 1 0.53 0.92 1 0.52 0.88 1 0.00086 0.00012 0 0.00027 0 0.00065 0.00026 0 0.00069 -0.054 5 / 36 (14%) 2 / 7 (29%) 1 / 7 (14%) 0.286 0.143 5.2e-05 0 0.00012 0 0 0 -Inf 2 / 11 (18%) 0 / 11 (0%) 0.182 0
PWY-7013~(S)-propane-12-diol degradation 0.67 0.88 1 0.35 1 1 0.59 0.99 1 0.85 0.94 1 0.61 0.92 1 0.29 0.88 1 0.0017 0.0016 0.0014 0.0021 0.0021 0.00093 0.0017 0.0013 0.0014 -0.3 34 / 36 (94%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0018 0.0016 0.00066 0.0012 0.0011 0.00099 -0.58 11 / 11 (100%) 9 / 11 (82%) 1 0.818
NONOXIPENT-PWY~pentose phosphate pathway (non-oxidative branch) 0.19 0.8 1 0.95 1 1 0.63 0.99 1 0.17 0.68 1 0.29 0.91 1 0.53 0.88 1 0.017 0.017 0.017 0.015 0.015 0.0029 0.015 0.017 0.005 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.018 0.02 0.0057 0.019 0.019 0.0028 0.078 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5723~Rubisco shunt 0.66 0.88 1 0.92 1 1 0.85 0.99 1 0.67 0.9 1 0.39 0.92 1 0.66 0.9 1 0.011 0.011 0.011 0.011 0.012 0.0025 0.011 0.012 0.0044 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.01 0.011 0.0037 0.011 0.01 0.0021 0.14 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6386~UDP-N-acetylmuramoyl-pentapeptide biosynthesis II (lysine-containing) 0.65 0.88 1 0.74 1 1 0.71 0.99 1 0.31 0.71 1 0.5 0.92 1 0.61 0.89 1 0.015 0.015 0.014 0.014 0.012 0.003 0.014 0.014 0.0049 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.015 0.014 0.0067 0.015 0.014 0.0029 0 11 / 11 (100%) 11 / 11 (100%) 1 1
P125-PWY~superpathway of (RR)-butanediol biosynthesis 0.99 0.99 1 0.9 1 1 0.78 0.99 1 0.76 0.9 1 0.7 0.93 1 0.87 0.96 1 0.00032 3.6e-05 0 1.1e-05 0 2.9e-05 1.8e-05 0 4.8e-05 0.71 4 / 36 (11%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 1.8e-05 0 6.1e-05 8e-05 0 0.00027 2.2 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
PWY-6780~hydrogen production VI 0.015 0.8 1 0.56 1 1 0.7 0.99 1 0.48 0.81 1 0.87 0.99 1 0.23 0.82 1 0.0082 0.0082 0.0072 0.011 0.013 0.0043 0.011 0.011 0.0056 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.007 0.0067 0.0021 0.0058 0.0063 0.0021 -0.27 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7344~UDP-α-D-galactose biosynthesis 0.088 0.8 1 0.26 1 1 0.21 0.91 1 0.091 0.68 1 0.57 0.92 1 0.69 0.91 1 0.034 0.034 0.032 0.03 0.027 0.0046 0.028 0.027 0.0029 -0.1 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.037 0.036 0.012 0.038 0.038 0.007 0.038 11 / 11 (100%) 11 / 11 (100%) 1 1
CYANCAT-PWY~cyanate degradation 0.25 0.8 1 0.52 1 1 0.48 0.97 1 0.086 0.68 1 0.18 0.85 1 0.24 0.84 1 0.0033 0.0033 0.0027 0.0024 0.0025 0.00094 0.0028 0.0024 0.0016 0.22 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0041 0.0027 0.005 0.0035 0.003 0.0022 -0.23 11 / 11 (100%) 11 / 11 (100%) 1 1
HOMOSER-METSYN-PWY~L-methionine biosynthesis I 0.54 0.84 1 0.47 1 1 0.25 0.91 1 0.38 0.73 1 0.38 0.92 1 0.16 0.8 1 0.00064 3e-04 0 0.00022 0 0.00041 0.00036 2e-04 0.00049 0.71 17 / 36 (47%) 3 / 7 (43%) 4 / 7 (57%) 0.429 0.571 0.00035 0.00022 0.00057 0.00026 0 0.00064 -0.43 6 / 11 (55%) 4 / 11 (36%) 0.545 0.364
ACETOACETATE-DEG-PWY~acetoacetate degradation (to acetyl CoA) 0.05 0.8 1 0.00096 0.53 0.53 0.03 0.76 1 0.027 0.68 1 0.0027 0.49 1 0.079 0.8 1 0.00072 0.00058 0.00059 0.00021 0 0.00026 0.001 0.00071 0.00079 2.3 29 / 36 (81%) 3 / 7 (43%) 6 / 7 (86%) 0.429 0.857 0.00052 0.00058 0.00039 0.00059 0.00062 2e-04 0.18 9 / 11 (82%) 11 / 11 (100%) 0.818 1
PWY-6629~superpathway of L-tryptophan biosynthesis 0.26 0.8 1 0.75 1 1 0.35 0.91 1 0.27 0.7 1 0.67 0.93 1 0.15 0.8 1 0.0022 0.002 0.0021 0.002 0.0013 0.0012 0.0027 0.0025 0.0021 0.43 33 / 36 (92%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0016 0.002 0.0011 0.0021 0.0021 0.00048 0.39 9 / 11 (82%) 11 / 11 (100%) 0.818 1
PWY0-1507~biotin biosynthesis from 8-amino-7-oxononanoate I 0.095 0.8 1 0.37 1 1 0.2 0.91 1 0.63 0.89 1 0.51 0.92 1 0.13 0.8 1 0.0028 0.0027 0.0023 0.0034 0.0027 0.0014 0.004 0.0045 0.0014 0.23 35 / 36 (97%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0022 0.0018 0.00097 0.0021 0.0016 0.0017 -0.067 11 / 11 (100%) 10 / 11 (91%) 1 0.909
PPGPPMET-PWY~ppGpp biosynthesis 0.49 0.83 1 0.43 1 1 0.95 0.99 1 0.11 0.68 1 0.16 0.85 1 0.18 0.81 1 0.003 0.0028 0.0016 0.0019 0.0015 0.0016 0.0024 0.00092 0.0022 0.34 34 / 36 (94%) 6 / 7 (86%) 7 / 7 (100%) 0.857 1 0.0026 0.0015 0.0023 0.0039 0.0024 0.0044 0.58 11 / 11 (100%) 10 / 11 (91%) 1 0.909
PWY-7196~superpathway of pyrimidine ribonucleosides salvage 0.8 0.93 1 0.6 1 1 0.18 0.91 1 0.92 0.98 1 0.59 0.92 1 0.31 0.88 1 0.00075 0.00029 0 0.00021 0 0.00033 0.00015 0 0.00026 -0.49 14 / 36 (39%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 0.00018 0 0.00036 0.00055 0 0.0012 1.6 4 / 11 (36%) 5 / 11 (45%) 0.364 0.455
PWY0-1297~superpathway of purine deoxyribonucleosides degradation 0.12 0.8 1 0.32 1 1 0.7 0.99 1 0.11 0.68 1 0.26 0.9 1 0.62 0.89 1 0.003 0.003 0.0024 0.0023 0.0023 3e-04 0.0021 0.0017 0.0016 -0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0038 0.0031 0.0024 0.0034 0.0031 0.0016 -0.16 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY66-422~D-galactose degradation V (Leloir pathway) 0.18 0.8 1 0.85 1 1 0.57 0.99 1 0.14 0.68 1 0.48 0.92 1 0.77 0.93 1 0.023 0.023 0.022 0.02 0.019 0.004 0.02 0.021 0.0057 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.024 0.024 0.01 0.025 0.026 0.0039 0.059 11 / 11 (100%) 11 / 11 (100%) 1 1
ASPARAGINE-BIOSYNTHESIS~L-asparagine biosynthesis I 0.73 0.89 1 0.57 1 1 0.6 0.99 1 0.6 0.88 1 0.58 0.92 1 0.73 0.91 1 0.019 0.019 0.019 0.019 0.018 0.0051 0.018 0.018 0.0041 -0.078 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.019 0.02 0.0098 0.019 0.019 0.0052 0 11 / 11 (100%) 11 / 11 (100%) 1 1
P461-PWY~hexitol fermentation to lactate formate ethanol and acetate 0.96 0.98 1 0.39 1 1 0.57 0.99 1 0.77 0.9 1 0.65 0.92 1 0.53 0.88 1 0.0026 0.002 0.0019 0.0015 0.0011 0.0013 0.0025 0.002 0.0027 0.74 28 / 36 (78%) 5 / 7 (71%) 5 / 7 (71%) 0.714 0.714 0.0014 0.0014 0.0011 0.0027 0.0024 0.0017 0.95 8 / 11 (73%) 10 / 11 (91%) 0.727 0.909
PWY-7966~5-methoxy-6-methylbenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 0.48 0.82 1 0.62 1 1 0.32 0.91 1 0.75 0.9 1 0.7 0.93 1 0.87 0.96 1 0.0049 0.0049 0.0047 0.0051 0.0046 0.00092 0.0049 0.0042 0.0019 -0.058 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0046 0.0048 0.0017 0.0052 0.0051 0.002 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5816~all trans undecaprenyl diphosphate biosynthesis 0.98 0.99 1 0.15 1 1 0.075 0.88 1 0.58 0.87 1 0.17 0.85 1 0.13 0.8 1 0.0012 0.0011 0.00077 0.001 0.00072 0.00083 0.00079 0.00084 0.00085 -0.34 32 / 36 (89%) 6 / 7 (86%) 5 / 7 (71%) 0.857 0.714 0.001 0.00076 0.001 0.0014 0.00098 0.0014 0.49 10 / 11 (91%) 11 / 11 (100%) 0.909 1
PWY-5120~geranylgeranyl diphosphate biosynthesis 0.17 0.8 1 0.56 1 1 0.26 0.91 1 0.036 0.68 1 0.34 0.92 1 0.15 0.8 1 0.0029 0.0029 0.0021 0.0015 9e-04 0.001 0.0013 0.00096 0.0012 -0.21 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0037 0.0021 0.0057 0.0039 0.0034 0.0025 0.076 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5485~pyruvate fermentation to acetate IV 0.69 0.89 1 0.93 1 1 0.93 0.99 1 0.27 0.7 1 0.49 0.92 1 0.54 0.88 1 0.018 0.018 0.018 0.018 0.018 0.0045 0.018 0.018 0.0066 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.019 0.016 0.0076 0.019 0.018 0.004 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6270~isoprene biosynthesis I 0.45 0.82 1 0.44 1 1 0.31 0.91 1 0.25 0.69 1 0.91 0.99 1 0.84 0.96 1 0.014 0.014 0.014 0.013 0.013 0.0022 0.012 0.012 0.0044 -0.12 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.015 0.016 0.0059 0.015 0.015 0.0022 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7343~UDP-α-D-glucose biosynthesis I 0.099 0.8 1 0.87 1 1 0.54 0.99 1 0.047 0.68 1 0.59 0.92 1 0.29 0.88 1 0.0089 0.0089 0.0079 0.0069 0.0068 0.002 0.0067 0.0068 0.0019 -0.042 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.0086 0.0089 0.0092 0.0079 0.0045 -0.26 11 / 11 (100%) 11 / 11 (100%) 1 1
ARGASEDEG-PWY~L-arginine degradation I (arginase pathway) 0.94 0.97 1 0.57 1 1 0.33 0.91 1 0.71 0.9 1 0.5 0.92 1 0.5 0.88 1 0.0014 0.00035 0 0.00017 0 0.00029 9.2e-05 0 0.00022 -0.89 9 / 36 (25%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 0.00031 0 8e-04 0.00067 0 0.0016 1.1 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
PHENOLDEG-PWY~phenol degradation II (anaerobic) 0.7 0.89 1 0.69 1 1 0.5 0.98 1 0.81 0.92 1 0.47 0.92 1 0.57 0.88 1 0.00071 0.00022 0 3e-04 0 8e-04 0.00032 0 8e-04 0.093 11 / 36 (31%) 1 / 7 (14%) 2 / 7 (29%) 0.143 0.286 9.7e-05 0 0.00022 0.00021 3e-05 0.00034 1.1 2 / 11 (18%) 6 / 11 (55%) 0.182 0.545
PWY3O-246~(RR)-butanediol degradation 0.52 0.83 1 0.46 1 1 0.59 0.99 1 0.89 0.96 1 0.84 0.99 1 0.97 0.99 1 0.00014 3.1e-05 0 5.8e-05 0 0.00013 1.7e-05 0 3e-05 -1.8 8 / 36 (22%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 2.7e-05 0 6.8e-05 2.6e-05 0 6.8e-05 -0.054 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
PYRIDNUCSYN-PWY~NAD de novo biosynthesis I (from aspartate) 0.71 0.89 1 0.46 1 1 0.81 0.99 1 0.37 0.73 1 0.15 0.85 1 0.35 0.88 1 0.01 0.01 0.01 0.0096 0.0097 0.0021 0.011 0.012 0.0043 0.2 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.01 0.01 0.003 0.011 0.01 0.0013 0.14 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6963~ammonia assimilation cycle I 0.88 0.95 1 0.58 1 1 0.19 0.91 1 0.45 0.79 1 0.63 0.92 1 0.76 0.93 1 0.034 0.034 0.035 0.032 0.034 0.0055 0.031 0.031 0.0093 -0.046 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.034 0.039 0.013 0.038 0.039 0.01 0.16 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5096~pyruvate fermentation to acetate and alanine 0.07 0.8 1 0.57 1 1 0.46 0.93 1 0.11 0.68 1 0.42 0.92 1 0.45 0.88 1 0.0025 0.0012 0 0.00028 0 0.00061 0.00053 0 0.00078 0.92 17 / 36 (47%) 2 / 7 (29%) 3 / 7 (43%) 0.286 0.429 0.0019 0.00064 0.0023 0.0015 0.00091 0.002 -0.34 6 / 11 (55%) 6 / 11 (55%) 0.545 0.545
ALANINE-VALINESYN-PWY~L-alanine biosynthesis I 0.25 0.8 1 0.6 1 1 0.88 0.99 1 0.26 0.69 1 0.79 0.97 1 0.72 0.91 1 0.00078 0.00019 0 0.00039 0 0.00081 0.00034 0 0.00083 -0.2 9 / 36 (25%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 0.00013 0 0.00034 3.9e-05 0 0.00013 -1.7 2 / 11 (18%) 1 / 11 (9.1%) 0.182 0.0909
PWY-7967~5-methoxybenzimidazolyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP 0.48 0.82 1 0.62 1 1 0.32 0.91 1 0.75 0.9 1 0.7 0.93 1 0.87 0.96 1 0.0049 0.0049 0.0047 0.0051 0.0046 0.00092 0.0049 0.0042 0.0019 -0.058 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0046 0.0048 0.0017 0.0052 0.0051 0.002 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6707~gallate biosynthesis 0.78 0.92 1 0.52 1 1 0.53 0.99 1 0.34 0.71 1 0.6 0.92 1 0.56 0.88 1 0.012 0.012 0.012 0.012 0.012 0.0016 0.011 0.011 0.0032 -0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.012 0.012 0.002 0.012 0.013 0.0022 0 11 / 11 (100%) 11 / 11 (100%) 1 1
P42-PWY~incomplete reductive TCA cycle 0.18 0.8 1 0.69 1 1 0.42 0.91 1 0.051 0.68 1 0.36 0.92 1 0.5 0.88 1 0.0028 0.0013 0 0.0013 0.00096 0.0012 0.0017 0.00036 0.0031 0.39 17 / 36 (47%) 6 / 7 (86%) 4 / 7 (57%) 0.857 0.571 0.00062 0 0.0014 0.0017 0 0.0037 1.5 4 / 11 (36%) 3 / 11 (27%) 0.364 0.273
MENAQUINONESYN-PWY~menaquinol-8 biosynthesis 0.18 0.8 1 0.34 1 1 0.3 0.91 1 0.15 0.68 1 0.77 0.97 1 0.67 0.9 1 0.0057 0.0057 0.0057 0.005 0.0052 0.0016 0.0045 0.004 0.0021 -0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0063 0.0064 0.0019 0.0065 0.0064 0.0018 0.045 11 / 11 (100%) 11 / 11 (100%) 1 1
SERDEG-PWY~L-serine degradation 0.72 0.89 1 0.48 1 1 0.24 0.91 1 0.73 0.9 1 0.37 0.92 1 0.18 0.8 1 0.00018 0.00011 7.8e-05 0.00016 6.4e-05 0.00026 0.00018 0.00013 0.00023 0.17 21 / 36 (58%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 8.4e-05 9.5e-05 7.3e-05 5.1e-05 0 6.8e-05 -0.72 7 / 11 (64%) 5 / 11 (45%) 0.636 0.455
PWY-6751~superpathway of hydrogen production 0.61 0.85 1 0.69 1 1 0.8 0.99 1 0.63 0.89 1 0.37 0.92 1 0.3 0.88 1 0.031 0.031 0.031 0.032 0.033 0.0063 0.032 0.036 0.011 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.03 0.031 0.0085 0.03 0.03 0.0075 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5600~pyruvate fermentation to acetate VII 0.26 0.8 1 0.76 1 1 0.28 0.91 1 0.74 0.9 1 0.37 0.92 1 0.94 0.98 1 0.017 0.017 0.017 0.017 0.018 0.0035 0.017 0.016 0.0046 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.015 0.013 0.0038 0.017 0.018 0.0043 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6517~N-acetylglucosamine degradation II 0.51 0.83 1 0.26 1 1 0.56 0.99 1 0.36 0.73 1 0.29 0.91 1 0.51 0.88 1 0.0016 0.0016 0.0014 0.0012 0.0011 0.00055 0.0018 0.0017 0.0014 0.58 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0015 0.0014 0.00087 0.0017 0.0015 0.0011 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
SALVPURINE2-PWY~xanthine and xanthosine salvage 0.044 0.8 1 0.29 1 1 0.22 0.91 1 0.94 0.98 1 0.97 1 1 0.76 0.93 1 0.0088 0.0088 0.0088 0.01 0.0094 0.0012 0.009 0.0084 0.0026 -0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0081 0.0081 0.002 0.0085 0.0089 0.0018 0.07 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5143~long-chain fatty acid activation 0.5 0.83 1 0.82 1 1 0.29 0.91 1 0.12 0.68 1 0.62 0.92 1 0.57 0.88 1 0.031 0.031 0.024 0.025 0.023 0.0086 0.024 0.023 0.011 -0.059 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.033 0.023 0.034 0.036 0.036 0.018 0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
CYSTSYN-PWY~L-cysteine biosynthesis I 0.53 0.84 1 0.39 1 1 0.95 0.99 1 0.28 0.7 1 0.037 0.84 1 0.25 0.85 1 0.013 0.013 0.013 0.011 0.011 0.003 0.012 0.012 0.0022 0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.013 0.012 0.0044 0.014 0.014 0.0031 0.11 11 / 11 (100%) 11 / 11 (100%) 1 1
COLANSYN-PWY~colanic acid building blocks biosynthesis 0.75 0.9 1 0.67 1 1 0.85 0.99 1 0.74 0.9 1 0.81 0.98 1 0.57 0.88 1 0.0028 0.0023 0.0018 0.0021 0.0019 0.002 0.0031 0.0023 0.003 0.56 29 / 36 (81%) 6 / 7 (86%) 5 / 7 (71%) 0.857 0.714 0.0019 0.0021 0.0015 0.0022 0.0011 0.0028 0.21 8 / 11 (73%) 10 / 11 (91%) 0.727 0.909
P161-PWY~acetylene degradation 0.58 0.85 1 0.55 1 1 0.96 0.99 1 0.53 0.84 1 0.22 0.88 1 0.43 0.88 1 0.003 0.0029 0.002 0.0024 0.0019 0.0019 0.0023 0.0011 0.0023 -0.061 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0039 0.0024 0.006 0.0027 0.002 0.0023 -0.53 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-7675~Kdo transfer to lipid IVA II 0.62 0.86 1 0.22 1 1 0.17 0.91 1 0.68 0.9 1 0.19 0.85 1 0.34 0.88 1 0.00074 0.00019 0 0.00017 0 0.00028 5.1e-05 0 0.00013 -1.7 9 / 36 (25%) 3 / 7 (43%) 1 / 7 (14%) 0.429 0.143 0.00012 0 0.00026 0.00035 0 0.00083 1.5 3 / 11 (27%) 2 / 11 (18%) 0.273 0.182
PWY-5667~CDP-diacylglycerol biosynthesis I 0.21 0.8 1 0.5 1 1 0.42 0.91 1 0.52 0.84 1 0.52 0.92 1 0.72 0.91 1 0.00096 0.00085 0.00076 0.0011 0.001 0.001 0.001 0.00086 0.00093 -0.14 32 / 36 (89%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.00065 0.00048 5e-04 0.00077 0.00071 0.00053 0.24 10 / 11 (91%) 9 / 11 (82%) 0.909 0.818
PWY-6123~inosine-5-phosphate biosynthesis I 0.43 0.82 1 0.95 1 1 0.59 0.99 1 0.23 0.69 1 0.51 0.92 1 0.96 0.99 1 0.0098 0.0098 0.0093 0.0084 0.0084 0.00073 0.0088 0.0096 0.0034 0.067 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.01 0.0092 0.0061 0.011 0.011 0.0028 0.14 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-1861~formaldehyde assimilation II (assimilatory RuMP Cycle) 0.51 0.83 1 0.094 1 1 0.81 0.99 1 0.62 0.89 1 0.13 0.85 1 0.71 0.91 1 0.0029 0.0028 0.0023 0.0027 0.0022 0.0021 0.0041 0.0029 0.0034 0.6 34 / 36 (94%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0019 0.0014 0.0014 0.0028 0.0036 0.0012 0.56 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-I9~L-cysteine biosynthesis VI (from L-methionine) 0.096 0.8 1 0.32 1 1 0.22 0.91 1 0.021 0.68 1 0.0083 0.82 1 0.0097 0.68 1 0.003 0.002 0.00073 0.00079 0 0.0015 0.001 0.00053 0.0014 0.34 24 / 36 (67%) 2 / 7 (29%) 5 / 7 (71%) 0.286 0.714 0.0033 0.00088 0.0068 0.0022 0.0015 0.0026 -0.58 9 / 11 (82%) 8 / 11 (73%) 0.818 0.727
PWY-7645~hyaluronan degradation 0.026 0.8 1 0.18 1 1 0.041 0.76 1 0.085 0.68 1 0.57 0.92 1 0.16 0.8 1 0.00031 6.1e-05 0 0.00017 0 0.00032 0.00011 0 2e-04 -0.63 7 / 36 (19%) 3 / 7 (43%) 2 / 7 (29%) 0.429 0.286 0 0 0 2.4e-05 0 5.3e-05 Inf 0 / 11 (0%) 2 / 11 (18%) 0 0.182
DETOX1-PWY~superoxide radicals degradation 0.092 0.8 1 0.49 1 1 0.38 0.91 1 0.046 0.68 1 0.59 0.92 1 0.55 0.88 1 0.0012 0.00049 0 0.00083 0.00028 0.0012 0.00072 0.00015 0.0012 -0.21 15 / 36 (42%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00025 0 0.00066 0.00036 0 0.00092 0.53 3 / 11 (27%) 3 / 11 (27%) 0.273 0.273
PWY-6952~glycerophosphodiester degradation 0.059 0.8 1 0.23 1 1 0.036 0.76 1 0.057 0.68 1 0.39 0.92 1 0.1 0.8 1 0.0011 0.00052 0 9e-04 0.00035 0.0011 0.00069 0.00013 0.0012 -0.38 17 / 36 (47%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00019 0 0.00037 0.00051 0 0.00075 1.4 3 / 11 (27%) 5 / 11 (45%) 0.273 0.455
THRESYN-PWY~superpathway of L-threonine biosynthesis 0.82 0.93 1 0.65 1 1 0.72 0.99 1 0.36 0.73 1 0.17 0.85 1 0.61 0.89 1 0.017 0.017 0.016 0.016 0.016 0.0037 0.017 0.017 0.0044 0.087 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.017 0.015 0.0082 0.018 0.018 0.0036 0.082 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY66-380~estradiol biosynthesis I (via estrone) 0.012 0.8 1 0.53 1 1 0.17 0.91 1 0.0036 0.53 1 0.13 0.85 1 0.1 0.8 1 0.0016 0.00087 0.00012 7e-05 0 0.00018 0.00015 0 0.00027 1.1 20 / 36 (56%) 1 / 7 (14%) 3 / 7 (43%) 0.143 0.429 0.0018 0.00087 0.0036 0.00084 0.00023 0.001 -1.1 8 / 11 (73%) 8 / 11 (73%) 0.727 0.727
AMMASSIM-PWY~ammonia assimilation cycle III 0.5 0.83 1 0.88 1 1 0.59 0.99 1 0.28 0.7 1 0.28 0.9 1 0.5 0.88 1 0.067 0.067 0.067 0.063 0.062 0.0092 0.063 0.065 0.013 0 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.069 0.072 0.02 0.07 0.066 0.0075 0.021 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-6754~S-methyl-5-thioadenosine degradation I 0.2 0.8 1 0.18 1 1 0.3 0.91 1 0.33 0.71 1 0.083 0.85 1 0.15 0.8 1 0.00065 5.4e-05 0 0.00012 0 0.00031 0.00016 0 0.00027 0.42 3 / 36 (8.3%) 1 / 7 (14%) 2 / 7 (29%) 0.143 0.286 0 0 0 0 0 0 NA 0 / 11 (0%) 0 / 11 (0%) 0 0
PWY-5480~pyruvate fermentation to ethanol I 0.85 0.94 1 0.76 1 1 0.91 0.99 1 0.71 0.9 1 0.71 0.94 1 0.66 0.9 1 0.0037 0.0037 0.0023 0.0033 0.0023 0.003 0.0032 0.0022 0.003 -0.044 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0045 0.0019 0.0072 0.0034 0.0033 0.0025 -0.4 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5004~superpathway of L-citrulline metabolism 0.81 0.93 1 0.88 1 1 0.44 0.92 1 0.62 0.89 1 0.89 0.99 1 0.9 0.97 1 0.0016 0.00027 0 0.00012 0 0.00031 7.9e-05 0 0.00021 -0.6 6 / 36 (17%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 0.00021 0 0.00055 0.00056 0 0.0013 1.4 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182
PWY-7586~β-14-D-mannosyl-N-acetyl-D-glucosamine degradation 0.6 0.85 1 0.44 1 1 0.11 0.88 1 0.59 0.87 1 0.44 0.92 1 0.17 0.8 1 0.0012 0.00019 0 0.00017 0 0.00037 8.4e-05 0 0.00022 -1 6 / 36 (17%) 2 / 7 (29%) 1 / 7 (14%) 0.286 0.143 0.00011 0 0.00037 0.00036 0 0.00082 1.7 1 / 11 (9.1%) 2 / 11 (18%) 0.0909 0.182
PWY-4983~nitric oxide biosynthesis II (mammals) 0.36 0.82 1 0.73 1 1 0.14 0.88 1 0.32 0.71 1 0.73 0.95 1 0.16 0.8 1 0.00053 0.00027 3.9e-05 0.00022 0 0.00029 0.00031 0 0.00045 0.49 18 / 36 (50%) 3 / 7 (43%) 3 / 7 (43%) 0.429 0.429 4e-04 0.00016 0.00053 0.00013 0 0.00019 -1.6 7 / 11 (64%) 5 / 11 (45%) 0.636 0.455
CENTFERM-PWY~pyruvate fermentation to butanoate 0.59 0.85 1 0.76 1 1 0.83 0.99 1 0.34 0.71 1 0.52 0.92 1 0.69 0.91 1 0.00064 0.00039 0.00033 0.00041 0 0.00074 0.00038 0.00032 0.00048 -0.11 22 / 36 (61%) 3 / 7 (43%) 4 / 7 (57%) 0.429 0.571 4e-04 0.00036 0.00038 0.00038 0.00044 0.00035 -0.074 7 / 11 (64%) 8 / 11 (73%) 0.636 0.727
PWY-5509~adenosylcobalamin biosynthesis from adenosylcobinamide-GDP I 0.48 0.82 1 0.62 1 1 0.32 0.91 1 0.75 0.9 1 0.7 0.93 1 0.87 0.96 1 0.0049 0.0049 0.0047 0.0051 0.0046 0.00092 0.0049 0.0042 0.0019 -0.058 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0046 0.0048 0.0017 0.0052 0.0051 0.002 0.18 11 / 11 (100%) 11 / 11 (100%) 1 1
MANNIDEG-PWY~mannitol degradation I 0.98 0.99 1 0.59 1 1 0.36 0.91 1 0.59 0.87 1 0.9 0.99 1 0.38 0.88 1 0.0026 0.0026 0.0023 0.0022 0.0016 0.0012 0.0028 0.0024 0.0026 0.35 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0022 0.0022 0.00094 0.0032 0.0027 0.0016 0.54 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5340~sulfate activation for sulfonation 0.18 0.8 1 0.32 1 1 0.28 0.91 1 0.17 0.68 1 0.027 0.82 1 0.035 0.68 1 0.0082 0.0082 0.0079 0.0068 0.0077 0.003 0.008 0.0082 0.0035 0.23 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0091 0.01 0.0041 0.0083 0.0078 0.0031 -0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5155~β-alanine biosynthesis III 0.51 0.83 1 0.96 1 1 0.44 0.92 1 0.8 0.92 1 0.99 1 1 0.53 0.88 1 0.0031 0.0031 0.003 0.0031 0.0026 0.0012 0.0035 0.0035 0.0023 0.18 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0027 0.003 0.00075 0.0033 0.0032 0.00095 0.29 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5971~palmitate biosynthesis II (bacteria and plants) 0.88 0.95 1 0.93 1 1 0.14 0.88 1 0.56 0.85 1 0.99 1 1 0.23 0.82 1 0.0044 0.0044 0.0032 0.0033 0.0036 0.0025 0.0038 0.0026 0.0039 0.2 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0039 0.0029 0.0043 0.006 0.0042 0.0044 0.62 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-3341~L-proline biosynthesis III 0.23 0.8 1 0.12 1 1 0.053 0.82 1 0.055 0.68 1 0.068 0.85 1 0.058 0.8 1 0.00083 0.00028 0 0.00028 0.00028 0.00026 0.00015 0 0.00026 -0.9 12 / 36 (33%) 5 / 7 (71%) 2 / 7 (29%) 0.714 0.286 0.00019 0 0.00051 0.00044 0 0.001 1.2 2 / 11 (18%) 3 / 11 (27%) 0.182 0.273
PWY-7180~2-deoxy-α-D-ribose 1-phosphate degradation 0.22 0.8 1 0.98 1 1 0.2 0.91 1 0.24 0.69 1 0.88 0.99 1 0.17 0.8 1 0.00064 0.00018 0 0.00012 0 0.00021 0.00012 0 0.00021 0 10 / 36 (28%) 2 / 7 (29%) 2 / 7 (29%) 0.286 0.286 0.00034 0 0.00043 9.1e-05 0 3e-04 -1.9 5 / 11 (45%) 1 / 11 (9.1%) 0.455 0.0909
GLUTAMINEFUM-PWY~L-glutamine degradation II 0.41 0.82 1 0.71 1 1 0.55 0.99 1 0.26 0.69 1 0.33 0.92 1 0.49 0.88 1 0.091 0.091 0.093 0.086 0.085 0.01 0.084 0.085 0.018 -0.034 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.094 0.1 0.026 0.095 0.094 0.011 0.015 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY0-862~(5Z)-dodecenoate biosynthesis I 0.84 0.93 1 0.91 1 1 0.14 0.88 1 0.51 0.83 1 0.97 1 1 0.17 0.8 1 0.0043 0.0043 0.0033 0.0032 0.0032 0.0026 0.0038 0.0026 0.004 0.25 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0038 0.0029 0.0041 0.0059 0.0042 0.0042 0.63 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-4984~urea cycle 0.46 0.82 1 0.57 1 1 0.038 0.76 1 0.65 0.9 1 0.52 0.92 1 0.069 0.8 1 0.002 0.0011 0.00041 0.00099 0.00051 0.0013 0.00092 0 0.0019 -0.11 20 / 36 (56%) 4 / 7 (57%) 3 / 7 (43%) 0.571 0.429 0.00051 0 0.00075 0.0019 0.0024 0.0016 1.9 5 / 11 (45%) 8 / 11 (73%) 0.455 0.727
LCYSDEG-PWY~L-cysteine degradation II 0.72 0.89 1 0.48 1 1 0.24 0.91 1 0.73 0.9 1 0.37 0.92 1 0.18 0.8 1 0.00018 0.00011 7.8e-05 0.00016 6.4e-05 0.00026 0.00018 0.00013 0.00023 0.17 21 / 36 (58%) 4 / 7 (57%) 5 / 7 (71%) 0.571 0.714 8.4e-05 9.5e-05 7.3e-05 5.1e-05 0 6.8e-05 -0.72 7 / 11 (64%) 5 / 11 (45%) 0.636 0.455
PWY-5839~menaquinol-7 biosynthesis 0.26 0.8 1 0.67 1 1 0.17 0.91 1 0.18 0.68 1 0.52 0.92 1 0.23 0.82 1 0.0015 0.00074 6.1e-05 0.00078 0.00061 0.00087 8e-04 0.00012 0.0011 0.037 18 / 36 (50%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00041 0 0.00095 0.001 0 0.0018 1.3 4 / 11 (36%) 5 / 11 (45%) 0.364 0.455
NAGLIPASYN-PWY~lipid IVA biosynthesis 0.29 0.82 1 0.31 1 1 0.013 0.64 1 0.13 0.68 1 0.22 0.88 1 0.021 0.68 1 0.0014 0.00068 0 0.00052 0.00053 0.00045 0.00033 9.7e-05 0.00048 -0.66 17 / 36 (47%) 5 / 7 (71%) 4 / 7 (57%) 0.714 0.571 0.00031 0 0.00066 0.0014 0 0.002 2.2 3 / 11 (27%) 5 / 11 (45%) 0.273 0.455
HEMESYN2-PWY~heme b biosynthesis II (anaerobic) 0.086 0.8 1 0.056 1 1 0.046 0.76 1 0.045 0.68 1 0.42 0.92 1 0.29 0.88 1 0.00051 5.7e-05 0 0.00017 0 0.00043 0.00011 0 3e-04 -0.63 4 / 36 (11%) 2 / 7 (29%) 1 / 7 (14%) 0.286 0.143 0 0 0 4.7e-06 0 1.6e-05 Inf 0 / 11 (0%) 1 / 11 (9.1%) 0 0.0909
PWY-5844~menaquinol-9 biosynthesis 0.18 0.8 1 0.34 1 1 0.3 0.91 1 0.15 0.68 1 0.77 0.97 1 0.67 0.9 1 0.0057 0.0057 0.0057 0.005 0.0052 0.0016 0.0045 0.004 0.0021 -0.15 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0063 0.0064 0.0019 0.0065 0.0064 0.0018 0.045 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5484~glycolysis II (from fructose 6-phosphate) 0.55 0.84 1 0.85 1 1 0.38 0.91 1 0.71 0.9 1 0.12 0.85 1 0.96 0.99 1 0.011 0.011 0.012 0.011 0.011 0.001 0.012 0.013 0.0034 0.13 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.011 0.011 0.0037 0.012 0.012 0.0032 0.13 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5766~L-glutamate degradation X 0.31 0.82 1 0.91 1 1 0.32 0.91 1 0.37 0.73 1 0.48 0.92 1 0.4 0.88 1 0.00096 5e-04 7.6e-05 5e-04 0.00014 0.00064 0.00071 0 0.0012 0.51 19 / 36 (53%) 5 / 7 (71%) 3 / 7 (43%) 0.714 0.429 0.00016 7.2e-05 0.00026 0.00072 0 0.0016 2.2 6 / 11 (55%) 5 / 11 (45%) 0.545 0.455
PWY-6599~guanine and guanosine salvage II 0.27 0.8 1 0.68 1 1 0.94 0.99 1 0.055 0.68 1 0.26 0.9 1 0.5 0.88 1 0.0017 0.0016 0.0014 0.0012 0.0011 0.0011 0.0014 0.0017 0.0011 0.22 34 / 36 (94%) 6 / 7 (86%) 6 / 7 (86%) 0.857 0.857 0.0018 0.0012 0.0019 0.0018 0.0018 0.00096 0 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-841~superpathway of purine nucleotides de novo biosynthesis I 0.31 0.82 1 0.2 1 1 0.039 0.76 1 0.63 0.89 1 0.11 0.85 1 0.066 0.8 1 0.0041 0.004 0.0034 0.0043 0.004 0.0021 0.0037 0.003 0.0031 -0.22 35 / 36 (97%) 7 / 7 (100%) 6 / 7 (86%) 1 0.857 0.0032 0.0024 0.0023 0.0046 0.0035 0.0032 0.52 11 / 11 (100%) 11 / 11 (100%) 1 1
PHESYN~L-phenylalanine biosynthesis I 0.47 0.82 1 0.54 1 1 0.59 0.99 1 0.32 0.71 1 0.36 0.92 1 0.56 0.88 1 0.0046 0.0046 0.0029 0.0032 0.0023 0.0018 0.004 0.0051 0.0022 0.32 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.0057 0.0025 0.0089 0.0047 0.0047 0.0037 -0.28 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5897~superpathway of menaquinol-11 biosynthesis 0.25 0.8 1 0.75 1 1 0.19 0.91 1 0.32 0.71 1 0.87 0.99 1 0.3 0.88 1 0.00069 7.7e-05 0 0.00015 0 0.00039 9.5e-05 0 0.00025 -0.66 4 / 36 (11%) 1 / 7 (14%) 1 / 7 (14%) 0.143 0.143 0 0 0 9.9e-05 0 0.00028 Inf 0 / 11 (0%) 2 / 11 (18%) 0 0.182
PWY-6471~peptidoglycan biosynthesis IV (Enterococcus faecium) 0.016 0.8 1 0.26 1 1 0.068 0.88 1 0.0056 0.53 1 0.024 0.82 1 0.011 0.68 1 0.0056 0.0036 0.00083 0.00066 0 0.0016 0.0015 2e-04 0.0027 1.2 23 / 36 (64%) 2 / 7 (29%) 4 / 7 (57%) 0.286 0.571 0.0066 0.004 0.012 0.0037 0.0031 0.0041 -0.83 9 / 11 (82%) 8 / 11 (73%) 0.818 0.727
PWY-1263~taurine degradation I 6.4e-05 0.035 0.035 0.94 1 1 0.66 0.99 1 5.2e-05 0.028 0.028 0.65 0.92 1 0.55 0.88 1 0.00077 0.00053 0.00022 4e-05 0 7.1e-05 3.9e-05 0 7.8e-05 -0.037 25 / 36 (69%) 2 / 7 (29%) 3 / 7 (43%) 0.286 0.429 0.00091 0.00087 0.00068 0.00079 9e-04 0.00056 -0.2 10 / 11 (91%) 10 / 11 (91%) 0.909 0.909
PWY-5505~L-glutamate and L-glutamine biosynthesis 0.69 0.89 1 0.9 1 1 0.69 0.99 1 0.33 0.71 1 0.19 0.85 1 0.42 0.88 1 0.047 0.047 0.048 0.045 0.046 0.0075 0.046 0.05 0.0093 0.032 36 / 36 (100%) 7 / 7 (100%) 7 / 7 (100%) 1 1 0.048 0.048 0.013 0.049 0.049 0.0046 0.03 11 / 11 (100%) 11 / 11 (100%) 1 1
PWY-5274~sulfide oxidation II (sulfide dehydrogenase) 0.97 0.99 1 0.52 1 1 0.21 0.91 1 0.54 0.84 1 0.89 0.99 1 0.52 0.88 1 9.5e-05 7.9e-06 0 2.3e-06 0 6.1e-06 0 0 0 -Inf 3 / 36 (8.3%) 1 / 7 (14%) 0 / 7 (0%) 0.143 0 3e-06 0 9.9e-06 2.2e-05 0 7.1e-05 2.9 1 / 11 (9.1%) 1 / 11 (9.1%) 0.0909 0.0909
PWY66-423~fructose 26-bisphosphate biosynthesis 0.31 0.82 1 0.7 1 1 0.88 0.99 1 0.28 0.7 1 0.86 0.99 1 0.94 0.98 1 0.0016 0.0013 6e-04 0.00056 0.00031 0.00064 0.00079 0.00052 0.001 0.5 30 / 36 (83%) 6 / 7 (86%) 5 / 7 (71%) 0.857 0.714 0.0019 0.00059 0.0042 0.0015 0.001 0.0018 -0.34 10 / 11 (91%) 9 / 11 (82%) 0.909 0.818
ARG-PRO-PWY~L-arginine degradation VI (arginase 2 pathway) 0.91 0.96 1 0.41 1 1 0.22 0.91 1 0.7 0.9 1 0.27 0.9 1 0.29 0.88 1 0.001 0.00023 0 0.00011 0 0.00016 5.1e-05 0 0.00014 -1.1 8 / 36 (22%) 3 / 7 (43%) 1 / 7 (14%) 0.429 0.143 2e-04 0 0.00057 0.00045 0 0.0011 1.2 2 / 11 (18%) 2 / 11 (18%) 0.182 0.182

Click here to open full-sized image in new window.

Click here to open full-sized image in new window.

Methods:

P lmer study group effect (sqrt): Differentially abundant functions were identified by linear mixed effect regression without confounders. Random effects: Participant (intercept). Fixed effects: Fibre_Intake, Treatment, Fibre_Intake vs Treatment. Effect tested: Fibre_Intake.

P lmer study group effect (clr): Differentially abundant functions were identified by linear mixed effect regression without confounders. Random effects: Participant (intercept). Fixed effects: Fibre_Intake, Treatment, Fibre_Intake vs Treatment. Effect tested: Fibre_Intake.

P lmer time effect (sqrt): Differentially abundant functions were identified by linear mixed effect regression without confounders. Random effects: Participant (intercept). Fixed effects: Fibre_Intake, Treatment, Fibre_Intake vs Treatment. Effect tested: Treatment.

P lmer time effect (clr): Differentially abundant functions were identified by linear mixed effect regression without confounders. Random effects: Participant (intercept). Fixed effects: Fibre_Intake, Treatment, Fibre_Intake vs Treatment. Effect tested: Treatment.

P lmer treatment effect (interaction) (sqrt): Differentially abundant functions were identified by linear mixed effect regression without confounders. Random effects: Participant (intercept). Fixed effects: Fibre_Intake, Treatment, Fibre_Intake vs Treatment. Effect tested: Fibre_Intake vs Treatment.

P lmer treatment effect (interaction) (clr): Differentially abundant functions were identified by linear mixed effect regression without confounders. Random effects: Participant (intercept). Fixed effects: Fibre_Intake, Treatment, Fibre_Intake vs Treatment. Effect tested: Fibre_Intake vs Treatment.

Glossary:

clr: Centered log-ratio transformation. P Welch's ANOVA (sqrt): Welch's ANOVA p-values (Anova was run on sqrt transformed abundances). It is an alternative to the classic ANOVA and can be used even if the samples have unequal variances and/or unequal sample sizes. P Welch's t-test (sqrt): Welch's T-test p-values (run on sqrt transformed abundances). It is an alternative to the classic Student's t-test and is more reliable if the data violates the assumption of homogeneity of variances and/or if the study conditions have unequal sample sizes. P Welch's ANOVA (clr): Welch's ANOVA p-values (Anova was run on clr transformed abundances). It is an alternative to the classic ANOVA and can be used even if the samples have unequal variances and/or unequal sample sizes. P Welch's t-test (clr): Welch's T-test p-values (run on clr transformed abundances). It is an alternative to the classic Student's t-test and is more reliable if the data violates the assumption of homogeneity of variances and/or if the study conditions have unequal sample sizes. P lmer XXX (clr): P-value of Linear Mixed-Effects Regression on clr transformed abundances, testing significance of XXX effect. Varying intercepts per subjects are used to control for repeated measures. Pbonf: Bonferroni corrected p-value. FDR: False Discovery Rate q-value. Mean Pos: Mean abundance in positive samples. Positive samples: The number and percentage of samples in which each function has been detected. Positive XXX: The number and percentage of positive samples in study group XXX. Positive_XXX_percent: Percentage of positive samples in study group XXX. P Welch's t-test (Aldex2): Expected P value of Welch’s t-test computed by Aldex2. FDR Welch's t-test (Aldex2): Expected Benjamini-Hochberg corrected P value for Welch’s t-test. P Wilcoxon rank test (Aldex2): Expected P value of Wilcoxon rank test computed by Aldex2. FDR Wilcoxon rank test (Aldex2): Expected Benjamini-Hochberg corrected P value of Wilcoxon test. P Kruskal-Wallace test (Aldex2): Expected P value of Kruskal-Wallace test. FDR Kruskal-Wallace test (Aldex2): Expected Benjamini-Hochberg corrected P value of Kruskal-Wallace test. P GLM test (Aldex2): Expected P value of generalized linear model. FDR GLM test (Aldex2): Expected Benjamini-Hochberg corrected P value of generalized linear model.

Differentially Abundant Microbial Functions

The following plots present the distribution of the top most differentially abundant microbial functions across all applied statistical analysis. Plots are ordered alphabetically.

Glossary:

"Rel. Abundance": Relative abundance data; "Rel. Abundance (sqrt)": sqrt (Hellinger) transformed relative abundances; "Rel. Abundance (clr)": centered log-ratio (clr) transformed read counts.
ARABCAT PWY L arabinose degradation I

GLUTAMATE DEG1 PWY L glutamate degradation I

GLYCOCAT PWY glycogen degradation I

NAGLIPASYN PWY lipid IVA biosynthesis

P108 PWY pyruvate fermentation to propanoate I

PWY0 823 L arginine degradation III arginine decarboxylase agmatinase pathway

PWY0 1582 glycerol 3 phosphate to fumarate electron transfer

PWY 40 putrescine biosynthesis I

PWY 46 putrescine biosynthesis III

PWY 2941 L lysine biosynthesis II

PWY 5123 trans trans farnesyl diphosphate biosynthesis

PWY 6348 phosphate acquisition

PWY 6471 peptidoglycan biosynthesis IV Enterococcus faecium

PWY 6893 thiamine diphosphate biosynthesis II Bacillus

PWY 6894 thiamine diphosphate biosynthesis I E coli

PWY 7459 kojibiose degradation

PWY 7686 L malate degradation II

PWY 7842 UDP yelosamine biosynthesis

PWY 7858 5Z dodecenoate biosynthesis II

PWY I9 L cysteine biosynthesis VI from L methionine